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Zusammenfassung
In sehr vielen biologischen und medizinischen Prozessen nehmen Enzyme ei-
ne wichtige Schlüsselfunktion ein [1–27], auf die Einfluss genommen werden
kann, wenn die betreffenden Enzyme gesteuert werden können. Dies jedoch
verlangt nach einem genauen Verständnis der enzymatischen Vorgänge, wel-
ches mithilfe der Fluoreszensmikroskopie verbessert werden kann. In dieser
Arbeit werden zwei unterschiedliche Ansätze zur fluoreszenten Enzymologie
für die Carboxypeptidase A und vier verschiedene Nukleasen vorgestellt und
ausgewertet.
Der erste dieser Ansätze nutzt fluoreszierende Enzymsubstrate, die sich die
intrinsischen elektronspendenden Eigenschaften der natürlich vorkommenden
Aminosäure Tryptophan und der Nukleinsäure Guanosin zu Nutze machen
[28–34].
Verschiedene Peptidsubstrate für die Untersuchung der Carboxypeptidase
A, und zwei Gruppen von sogenannten ’smart probes’ für die Untersuchung
der DNaseI, DNaseII, S1-Nuklease und der DNaseX werden vorgestellt, cha-
rakterisiert und im weiteren Verlauf für die Analyse spezifischer Enzymeigen-
schaften angewandt. Schon kleine Unterschiede in Amino- und Nukleinsäu-
resequenzen dieser Substrate führen zu großen Veränderungen der relativen
Quantenausbeuten, des Hitzeverhaltens der Substrate und des Enzymumsat-
zes. Die fluoreszenten Substrate werden genutzt, um den Effekt des ange-
brachten Farbstoffs auf die Akzeptanz und die Umsatzgeschwindigkeit durch
das Enzym zu bestimmen. In dieser Arbeit werden außerdem Untersuchun-
gen zu thermischen Eigenschaften der Carboxypeptidase A, der DNaseI und
der DNaseX anhand einzelner Messungen bei unterschiedlichen Temperatu-
ren und durch eine innovative Methode, die sich lange stetige Phasen in der
Enzymkinetik zu Nutze macht, vorgestellt. Weiterhin wird die Anwendbarkeit
fluoreszenter Substrate für die Ermittlung von Michaelis-Menten Parametern
und für Messungen auf Einzelmolekülebene sowie in lebenden Zellen belegt.
Der zweite vorgestellte Ansatz macht von der Enzym-Immunofärbung Ge-
brauch. Hier wird eine optimierte Färbemethode für die Detektion und Loka-
lisierung eines spezifischen Enzyms in einer Vielzahl nativer Zelllinien ange-
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wandt. Außerdem wird eine modifizierte Nieren-Zelllinie in ihrem spezifischen
Enzym-Expressionsverhalten mithilfe der konfokalen Fluoreszenzmikrosko-
pie, sowie durch die hochauflösende dSTORM Methode untersucht [35].
Die vorgestellten fluoreszenten Methoden unterscheiden sich sehr stark
in ihrem Wesen, ihrer Anwendbarkeit und in ihren möglichen Ergebnissen.
Nichts desto trotz können sie effizient kombiniert werden und somit die Un-
tersuchung einer Vielzahl biologischer und medizinischer Fragestellungen er-
möglichen, was in dieser Arbeit erfolgreich präsentiert wird.
Abstract
Enzymes engage key roles in a wide variety of important physical and medical
processes [1–27], which thus can be altered by manipulating the behavior of
enzymes in charge. The capability for manipulation requires an exact under-
standing of enzymatic operation modes though, which can be increased by
employing fluorescence microscopy. In this work, two approaches for fluores-
cence based enzyme research are presented and evaluated for Carboxypepti-
dase A and four different nucleases.
The first presented approach uses fluorescent enzyme substrates, which take
advantage of intrinsic electron donating properties of the naturally occurring
amino acid tryptophan and the nucleic acid guanosine [28–34].
Several peptide substrates for Carboxypeptidase A and two sets of smart
probes for DNaseI, DNaseII, S1-Nuclease and DNaseX are introduced, char-
acterized and, furthermore, utilized for the investigation of specific enzyme
characteristics. Even small amino and nucleic acid sequence alterations of
these substrates are found to result in strong differences concerning relative
fluorescence quantum yields, thermal substrate behaviors and enzyme proces-
sion velocities. With these fluorescent substrates, the effect of the attached
label on enzyme acceptance and velocities is examined. Furthermore, evalua-
tions of the thermal characteristics of Carboxypeptidase A, DNaseI and DNa-
seX are presented by means of single measurements at various temperatures
and by a novel approach, utilizing long steady state kinetics. Additionally,
the suitability of fluorescent substrates for the determination of Michaelis-
Menten parameters and for enzyme examinations on a single molecule scale
and in living cells is proved.
The presented second approach is established on the method of enzyme
immunolabeling. Here, an optimized labeling method is utilized for the de-
tection and localization of a specific enzyme in a variety of native cell lines.
Furthermore, a modified kidney cell line is examined in its specific enzyme
expression characteristics with confocal fluorescence microscopy as well as
with the high resolution dSTORM method [35].
The demonstrated fluorescent approaches vary distinctly in their nature,
v
suitability and obtainable results. Still, they can be efficiently combined to
diminish any disadvantage and allow research on a wide range of biological
and medical questions, which will first be described in this work.
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1 Introduction
Enzymes are a fundamental principle of life, because they lower required
energy barriers that have to be surpassed in a high percentage of biological
processes. Therefore, enzymes take over key roles in cell functioning and
in genetic engineering. Besides their relevance in these processes, enzymes
have become of great importance in diagnostics and medical treatments, since
many different enzymes have been related to an immense number of even the
severest of diseases - either in respect to their genesis, their causes, their
detection or their treatment methods. In 2007, for example, Sarkar et al.
presented a recombinase1, which excises integrated HIV pro-viral DNA from
the genome of infected cells [1], promising an efficient and precise cure for
the Acquired Immune Deficiency Syndrome (AIDS).
One year later, Hanna et al. described a possibility of controlling Calpain,
an enzyme involved in stroke and heart disease, which could be utilized to
minimize the essentially hazardous sanitary aftermath [2]. Also, there have
been numerous associations with different enzymes to cancer, e.g. the Wild-
type p53-Induced Phosphatase 1 (WIP1) [27], the Anti-Plasmin Cleaving
Enzyme (APCE) [26], the triboleum castaneum telomerase catalytic subunit
(TERT) [25] and various types of nucleases [3–24].
When a native enzyme is first associated with a certain disease, usually, its
precise function and its outcome are completely vague. In some cases even the
question arises, whether the enzyme only developed upon the occurrence of
the disease and whether the enzyme caused it, or was caused by it. Also, the
temporal enzyme concentration can be linked to, or even evoke the process
of the disease.
Amongst the nuclease associations to cancer, a lot of them describe variant
nuclease levels in miscellaneous compartments of the human organism [4, 5,
8–10,14–16,18,19,22]. A favorite candidate for these correlations is DNaseI,
a 31 kDa globular hydrolase, depicted in figure 1.1.
1This artificial recombinase is called ’Tre’ recombinase in respect to its natural ancestor
’Cre’ recombinase.
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Figure 1.1: Crystal structure of DNaseI,
determined by X-ray diffraction with a res-
olution of 1.6Å [36].
In 1996, Coy et al. detected the enzyme DNaseX, named after its localiza-
tion on the human X-chromosome. This nuclease was found to have a high
homology to DNaseI in respect to their nucleotide and amino acid levels, as
well as their exon-intron boundaries. Therefore, it was suggested, that both
enzymes are derived from a common ancestor and execute similar functions
in the human body [37].
In 2000, Los et al. suggested, that DNaseX may be involved in apoptosis
[38], which was further examined by Shiokawa et al. in 2001 [39], who found
DNaseX transcripts in various types of healthy tissue. One year later, J.F.
Coy and his colleague A. Poustka finally had enough evidence to claim a
connection of DNaseX to early stages of cancer in their European Patent
Application [40]. Despite intensive research by Shiokawa and others [41–44],
this role has not been fully identified nor understood. Furthermore, early
publications connecting DNaseI levels with cancer, might have actually also
monitored DNaseX when examining DNaseI levels, regarding the fact that
detection methods have advanced immensely only in the past few years.
Summing up, there is a high potential for the utilization of DNaseX in the
detection, classification and maybe even the treatment of cancer. To reach
that, though, many questions need to be answered: How does DNaseX occur-
rence correlate with cancer stages? Is DNaseX occurrence cancer-induced?
Does DNaseX represent an autogenetic defense mechanism against cancer,
or is it actually a cancer inherent instrument in its fight against the immune
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system? Which specific function does DNaseX have?
The search for answers to these questions and associations and their utiliza-
tion, can only be accomplished with confident techniques for sensitive proof of
presence and distinct activity determinations of the specific enzymes. Among
the high number of investigation techniques, that are commonly applied in
enzyme research, fluorescence microscopy is least invasive to enzymes but
limited by appropriate fluorescent probes. In the ideal case, the molecular
system signals selective recognition or binding events by a change or accumu-
lation of fluorescence intensity, that can be conveniently transmitted into an
electronic signal by the appropriate detector, with an efficiency of up to 80%.
Another advantage of fluorescence microscopy for enzyme research relies on
the fact, that many structural factors of fluorescent dyes and their intra- and
intermolecular interactions, which finally control their fluorescence efficiencies
are well understood.
Commercially available fluorescent substrates are usually not specific for a
certain enzyme. Furthermore, they mostly consist of unpublished structures
and are labeled with fluorophores in the green spectral range.
Custom made fluorescent samples, on the other hand, commonly consists
of the enzyme’s specific substrate, flanked by two fluorophores, showing fluo-
rescence resonance energy transfer (FRET) at short distances between donor
and acceptor. These substrates can be adapted to any desired spectral range
and, therefore, mostly contain red-absorbing fluorophores [45–47], due to the
low autofluorescence intensities at these wavelengths [48,49].
However, FRET based substrates comprise several disadvantages due to
their structure. First, a labeling of the natural substrate with two different
fluorophores implies the need for two specific coupling reactions, which is
rather complicated and expensive. Additionally, two chemical modifications
on a natural substrate can generally hamper the affinity between substrate
and enzyme, which can, therefore, diminish the experimental sensitivity. Fur-
thermore, those substrates, that were improperly labeled with only one part-
ner of the FRET pair, can seriously increase the background signal.
These problems can be reduced by the incorporation of only one appro-
priate fluorophore in combination with naturally occurring compounds of
the specific enzyme substrate. At close vicinity, fluorophores like the ox-
azine derivatives MR121 and Atto 655 show Photoinduced Electron Transfer
(PET) with the naturally occurring amino acid tryptophan and the nucleotide
3
1 Introduction
guanosine. If the quenching interactions between the fluorophore and trypto-
phan or guanosine diminish by specific target interactions, for example due to
the cleavage of the connecting peptide or nucleotide by a hydrolytic enzyme,
the fluorescence of the sensor is restored [30–33,44,50–56].
This method can elaborately be utilized for the development of a specific
DNaseX substrate. A nucleotide sequence can be designed to form a DNA
hairpin that comprises the preferred substrate sequence which is recognized
by the enzyme in the double stranded or single stranded region of the hair-
pin. The attachment of an appropriate fluorophore onto the 5’-end and the
incorporation of several guanosine residues at the 3’-end of the nucleotide se-
quence will result in efficient PET quenching, as long as the hairpin structure
is intact.
Figure 1.2: Examples of fluorescent hairpin sub-
strates, initially quenched by photoinduced electron
transfer to guanosine residues. Upon single stranded
and double stranded scission, the hairpin structure is
destroyed and fluorescence fully restored.
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To date it is not known, whether DNaseX prefers double stranded (ds)
or single stranded (ss) regions, nor whether there is a specific nucleotide se-
quence. Therefore, the hairpins have to be designed carefully, to function at a
wide range of cleavage site possibilities. Once the DNaseX processes the hair-
pin at any position, the spatial contact between fluorophore and quenchers
is supposed to get lost, restoring the full fluorescence intensity of the sensor
(cf. figure 1.2).
Since tryptophan is an efficient photoinduced electron transfer quencher,
the method can also be applied in peptides and therefore for peptidase re-
search.
As a model, the very well studied Carboxypeptidase A (CPA) will be ap-
plied. This rather small and globular enzyme is part of the digestive system
and secreted by the pancreas [57]. Carboxypeptidase A has not been directly
related to any disease, it can be utilized, though, in the detection of other
enzymes, connected to specific affections.
In 2004, Marme et al. demonstrated the principle by means of the HIV-1
protease2 [31, 52], which is essential for the HI virus and only occurs upon
HIV infection [58,59]. This enzyme is an endoprotease, recognizing substrates
with a minimum length of seven amino acids residues [60, 61], with a high
preferences for phenylalanine and tyrosine [62], but no specific cleaving posi-
tion within this heptapeptide [63]. Therefore, the design of a PET quenched
peptide probe, that immediately starts fluorescing upon HIV-1 protease scis-
sion is not conveniently possible, since either, the substrate would not be
sufficiently quenched initially, or there would be a high risk that tryptophan
residues stay in close vicinity to the fluorophore.
The elaborate solution to this, presented by Marme et al., is the incorpora-
tion of consecutive tryptophans at close distance to the fluorophore and the
attachment of three prolines to the C-terminus of the peptide substrate. The
substrate cannot be processed solely by Carboxypeptidase A, since this en-
zyme is only capable of cleaving mono-, di- and tripeptides, beginning from
the C-terminus [64–68], but shows no action on proline [65]. If the HIV-
1 Protease is present alongside with Carboxypeptidase A, though, first the
substrate can be degraded by HIV-1 protease, and is then consecutively pro-
cessed by Carboxypeptidase A, until all tryptophans have been removed from
the fluorophore and the HIV-sensor is fully fluorescent.
2HIV-1 protease is also named HIV-1 retropepsin.
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Fluorescence based enzyme detection methods show an extraordinary sen-
sitivity with the capability of revealing minute amounts of enzymes, when
these PET sensors are carefully designed, as sketched in figure 1.3.
Figure 1.3: Exemplary fluorescently la-
beled peptide substrates, quenched effi-
ciently by photoinduced electron transfer
to tryptophan.
In this work the general validity of enzyme analysis with different PET
based substrates will be shown for Carboxypeptidase A as a representative
for proteases in general and for DNaseX, to demonstrate the experimental
range, that PET sensors provide for a mostly unknown enzyme. Because of
the stated DNaseX similarity to DNaseI, this nuclease will also be examined
with the very same substrates. Furthermore, DNaseII and S1-Nuclease, both
foreign to the DNaseI family, will be utilized to characterize the similarities
of DNaseX and DNaseI.
As a prerequisite for their utilization in the presence of enzymes, all sub-
strates will first be characterized, together with a FRET based DNA hairpin
and a commercially available substrate of unknown structure. In section 4.1.1,
information about the spectral and thermal characteristics, as well as the rel-
ative fluorescence quantum yields in the initial states will be given for all
tested enzyme substrates. In section 4.1.2, the temporal fluorescence inten-
sity profiles of these substrates in presence of their corresponding enzymes will
be presented and discussed, before Michaelis-Menten kinetics will be focused
on with one combinational example in section 4.1.3.
When dealing with a chemically modified natural enzyme substrate, of
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course the question about modification effects to enzyme acceptance has to
be addressed. This will be done for Carboxypeptidase A and its best suited
PET substrate MR121 -Gly -Trp, as well as for DNaseI and its evolutionary
most important PET sensor SP2 in section 4.1.4.
In section 4.1.5, different ways for the examination of ideal measurement
settings will be presented in respect to Carboxypeptidase A, DNaseI and
DNaseX with their appropriate PET substrates. Next to a common way of
testing their optimum working temperature, a novel approach, taking advan-
tage of the easy to monitor steady state fluorescence based kinetics, will be
introduced. Furthermore, the presented PET sensors will be proven to be
generally suitable for single molecule measurements in section 4.1.6 and in
heterogeneous samples like living cells in section 4.1.7.
In this last section it will be seen, though, that PET sensors also bare dis-
advantages. These drawbacks can be solved with another fluorescence based
enzymology approach, which will be presented in the second part of this work.
Since there are a lot of enzymes that are able to process one and the same
specific substrate, it is not possible, to account a certain enzymatic reaction
to the enzyme of interest in a complex environment. Clinical tests for specific
enzymes, nonetheless, need to take place in blood, sera, tissue or any other
kind of heterogeneous sample. For this, the method of immunostaining has
proven to yield fantastic results [69]. Specific antibodies recognize their target
antigen even in highly divers samples. Additionally, these antigens are not
unspecifically bound by foreign antibodies3.
The best known fluorescence based immunohistochemical method is the
Enzyme-Linked Immunosorbent Assay (ELISA), which has been simultane-
ously developed by two research groups in 1971 [70–72]. To date, several
ELISA versions have emerged. The Sandwich-ELISA, that has first been de-
scribed in 1976 [73], captures antigens by surface bound specific antibodies.
These antigens are then again bound by a specific primary antibody. An
enzyme-linked secondary antibody binds the primary antibody, before a sub-
strate is added to the sample, which is converted by the added enzyme to a
fluorimetric form. Since the antigen signal is strongly amplified by this en-
zyme, ELISAs are sensitive enough to detect antigen concentrations of down
3Indeed, there are cases, where antibodies bind wrong antigens, which is the case in any
auto-immune deficiency.
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to 10-13M [74].
Despite, ELISAs also have a high risk of false positive signals4. Further-
more, the only task that can be accomplished with this method, is to find
out about the existence of antigens in the examined sample. However, for
enzyme research, it is not only of interest, whether the antigen is present in
in native environments, but also where and how. Therefore, the sandwich
ELISA method has to be adapted to native samples. Imagining the enzyme
of interest to be solidly bound, may it be by membrane attachment or by
the fixation of tissue, allows an attachment of a specific primary antibody,
followed by a labeled secondary antibody as depicted in figure 1.4.
Figure 1.4: Indirect immunolabeling scheme. The
enzymes (black pentagons) are solidly bound to
a cell membrane. An attached specific primary
antibody is indirectly labeled with a fluorophore
tagged secondary antibody.
If specific antibody is available, also enzyme research is possible with this
immunostaining method, as will be seen in this work. Furthermore, counter-
staining procedures can be applied to localize cell membranes and nuclei.
Once a sample is labeled, it can easily be excited at different wavelengths
with fluorescence microscopy methods. The most convenient for this research
task, though, is the confocal fluorescence microscopy, showing a low back-
ground intensity due to detection volume limiting pinholes. Since the focus
position can be varied not only axially, but also laterally, a three dimensional
image of a sample can be obtained.
4One should bear the standard procedure of accomplishing a Western Blot test in any
common positive HIV test in mind.
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Since confocal microscopes allow an axial resolution determination of a few
µm, the localization of labeled enzymes is easily possible, as can be seen in
figure 1.5.
Within the last few years, several high resolution fluorescence methods have
evolved, among them Stimulated Emission Depletion (STED) Microscopy
[75], based on a confocal microscope, and the Stochastic Optical Recon-
struction Microscopy (STORM) [76], based on a Total Internal Reflection
Fluorescence (TIRF) Microscope. This method was further modified to di-
rect STORM (dSTORM) [35] using standard organic fluorophores, allowing
a lateral resolution of down to 20 nm and, therefore, being able to reveal
structures that cannot be obtained with a diffraction limited microscope.
In this work, both, the diffraction limited confocal microscope, as wells as
the high resolution dSTORM method was applied for the immunolabeling
based detection of DNaseX in native cells in section 4.2.2, after examination
of the labeling technique in section 4.2.1.
As a model system, a cell line with a DNaseX over-expression, was ex-
amined on a confocal microscope in section 4.2.3 as well as with the high
resolution technique in section 4.2.4 for their occurrence and assembly.
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Figure 1.5: Exemplary immunolabeling of HEK 293T cells. The nu-
cleus is labeled with a DNA intercalator and depicted in cyan, the hardly
visible cytoskeleton, depicted in grey, is labeled via phalloidin while the
red signal results from indirect immunolabeling of membrane bound pro-
teins. The image shows a maximum intensity projection of 50 different
cell layers with a distance of 0.3µm and a dimension of 65 µmx40 µm.
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This interdisciplinary work naturally utilizes many fundamentals. The fol-
lowing introduction to theoretical backgrounds covers the principles of flu-
orescence, the corresponding spectroscopy and the microscopic methods, as
well as a biological introduction to enzymes. In the end of this chapter,
the possibilities and hazards of fluorescence based enzyme research will be
presented.
2.1 Principles of Fluorescence
An electron in the energetically lowest possible state of a molecule, the ground
state, can be elevated to a higher excited state by the absorption of a photon.
The absorption of light can be measured using the Lambert-Beer law:
(2.1) I = I0 · eε·C·d,
where I0 is the initial and I the transmitted light intensity, C the sample
concentration, d the light path length in the sample and ε the specimens
specific absorption coefficient for the applied wavelength.
The complete excitation energy of a molecule does not only consist of the
electron excitation but, furthermore, also of rotational and vibrational exci-
tations, which results in the familiar band spectra for molecules instead of
the discrete spectra known from single atoms. Rotational energy transitions
take place in the far infrared to microwave range and, therefore, usually do
not display in electronic energy transition illustrations like the Jablonski di-
agram in figure 2.1. Vibrational energy transitions, though, take place in the
infrared and, therefore, strongly account to the familiar continuous spectra.
When a molecule absorbs a photon of the energy
(2.2) E = h · ν,
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with the Planck constant h and the frequency ν, an electron is most often
not only lifted to the lowest possible energy state, but to a higher excited
vibrational state of the 1st (S1) or nth (Sn) excited electronic state, dependent
on the available photon energy and the energy gaps in the concerned molecule.
This light absorption process (Abs) happens in the range of femtoseconds.
Due to overlaps of the different vibrational states, the electron relaxes to the
lowest excited energy state with the radiation free release of the energy E−
in a timescale of picoseconds. This is known as internal conversion (IC) and
is a prerequisite for the Kasha rule, which says, that a molecule in condensed
phase can only emit out of the lowest excited electronic energy state.
Figure 2.1: Jablonski diagram, describing the possible electronic
transitions of a molecule: absorption (Abs), inner conversion (IC),
fluorescence emission (Fl), intersystem crossing (ISC) and phospho-
rescence (Ph).
The emission from this lowest excited singlet state (S1) to the ground state
(S0) occurs within nanoseconds under emission of radiation, called Fluores-
cence (Fl). The emitted photon carries the energy E∗, with
(2.3) E − E− = E∗.
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Therefore, the maintained energy is composed of
(2.4) E∗ = h · ν∗,
with
(2.5) ν∗ ≤ ν.
Thus, the emitted light most often has a shorter wavelength than the ab-
sorbed light, which is called the Stokes Shift. For the absorption as well as
the emission of photons, the Franck-Condon Principle applies, which gives
information on probabilities for certain transitions. Since electron transi-
tions are fast in comparison to nucleic movements, the position of nuclear
coordinates does not change in an electronic transition (Born -Oppenheimer
approximation). Therefore, these transitions are plotted vertically in the
Franck-Condon diagram, depicted in figure 2.2 [77].
The graph shows, that transitions are most likely to occur if the two vi-
brational wave functions overlap significantly. These varying transition prob-
abilities result in an inhomogeneous distribution of photonic energies, that
are absorbed and emitted, as can be seen in figure 2.3. Furthermore, the
Franck-Condon principle yields a reflection of each resulting absorption peak
in the emission spectrum, theoretically resulting in the complete mirroring of
absorption and emission spectra.
In the described energetic cycle, each absorbed photon finally results in the
emission of fluorescence. Therefore, the quantum yield, defined as ratio of
emitted to absorbed quanta, equals 1. Practically, this is a vary rare occasion,
though, because there are a number of radiation free competitive processes.
Figure 2.1 shows a transition from an excited electronic singlet state to
an energetically lower triplet state, named intersystem crossing (ISC). This
transition implies the need of a change in spin orientation, which is quantum
mechanically forbidden. Once the electron is in the triplet state, it can relax
to the ground state under emission of radiation by another spin transition,
called phosphorescence (Ph). Since this, again, is not allowed, the lifetime of
this state is comparably long. Furthermore, the electron in the first triplet
state can also be excited to higher triplet states and back to the nth singlet
13
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Figure 2.2: Franck-Condon diagram. Possible transitions between elec-
tronic states of a molecule most often occur between overlaps of vi-
brational wave functions. Transitions happen too fast for the nuclear
distance r to change.
Figure 2.3: Probabilities of electronic transitions in absorption and
emission processes (cf. figure 2.2). Excitation and emission probabilities
are mirrored, as well as the resulting spectra.
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state, undergoing inner conversion again. If the electron then relaxes to the
ground state, the process is called delayed fluorescence [49,78].
Apart from intersystem crossing, the emission of a fluorescence photon can
also be prevented by quenching mechanisms, which will be introduced in
section 2.2.2.
2.2 Fluorescence Spectroscopy
Every single molecule has its own specific composition of electronic and vi-
brational states. This results in the fact, that each molecule has its specific
absorption and emission spectra, which are not necessarily in the visible range
of electromagnetic radiation. Additionally, the probability for competitive
processes greatly depends on the molecular electronic states, which effects
the specific quantum yields.
2.2.1 Fluorophores
Molecules with an emission spectrum in the visible range and a high quantum
yield are generally called fluorophores. There are natural fluorophores like
the Green Fluorescent Protein (GFP) [79,80], which is shown in figure 2.4.
Figure 2.4: Stereo view of the green fluores-
cent protein ’GFP’ [79].
This very popular fluorophore has a quantum yield of 0.72 [81] and was found
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in the jellyfish Aequorea victoria, where it is excited by another chromophore
(aequorin) via FRET (see section 2.2.2) [82].
Fluorescent proteins generally have the great advantage to be applicable
for the fusion with other proteins, allowing a specific intrinsic labeling of
a protein of interest by the examined organism itself. Still, these natural
fluorophores generally have disadvantages in their size, quantum yields and
photostability.
a) absorption and emission spectra b) chemical structure
Figure 2.5: Spectra and chemical structure of the artificial fluorophore MR121.
Therefore, a high number of artificial fluorophores have been designed.
Figure 2.5 shows the chemical structure and the spectra of one of these fluo-
rophores, named MR121. As can be clearly seen, there is a stokes shift (see
section 2.1) of 19 nm between absorption and emission maxima.
2.2.2 Fluorescence Quenching
There is a variety of processes that diminish fluorescence intensities, which
is called quenching. Fluorescence decrease upon collisional quenching, that
occurs, when an excited fluorophore is hit by another molecule in the solution,
is mathematically described with the Stern-Volmer equation:
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(2.6) F0
F
= 1 +K · [Q] = 1 + kq · τ0 · [Q],
with F0 and F are the initial and the remaining fluorescence intensity, K
the Stern-Volmer quenching constant, [Q] the quencher concentration, kq
the bimolecular quenching constant and τ0 the unquenched lifetime of the
fluorophore.
The most famous collisional quencher is molecular oxygen [83], which is the
reason for its removal from surrounding buffer in certain measurements (cf.
section 2.3.2).
Aside from this dynamic collisional quenching, fluorophores and quenchers
can build non fluorescent complexes, which is then entitled static quenching.
The fluorescence yield upon static quenching can be described by
(2.7) F0
F
= 1 +KS · [Q],
with the association constant KS . This constant can be expressed by the
given concentrations of the uncomplexed fluorophore F , the quencher Q and
the total fluorophore concentration F0.
(2.8) KS =
[F0]
[F ] · [Q] −
1
[Q] .
A way to distinguish between dynamic and static quenching is to examine the
absorption spectra of the quenched samples in contrast to unquenched fluo-
rophore: While dynamic quenching only affects fluorophores in the excited
state, static quenching interferes with the excitation, resulting in a change of
absorption intensities. Fluorophores can be quenched dynamically and stat-
ically by the same quencher, though. This can be determined by nonlinear
behavior in a Stern-Volmer plot, where the fraction of quenched fluorophore
is plotted against the quencher concentration.
In general, quenching processes are strongly distance dependent, as can be
expressed by the formula
(2.9) kE(r) = A · e−β·(r−rc),
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with kE(r) the quenching rate at a distance r between fluorophore and
quencher, rc the closest distance at molecular contact and A and β constants
of 1013s−1 and 1Å−1.
The mechanisms, that explain quenching processes are various. There are
intersystem crossing (or heavy atom effect), electron exchange (or dexter
interactions) and photoinduced electron transfer (PET), of which only the
latter is relevant in this work.
In PET, fluorophore and quencher form a complex, that shows two electron
exchange processes in two different trails.
Figure 2.6: Photoinduced electron transfer between fluo-
rophore and quencher. Here, the fluorophore acts as elec-
tron acceptor while the quencher donates an electron.
Either, the fluorophore is the electron donor and the quencher accepts the
electron, or the fluorophore acts as electron acceptor, while the quencher is
the electron donor, as depicted in figure 2.6. Here, the fluorophore is excited
by a photon, which results in the elevation of an electron from the highest oc-
cupied molecular orbital (HOMO) to the lowest unoccupied molecular orbital
(LUMO). Then, an electron from the quenchers highest occupied molecular
orbital migrates to the single occupied molecular orbital. The electron in the
fluorophores excited state, therefore, cannot relax to its parental state any-
more, since this is already occupied. Because the quenchers single occupied
molecular orbital is energetically favorable, the electron passes over to the
quencher. All of these processes happen without the emission of radiation.
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Photoinduced electron quenching does only occur at close contact between
appropriate pairs, as the Rehm-Weller equation clarifies:
(2.10) ∆GCS = Eox − Ered − E0,0 − e
2
ε · d
where ∆GCS is the energy released, Eox the oxidation potential, Ered the
reduction potential and E0,0 the fluorophore transition energy from ground to
first excited state. The last term e2ε·d is the solvent effect with ε the dielectric
constant and d the charge separation distance. This term is rather small
though and is, therefore, often neglected.
The potentials of several chromophores and some natural compounds are
given in table 2.1.
Table 2.1: Published redox properties of flu-
orophores, tryptophan (Trp), all nucleic acids
and 7-Deaza-2’-deoxyguanosine [32,50,84–90].
For further information, see [56].
Eox Ered E0,0
[V/SCE] [V/SCE] [eV ]
R6G 1.39 - 0.95 2.27
MR121 1.40 - 0.50 1.90
Atto 6551 1.40 - 0.50 1.90
Cy 5 0.82 - 0.88 1.88
Trp 0.81
dG 1.25 <- 3.00
dG7 0.95
dC 1.90 - 2.59
dA 1.72 - 2.76
dT 1.87 - 2.42
Obviously, MR121 (as well as Atto 655) has a very high reduction potential
at a comparably low transition energy. Among the naturally occurring nucleic
1Atto 655 is expected to have an identical structure and, therefore, very similar redox
characteristics.
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acids, guanosine has the lowest oxidation potential, which is even exceeded
by its modification 7-Deaza-2’-deoxyguanosine. This is still overtopped by
tryptophan, though.
Many of these combinations have been used for PET sensors, since pho-
toinduced electron transfer is very limited in its distance and, therefore, gives
an immediate response about contact loss [91–95]. In this work, the combi-
nation of MR121 with Trp and of Atto 655 with dG and dG7 have been
employed. The energies for these reactions at neglected solvent effect are
∆GCS = −0.15eV for Atto 655 with dG, ∆GCS = −0.35eV with dG7 and
∆GCS = −0.59eV for MR121 with Trp.
Whenever a fluorophore in an excited state is in close contact to a molecule,
that has an absorption spectrum overlapping with the fluorophore emission
spectrum, also Fluorescence Resonance Energy Transfer (FRET) by dipole-
dipole interaction can occur. The FRET efficiency is determined by the
spectral overlap and the distance r between the partners, as equation (2.11)
shows.
(2.11) E = R
6
0
R60 + r6
,
where R0 equals the Förster radius, which is the distance, at which energy
transfer is 50% efficient. The Förster radius is related to the energy transfer
rate kτ (r) via
(2.12) kτ (r) =
1
τD
· (R0
r
)6,
with the fluorescence donor lifetime τD in absence of the fluorescence acceptor
and can furthermore be described with the dipole orientation factor κ2:
(2.13) R0 =
9 ·Q0 · ln10 · κ2 · J
128 · pi5 · n4 ·NA ,
where Q0 is the donor fluorescence quantum yield in absence of the acceptor,
J is the spectral overlap, n is the refractive index of the surrounding medium
and NA the Avogadro number.
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Since the Förster distance is in the range from 3 to 6 nm, FRET can be
efficiently used as a spectroscopic ruler [96] and for the determination of
enzyme activity in a molecular beacon [51], as described in section 2.5 [49,78].
2.3 Fluorescence Microscopy
For as long as human beings roam the Earth, there has been research.
As most of the apparent facts had been discovered, mankind felt the urge
for going deeper into detail. This bore many difficulties, though, regardless
of the specific direction that was headed. In a lot of these cases, optical
instruments could be utilized and aided various important discoveries. One
of these directions was the query for small components of familiar structures,
that could not be dissolved with the unaided human eye.
Figure 2.7: Size scale of different components of life with the appropriate detection
methods [97].
21
2 Theoretical Background
As figure 2.7 shows, the human eye can dissolve structures down to one mil-
limeter. Below that, auxiliary means have to be applied. Popular methods
like X-ray Crystallography, Nuclear Magnetic Resonance (NMR) and Trans-
mission Electron Microscopy (TEM) cover a wide range of sample dimen-
sions, even down to less than a nanometer. As the Atomic Force Microscopy
(AFM), that is only applicable for rather small samples, these methods are
quite complex and invasive. The light microscope on the other hand, which
has greatly evolved over the last 350 years, has become an indispensable
method for applications down to several nanometers due to its harmlessness
and easy handling. Among the different light microscopic methods, one of
the most unlimited and sensitive is fluorescence microscopy. This approach
only gained serious attention in the 1950s, although fluorescence had long
been an issue by that time.
The drawback of this method lies in its nature, the nature of light. Since
visible light has a wavelength of 300 nm to 700 nm, it is self-evident, that
structures distinctly below this wavelength can generally not be dissolved.
One solution to this is the utilization of FRET as spectroscopic rulers, as
described in section 2.2.2. By now, though, there are even much wider appli-
cable fluorescence microscopy means to enhance the natural resolution - or
correctly speaking: to circumvent it.
2.3.1 Diffraction limited Techniques
A fluorescing molecule is distinctly smaller, than the wavelength of the pho-
tons, it emits. Since it can be regarded as a point light source, the light it
emits is not aligned, which results in a fuzzy disk when imaged on a plane.
This disk, called Airy disk, shows an inhomogeneous intensity distribution.
This distribution is mathematically described by the Point Spread Function
(PSF), a two dimensional Bessel function. An example of the Airy disc and
its according PSF is given in figure 2.8.
The Airy disk radius from the center to the first minimum is the aspect that
limits the resolution according to the Rayleigh criterion: Only if two point
light sources are a minimum of the airy disk radius away from each other,
it is possible to distinguish between these both. The radius rAiry depends
on the wavelength of fluorescence light λ, and the numerical aperture of the
applied objective NA with
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Figure 2.8: 2-dimensional Airy disc
and according 3-dimensional point spread
function.
(2.14) rAiry = 0.61 · λ
NA
.
The lateral resolution that can therefore be obtained for an object emitting
fluorescence light of 680 nm with an objective of a numerical aperture of 1.42
is 296 nm and with an NA of 1.453 the lateral resolution is 286 nm.
The axial resolution, however, is distinctly worse, since it is determined
with the formula
(2.15) zmin =
2 · λ · n
(NA)2 ,
resulting in 957 nm for an objective with NA = 1.45 and 1027 nm for NA =
1.40.
2as is applied in this work in confocal microscopy
3as is applied in this work in TIRF microscopy
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With a limitation of the detection volume, these scales can be lowered. One
approach to this incorporates the utilization of total internal reflection and is,
therefore, called Total Internal Reflection Fluorescence (TIRF) Microscopy.
Total Internal Reflection Fluorescence Microscopy
At the interface of two different media, a light beam changes its direction due
to various refractive indices, following the Snell’s law:
(2.16) n1 · sinθ1 = n2 · sinθ2,
with ni the refractive indices of the media and θi the beam angles in the
different media, as depicted in figure 2.9.
Figure 2.9: Light path variation
upon change of refractive indices.
At an intersection from optically denser medium to a medium with lower
refractive index, there is a critical angle, at which the beam does not enter
the second medium. If the angle is increased further, the beam is totally
reflected at the interface. This results in an evanescent wave in the medium
with low refractive index, which has a penetration depth d of
(2.17) d = λ04 · pi · (n
2
2 · sinθ2 − n21)−
1
2 ,
where λ0 is the incident wavelength in a vacuum. For λ0= 647 nm and an
incident angle θ2 of 72°, the penetration depth at a glass water interface
accounts to 90 nm only, which is only a tenth of the axial resolution. The
intensity I of the evanescent wave at a certain distance z from the surface
naturally relates to the penetration depth with
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(2.18) I(z) = I0 · e
−z
d ,
with the initial intensity I0 at the interface.
This approach to limit the excitation volume has been successfully utilized
in the total internal reflection fluorescence microscope, as is schematically
depicted in figure 2.10.
Figure 2.10: TIRF Microscope scheme.
A laser beam is focused onto the back focal plane of an objective with a
high numerical aperture, after it has been reflected on a dichroic mirror. If
the beam is coupled into the objective, close to its boundary, it experiences
a collimating deflection, so that it hits the surface at an angle bigger than
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the critical angle, yielding an evanescent field in the sample. The reflected
laser beam is again reflected on the dichroic mirror and does, therefore, not
interfere with the detection system. The fluorescence light is collected by the
objective and passes the dichroic mirror due to the Stokes shift, so it can be
detected by a subsequent Charge Coupled Device (CCD) camera.
Instead of limiting the excitation volume, it is also applicable to limit the
detection volume, as it is done in the confocal fluorescence microscope.
Confocal Fluorescence Microscopy
Figure 2.11 shows a schematic drawing of a standard confocal microscope.
The collimated laser beam is reflected on a dichroic mirror and focused by the
objective. Therefore, a comparably wide area in the sample is excited. The
resulting fluorescence is collected by the objective and passes the dichroic
mirror due to the Stokes shift. A convex lens focuses exactly that part of
the fluorescence light that was emitted at the laser focus position into the
aperture of a pinhole. Any other fluorescence light origin is focused ahead
or after this position, so that only a small fraction of defocused light passes
the pinhole. The divergent fluorescence light is then focused onto a sensitive
detector. With a movable specimen stage or a maneuverable optical path,
samples can be scanned laterally and axially, yielding a pointwise detected
3-dimensional image of the sample.
The utilization of this confocal principle enhances the resolution, given by
equation (2.14) and equation (2.15), by a factor of 1.41. This results in a
lateral resolution of 210 nm and an axial resolution o 728 nm, respectively,
for a objective with a numerical aperture of 1.4 and a fluorescence wave-
length of 680 nm. A still distinctly higher resolution can be obtained with
superresolution techniques.
2.3.2 Superresolution Techniques
The specimen, that need to be sampled quite often in fluorescence microscopy,
are usually labeled with a high number of emitters. Two fluorophores in
close distance to each other can only be resolved in conventional microscopy,
if their distance is approximately the same as the wavelength of light they
emit, though, while a single fluorophore can be resolved with a much higher
accuracy, because the obtained intensity distribution in the Airy disk can be
deconvolved with a two-dimensional Gaussian function.
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Figure 2.11: Standard confocal micro-
scope.
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Within the last years, there have been many efforts to detect single mo-
lecules in a highly labeled sample by taking advantage of photoswitching
properties. Generally, there are two main directions for this, the spatial
limitation of fluorescent molecules and the temporally limited emission of
single fluorophores.
The most prominent spatially limiting high resolution method has been
introduced by Hell et al. in 1994 [75]. This Stimulated Emission Depletion
(STED) Microscopy is based on a standard confocal microscope. After the
standard excitation, a secondary donut-shaped beam illuminates the very
same spot, leading to the stimulated emission of the excited fluorophores in
this area. Therefore, only a small volume of excited fluorophores is left to
spontaneously fluoresce. This method leads to a strong resolution enhance-
ment of down to 5.8 nm laterally [98].
The most popular method for resolution enhancement by temporally lim-
ited fluorophore emission is represented by the (direct) Stochastic Optical
Reconstruction Microscopy (d)STORM.
(direct) Stochastic Optical Reconstruction Microscopy
In 2006, Bates et al. published a method that takes advantage of a stochastic
photoswitching of all present fluorophores in a sample [76]. The deconvolution
of the fluorescent signals can be used for a reconstruction the fluorophore
positions and, therefore, yield an imaging resolution of 20 nm.
While the stochastic switching is achieved with an activator fluorophore
in close proximity to the detected fluorophores in STORM, dSTORM only
utilizes an organic chromophore such as Cy5 or Alexa 647, as published by
Heilemann et al. [35, 99].
The sample of interest can, therefore, be labeled with only a single fluo-
rophore and imaged on a TIRF microscope. For the efficient photoswitching,
quenching processes need to be inhibited. Therefore, oxygen has to be effi-
ciently removed from the sample. By applying a strong laser power to read
out the fluorophores, they are efficiently deexcited, which can be reversed
with an additional irradiation at 514 nm with a comparably low intensity.
This way, only a subset of molecules fluoresce simultaneously. The computa-
tional localization of a set of subsequent images then leads to a reconstructed
dSTORM image, as depicted in figure 2.12.
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a) TIRF b) dSTORM
Figure 2.12: Resolution enhancement by dSTORM. The cell membrane
is indirectly labeled with Alexa 647 and irradiated with 647 nm. While the
TIRF image shows a blurry image of an overlap of two cell shapes, the
dSTORM image reveals fluorophore agglomerations and hidden structures.
2.4 Enzymes
Enzymes are catalysts, which means that they accelerate reactions, that
would mostly not happen on their own even within years.
As depicted in figure 2.13, a conversion from substrate to product requires
a certain energy that has to be surpassed in order to take place (∆EA), while
an enzyme lowers this required energy (to ∆EC).
Most occurring reactions are catalyzed by a specially designated enzyme.
The total number of existing enzymes can only be guessed. In the bacterium
Escheria coli (E. coli), 1701 enzymes have been found, which represents two
thirds of the proteins, that have been characterized for this organism so far
[100]. Since E. coli are rather simple in contrast to any eukariotic organism,
it can be assumed, that the number of enzymes is a lot bigger there.
Enzymes generally consist of chained α - amino acids, building secondary
and tertiary structures, which results in the formation of the active site.
These can most efficiently be determined by X-ray crystallography, where
enzymes are mostly static due to the crystallization process. However, struc-
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Figure 2.13: Energy barriers that have to be sur-
passed for a specific reaction from substrate (S) to
product (P) with (black) and without (red) enzyme.
tural analysis by Nuclear Magnetic Resonance (NMR) revealed, that enzymes
are rather flexible in solution [100], which is essential for the binding of sub-
strates [101] (see section 2.4.1). The compact folded form of an enzyme is
thermodynamically only a little more stable than the unfolded form [102].
Therefore, they can be easily unfolded (’denatured’) via strong heat, extreme
pH, detergents or high concentrations of urea or guanidium chloride [103–105]
with a mostly sharp transition range [102, 106]. This enzyme unfolding pro-
cess is mostly reversible on a very short time scale and has been widely studied
in protein folding research [107].
However, an enzyme molecule does not act forever. In a living organism,
each protein is continuously replaced as part of an intrinsic control mecha-
nism. These enzyme ’turnovers’ take place in a wide range of time scales and
are, therefore, a characteristic feature for each specific enzyme. While the
mechanisms of enzyme synthesis have been well understood, enzyme degra-
dation is still a flowering aspect in research [100].
Enzymes have found a wide utilization in clinical and industrial aspects.
Food, pharmaceutical and chemical industries utilize enzymes so naturally,
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that mankind does not even take great notice anymore4.
2.4.1 Interactions between Enzyme and Substrate
As individual as enzymes are, as individual are their substrates. There are
enzymes, that can only catalyze one single reaction with a specific natural
substrate, e.g. Caspase 1, that solely cleaves peptides carrying the recognition
sequence Trp -Glu -His -Asp [110]. Other enzymes process huge varieties of
substrates, for example those utilized in this work (see section 2.4).
An appropriate substrate needs to be noncovalently bound by the enzyme
at its active site in order to be catalyzed. The easiest model for this binding
is the lock-and-key model, where the substrate and eventual cofactors pre-
cisely fit in a provided binding pocket (see figure 2.14 a)). Mostly, enzymes
undergo formational changes upon substrate binding though, which is called
the induced fit model (see figure 2.14 b)).
The induced fit model supports the formation of catalytic intermediate
states, because it alters the substrate conformation. An irreversible reaction
scheme with a single intermediate is generally described as in equation (2.19).
(2.19) E + S k1−−⇀↽−
k−1
ES
k2−⇀ E + P
Here, E is the enzyme, S the substrate and P the product. The rate for the
formation of the enzyme-substrate complex is expressed by k1, k−1 expresses
the dissociation rate and k2 stands for the product formation rate.
In a kinetic process, these compounds vary in their concentrations over
time, as depicted in figure 2.15.
In the beginning of the reaction, it needs a certain time for the enzymes to
bind substrates. This first reaction phase is called pre steady state. After all
enzyme molecules have bound a substrate molecule, the concentration of free
enzyme is constantly negligible in the steady state phase, if two prerequisites
are fulfilled:
• The overall substrate concentration is high in comparison to enzyme
concentration.
4There is a high number of chapters and whole books dedicated to either of these aspects
(e.g. [100, chapters 10 and 11], [108], [109] and many more) which should be referred to for
further reading.
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a) lock-and-key model
b) induced fit model
Figure 2.14: Standard models for the description of enzyme substrate com-
plex conformation.
• The complex formation (k1) is much faster than the complex decompo-
sition (k−1 + k2).
As soon as there is no more substrate available to instantly supply each
freshly released enzyme molecule, the ES complex concentration slowly de-
creases until all enzyme molecules exist in the initial form.
Regarding the product formation in this course, the pre steady state phase
only shows a little increase, while a linear increase is obtained in the steady
state phase, before a saturation value is approached in the last reaction phase.
A mathematical description of the temporal development of all components
looks as follows:
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Figure 2.15: Temporal variations of substrate (S),
product (P), enzyme (E) and enzyme substrate com-
plex (ES) concentrations in an enzymatic reaction.
(2.20) δ[S]
δt
= −k1 · [S] · [E] + k−1 · [ES]
(2.21) δ[E]
δt
= −k1 · [S] · [E] + (k−1 + k2) · [ES]
(2.22) δ[ES]
δt
= k1 · [S] · [E]− (k−1 + k2) · [ES]
(2.23) δ[P ]
δt
= k2 · [ES] =: v,
where v is the velocity of the reaction.
Employing the steady state prerequisites, equation (2.21) and equation (2.22)
simplify to
(2.24) δ[E]
δt
= 0
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and
(2.25) δ[ES]
δt
= 0.
Therefore, this gives
(2.26) 0 = −k1 · [S] · [E] + (k−1 + k2) · [ES].
Since [E]+[ES] equals the initial enzyme concentrations [E0], it follows from
equation (2.26):
(2.27) [ES] = k1 · [S] · [E0]
k1 · [S] + k−1 + k2
The maximum velocity v0 can be described with
(2.28) v0 := k2 · [ES].
Setting the Michaelis-Menten constant KM
(2.29) KM :=
k−1 + k2
k1
,
it follows from equation (2.27) after multiplication with k2 and insertion of
v0 and KM :
(2.30) v = v0 · [S]
KM + [S]
which is called the Michaelis-Menten equation. KM can be described as the
substrate concentration, at which half the maximum speed of the reaction
is obtained. Therefore, each combination of substrate and enzyme has its
specific KM value. It can be determined by measurement of starting veloc-
ities v0 in individual kinetics of constant enzyme concentration but varying
substrate concentrations. Plotting the determined starting velocities against
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Figure 2.16: Theoretical Michaelis-Menten plot with two different
enzyme concentrations.
the applied substrate concentrations, results in one hyperbola for each tested
enzyme concentration, as presented in figure 2.16.
Here, vmax represents the maximum velocity for the observed reaction,
which obviously corresponds to the enzyme concentration. The asymptote
and therefore also KM can be easily fit, if there is a distinct gradient.
If the gradient is missing, however, there are linearization methods, that
still allow the determination ofKM and vmax. The most popular linearization
types are shown in figure 2.17.
The linearization equations follow directly from the Michaelis-Menten eval-
uation (equation (2.30)).
(2.31) 1
v0
= KM
vmax
· 1[S] +
1
vmax
Lineweaver Burke
(2.32) v0 = −KM · v0[S] + vmax Eadie Hofstee
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a) Lineweaver-Burke plot b) Eadie-Hofstee plot c) Hanes plot
Figure 2.17: Linearization methods for the determination of KM and vmax.
(2.33) [S]
v0
= 1
vmax
· [S] + KM
vmax
Hanes
These linearizations are very sensitive to measurement deviations though,
and should, therefore, not be applied if possible otherwise.
The parameters KM and vmax are commonly used for a characterization of
enzyme-substrate reactions, where low KM values indicate a high affinity of
the enzyme substrate complex [100,111].
Michaelis-Menten constants for enzyme catalyzed reactions range from
0.2 nM, for the DNA-(apurinic or apyrimidinic site) lyase on DNA contain-
ing thymine glycol [112], up to 10M, for the glucose 1-dehydrogenase on D-
Galactose [113]. However, common constants are in the micro- to milli-Molar
regime.
Enzyme kinetics are not always this easy to describe. Generally, enzyme
catalysis can consist of more than a single step and, therefore, more than
these three rate constants. Also, reactions can be dependent on multiple
substrates or constraint to the presence of cofactors and inhibitors [100,111].
2.4.2 Enzyme Characterization
Enzymes are categorized into main classes by Enzyme Commission numbers
due to their catalyzed reactions as presented in table 2.2 [114].
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Table 2.2: Enzyme main classes as categorized by the Enzyme Commission [115–
122]
main main
class class catalyzed
number name reaction
EC 1 Oxidoreductases redox reactions
EC 2 Transferases intermolecular transfer
of functional groups
EC 3 Hydrolases hydrolytic cleavage
EC 4 Lyases breaking of chemical bonds
other than hydrolysis and oxidation
EC 5 Isomerases conversion to isomeric structures
EC 6 Ligases binding of two molecules by
Adenosine-5’-triphosphate consumption
Within these main classes, enzymes are further categorized into subclasses.
For the class of hydrolases, for example, there are 13 subclasses that specify
the kind of bond the hydrolase works on. Any nuclease is therefore gath-
ered in subclass 3.1, while subclass 3.4 describes all characterized pepti-
dases [115–122]. Enzyme commission numbers consist of two more digits,
providing information about required cofactors, substrate preferences or cat-
alyzed products, which does not follow any universal method, though.
2.4.2.1 Peptidases
The subclass of peptidases, EC number 3.4, is further divided into 19 dif-
ferent categories, containing 1161 different enzymes [116–122], which is both
subject to regular changes. Highly popular substitutes are the Cathepsines,
Collagenases, HIV-1 Protease, Pepsin, Thrombin and Trypsin.
Carboxypeptidase A
Another popular and well studied peptidase is the Carboxypeptidase A. It
is registered with the EC number 3.4.17.1 and was, therefore, the first met-
allocarboxypeptidase to be categorized. Carboxypeptidase A from bovine
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pancreas (Bos taurus) is a globular monomer with a molecular weight of
34.49 kDa, consisting of 300, 305 or 307 amino acids and is exocytosed from
the secretory granule [64, 123]. Its active site is built by five amino acids,
which is stabilized by a zinc ion [124]. The amount of zinc excreted by the
pancreas is related to enzyme output [125], but amounts to 0.98 - 1.03 mol
Zn2+ per mol enzyme [123]. The zinc ion position in the native Carboxypep-
tidase A molecule is depicted in the crystal structure in figure 2.18.
Figure 2.18: Crystal structure of Car-
boxypeptidase A, determined by X-ray
diffraction with a resolution of 1.25Å [126,
127]. Zinc ion depicted as grey sphere.
Carboxypeptidase A has a pH optimum in the neutral range [64] and an
optimum temperature for kinetic assays at 25°C [123, 128]. The optimum
temperature for immobilized enzymes is published to be at 50°C [129].
This peptidase does not have a specific substrate, but cleaves any peptide
bond except for those to proline, arginine and hydroxyproline. It shows only
little action on glycine, lysine, aspartic acid and glutamic acid. Peptide bonds
linking amino acids that contain aromatic rings are preferred [65, 130]. Car-
boxypeptidase A is an exopeptidase and produces mono-, di- and tripeptides
beginning from the C-terminus of the substrate [64–68]. Furthermore, Car-
boxypeptidase A can also cleave esters, some even faster than their analogue
peptide bonds [68]. Typical KM - values for natural peptide bonds are in the
range of 1mM [64].
Carboxypeptidase A can be inhibited by a variety of chemical compounds,
most interestingly also by D-Cys [131], L-Cys [132], D-Phe [123], L-Phe [64]
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and D-His [123].
2.4.2.2 Nucleases
Nucleases are categorized into the subclass of Hydrolases acting on ester
bonds (EC number 3.1) and can be further classified by their cleavage site
behavior. There are five sub-subclasses describing exonucleases and eight
describing endonucleases [116–122]. The most common of these nucleases are
DNaseI and DNaseII.
DNaseI
Deoxyribonuclease I (EC number 3.1.21.1) is the first described endodeoxyri-
bonuclease producing 5’-phosphomonoesters [116–122]. It is derived from
the bovine pancreas (Bos taurus). DNaseI is also a globular monomer with
a molecular weight of 31 kDa and a peptide length of 282 amino acids [133].
This enzyme naturally occurs in the cytoplasm of cells [134].
Its activity is dependent upon magnesium and calcium ions at a milli-Molar
concentration [135, 136]. Deoxyribonuclease I can be inhibited by a Ca2+
concentration above 1mM [137] and by G-Actin [135]. A G-Actin inhibited
DNaseI is depicted in the crystal structure in figure 2.19.
Figure 2.19: Crystal structure of DNa-
seI bound to Actin, determined by X-
ray diffraction with a resolution of 1.85Å
[138].
The optimum pH value for DNaseI activity is 7 - 7.5 [136] and the optimum
temperature has been published to be at 37°C [139]. Beginning from 65°C,
the enzyme gets inactivated [140].
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DNaseI can hydrolyze both, double and single stranded DNA [136], but
has a preference for double-stranded DNA [133,135], where it produces nicks
on one strand in preference to scission of both strands. Autoretardation then
causes the continuous formation of products, which are poorer substrates,
than those from which they are derived [133]. There is no preference for any
specific nucleotide [135].
DNaseX
Deoxyribonuclease X (EC number 3.1.22.5) is an endodeoxyribonuclease, pro-
ducing 3’-phosphomonoesters. Therefore, this enzyme belongs to another
sub-subclass of enzymes than DNaseI [116–122].
This enzyme is still mostly unknown. DNaseX from E. coli preferentially
cleaves supercoiled plasma DNA at a pH optimum of 8, absolutely requires
Mg2+ and Ca2+ ions, but is also inhibited by them at concentrations above
5mM respectively 1.5mM [141].
Human DNaseX, has a coding sequence on the human X chromosome
and was the first detected gene to encode a DNaseI homologous protein
[37, 142, 143]. The enzyme is located on the cell surface by its glycosylphos-
phatidylinositol (GPI) - anchor, where it is supposed to hydrolyze endocy-
tosed extracellular DNA [43]. DNaseX is highly expressed in cardiac and
skeletal muscles and has an extra hydrophobic stretch at its C-terminus [39].
It has a peptide length of 285 amino acids and a molecular weight of 35 kDa.
As DNaseI, this enzyme is dependent on Ca2+ and Mg2+ ions and inhibited
by G-Actin, but only at higher inhibitor concentrations. Its ideal pH has
been roughly determined to be at 6.8 [39, 42, 43]. Crystal structures are not
yet available for this enzyme.
DNaseII
Deoxyribonuclease II (EC number 3.1.22.1) is the first described endodeoxyri-
bonuclease [144] that produces 3’-phosphomonoesters [116–122]. The enzyme
from bovine spleen (Bos taurus) has a molecular weight of 41 kDa [145] and
is found in the nucleus [146] and in the lysozome [100]. It functions best at a
pH value of 4.8 on ds DNA [145]. DNaseII is inhibited by Mg2+ at a concen-
tration above 10mM [145]. Most surprisingly, there is only little information
as well as no crystal structure available for DNaseII.
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S1-Nuclease
S1-Nuclease belongs to the sub-subclass of endoribonucleases that are active
with either ribo- or deoxyribonucleic acids and produce 5’-phosphomonoesters
and has the EC number 3.1.30.1 [116–122].
It occurs extracellular [147] in the sprout of Aspergillus oryzae [148]. S1-
Nuclease consists of a single peptide chain of 270 amino acids [149], resulting
in a molecular weight of 36 kDa [150]. The crystal structure is shown in
figure 2.20.
Figure 2.20: Crystal structure of S1-
nuclease with a substrate analog, deter-
mined by X-ray diffraction with a resolu-
tion of 1.8Å [149].
S1-Nuclease requires zinc for its activity [147]. Its optimum pH is at 4.5 -
4.6 [151, 152]. The published optimum temperatures vary immensely from
37°C [153,154] to 65°C (for immobilized enzymes) [155]. The enzyme is 75000
times more active on single-stranded than on native DNA [156] and shows a
five fold more activity on DNA than on RNA [152]. Published KM - values
are 0.0142mM for DNA and 0.144mM for RNA [151].
2.5 Fluorescence based Enzyme Research
Enzyme research can be accomplished with various methods, like X-ray Crys-
tallography, NMR, AFM, Scanning Electron Microscopy (SEM) and TEM.
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The specimen preparation for these methods, however, is mostly complex,
time-consuming and invasive to the samples.
Fluorescence based methods are generally non-invasive and are, therefore,
ideally suited for the research on any living material. Thus, fluorescence has
been employed very early for enzyme research, first represented by ELISAs,
that started in the 1970s [70, 71], and western blots, which began in the
1980s [157].
Both methods employ antibodies, which are specifically directed against
the antigen of interest. In a standard ELISA, the antigens are bound to
a surface, incubated first with a specific primary antibody and then with a
secondary antibody, carrying an enzyme like Horse Radish Peroxidase (HRP).
For the detection of antigen, therefore, specific HRP substrate is added, which
gives a colorimetric information about the presence of antigen down to a
concentration of 10-13M [74]. Due to unspecific antigen adsorption, ELISAs
bear a high risk of false positive signals.
The western blot method is a lot more confident in this concern, since pro-
teins are initially unraveled by gel-electrophoresis in respect to their three
dimensional structure or their protein length. The purified proteins are then
transferred to a membrane and detected by incubation with specific primary,
consecutive secondary enzyme-linked antibody and the addition of appropri-
ate enzyme substrate.
These fluorescent methods, thus, are only capable of the detection of dis-
solved enzymes. The specific interaction between antibodies and their anti-
gens can also be utilized, though, for the detection of proteins for immunola-
beling in their native environments [158,159]. Thus, enzymes, that are linked
to a cell compartment, e.g. the outer membrane, can be bound by their spe-
cific antibody, which is then bound by a secondary labeled antibody, directed
against the primary antibody. This scheme is depicted in figure 1.4.
Such a specimen, therefore, allows the examination of the native occurrence
of enzymes. However, the tissue mostly gets fixed in the sample preparation.
The fluorescence based research on living enzymes utilizes natural enzyme
substrates that are bound to one or more fluorophores, that either yield
a FRET or a PET pair (see section 2.2.2). In both ways, the fluorescent
substrate needs to show a change in fluorescence signal upon the specific
enzymatic reaction. For hydrolases, therefore, the cleavage generally results
in a spatial contact loss, which restores fluorescence of an initially quenched
42
2.5 Fluorescence based Enzyme Research
fluorophore via FRET [47, 160, 161] or PET [31–33, 54, 55, 162]. The design
of those fluorescent substrates, that take advantage of intrinsic electron do-
nating properties of tryptophan and guanosine residues (cf. section 2.2.2), is
exemplarily depicted for nucleotides and peptides in figure 1.2 and figure 1.3.
This method can also be adapted to any other substrate with an extra at-
tachment of these natural compounds, if they are not already incorporated.
The fluorescence signal of the modified substrate can be read out with any
fluorescence detector based device, beginning from a fluorescence spectrome-
ter over wide field microscopes to confocal and TIRF microscopes, including
’super-resolution’ techniques such as STED and dSTORM. Therefore, fluo-
rescent substrates offer a wide range of applications for the analysis of enzyme
activity.
Autofluorescence
When dealing with biological samples for any fluorescence based method, the
specific autofluorescence of the specimens have to be regarded. Figure 2.21
shows the yield of intrinsic fluorescence of two different mammalian cells upon
an irradiation with 488 nm.
a) A - 549 b) HEK293T
Figure 2.21: Autofluorescence of different cell types at excita-
tion with 488 nm.
The molecule of interest should, therefore, be examined employing a flu-
orophore in the spectral range of least autofluorescence intensity. Natu-
rally, this range varies with the utilized application. Whereas plant cells
show a high autofluorescence in the red spectral range due to lignins, such
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a) absorption
b) fluorescence
Figure 2.22: Absorption (a)) and fluorescence (b))
spectra of different natural compounds in the visible
spectrum [163].
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as chlorophylls, the intrinsic fluorescence of mammalian cells is rather low
at these wavelengths. In mammalian cells, autofluorescence is mostly due
to flavin coenzymes (FAD5 and FMN6) and reduced pyridine nucleotides
(NADH7) [164,165].
Figure 2.22 shows the spectrally dependent absorption and fluorescence in-
tensities of these and other important fluorescent compounds in mammalian
organisms. Only the blood component porphyrin shows a noteworthy flu-
orescence intensity above 650 nm [163]. Sample examination in these cells,
therefore, mostly utilizes red fluorescing fluorophores.
5flavin adenine dinucleotide
6flavin mononucleotide
7nicotinamide adenine dinucleotide
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3 Materials and Methods
In this section all utilized hardware devices and microscopic setups, samples
and their preparations as well as their measurements and data evaluation will
be described.
3.1 Hardware Devices and Setups
The presented work was carried out on several ready-to-use hardware devices
like the absorption and the fluorescence spectrometer, a multiplate reader and
a high performance liquid chromatograph. Furthermore, an easy to handle
confocal microscope and a custom made total internal reflection fluorescence
microscope were used. This section will describe the equipment, components
and configurations of these instruments.
3.1.1 Absorption Spectrometer
Absorption spectra were measured with a Perkin Elmer Lambda 25 UV/VIS
Spectrometer at room temperature. For a zero balance, the measurement
buffer was used in the applied cuvettes. Spectral ranges were adjusted to
each fluorophore, while the scan speed remained constant at 240 nm/min.
Each ensemble measurement was performed in quartz SUPRASIL®precision
cells (Hellma®).
3.1.2 Fluorescence Spectrophotometer
Emission spectra measurements, enzyme kinetics and thermal stability mea-
surements were carried out with a Cary Eclipse Fluorescence Spectropho-
tometer. In all measurements, emission light was collected for 0.1 s. Each
ensemble measurement was performed in quartz SUPRASIL®precision cells
(Hellma®). Up to 4 concurrent measurements can be realized in the tem-
pered cuvette holder. Emission spectra were acquired in the scan-mode of
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this device at 25°C, excited and detected at individual, appropriate spec-
tral ranges (see section 3.3). Measurements on thermal characteristics were
carried out with custom excitation wavelengths for each fluorophore and a de-
tection wavelength, destined by the appropriate spectral emission maximum.
Temperatures varied from a minimum of 15°C to a maximum of 90°C or less,
dependent upon the examined sample. Temperature variations were chosen
to be as slowly as possible to guarantee a thermal balance between sensor
and sample, but still fast enough to minimize side effects like evaporation
of sample liquids. Typical velocities were in the range of 1°C/min. Kinetic
measurements were accomplished at 25°C for CPA experiments, at 37°C for
DNaseI, DNaseII and DNaseX experiments and at 20°C for S1-Nuclease mea-
surements. Temporal measurement intervals were adjusted to each reaction,
but took place in a maximum frequency of 4 times a minute for fast kinetics
up to a waiting time of 30minutes for very slow kinetics.
3.1.3 Multiplate-Fluorescence Reader
Multiplate based experiments were carried out on a FLUOStar Optima (BMG
LABTECH) at the Laser Research Laboratory (LFL) in Munich. The gain
was set to 2500. Every 10 minutes one data point can be collected for each
sample with an excitation wavelength of 650 nm and and emission wavelength
of 680 nm.
3.1.4 High Performance Liquid Chromatograph - HPLC
The High Performance Liquid Chromatograph by Agilent Technologies (1100
series) was used for separation of labeled oligonucleotide for CPA single
molecule measurements as well as for the analysis of cleaving sites in peptidase
substrates. In every case, the two eluents (0.1M Tetraethylammoniumacetat
in water (A) and 0.1M Tetraethylammoniumacetat in acetonitrile and water
(3:1) (B)) were run with a gradient from 100% A to 100% B in 20 minutes.
Absorption was observed for 260 nm and 630 nm and emission for 360 nm and
680 nm.
3.1.5 Zeiss Laser Scanning Microscope 710 - LSM
The LSM 710 is a confocal microscope (see section 2.3) by Carl Zeiss AG, Ger-
many. It is equipped with a Helium Neon (HeNe) Laser and an Argon Ionen
48
3.1 Hardware Devices and Setups
(Ar+) Laser. Therefore, it provides five wavelengths to work with: 458 nm
(Ar+), 488 nm (Ar+), 514 nm (Ar+), 543 nm (HeNe) and 633 nm (HeNe).
Laser powers can only be governed by a remote control dial (only in case of
Ar+) with arbitrary units and the software in relative units. Furthermore,
due to the optical path and security mechanisms it is not possible to measure
applied laser powers with an external device. At instrument setup the origi-
nal powers for each line were measured to 1.42mW for 458 nm, 7.18mW for
488 nm, 5.76mW for 514 nm, 0.56mW for 543 nm and 1.71mW for 633 nm.
Since Ar+ remote control dial is adjusted to maximum power it can be as-
sumed that 100% laser power roughly correlates with the original absolute
power.
Two independent galvanometric scan mirrors lead the laser focus through a
Plan-Apochromat 63x/1.40 Oil objective (Zeiss) into the sample. The fluores-
cent answer is collected by the same objective, passes a filter and is directed
to the master pinhole. The fluorescent light is then spectrally separated by a
grid and nanometer-wise directed into three different paths. Here, the spec-
tral ranges are reduced to the desired detection range by adjustable blockades.
With this a resolution of 3 nm on the three QUASAR photomultiplier tubes
(PMTs) can be reached.
The LSM 710 is, furthermore, supplied with an ’Axio Observer’ z-drive to
scan various specimen samples with a minimum step size of below 25 nm.
The standard software ’Zen’ that is supplied with the LSM 710 allows a
high number of individual settings and automation procedures. The most
interesting for this work is the z-stack function, that after setting a center,
number of layers and step size automatically produces a 3D-image of the
defined region of interest. This image can be further depicted as simple
(xy) and orthogonal cut (xy, xz, yz) for any given layer, maximum intensity
projection and 3d animation. For any of these functions there are different
design elements like depth coding, brightness, gamma and contrast settings,
color table selection and modification and drawing tools. Derived images
can also be analyzed with colocalization, histogram and measurement tools.
Any produced image can be saved as .lsm with the according measurement
parameters and be exported with more than 20 data formats (PNG , TIF,
BMP, JPG, PSD, PCX, GIF, AVI, Quicktime ...) for further processing and
presentation.
49
3 Materials and Methods
3.1.6 Total Internal Reflection Fluorescence Microscope
Single molecule measurements on CPA activity were accomplished on a TIRF
microscope setup based on an Olympus inverted research microscope IX71.
A collimated laser beam (531 nm/647 nm, selected by an acousto-optical tun-
able filter (AOTF)) of an Ar+Kr+ mixed gas laser (Innova 70C by Coherent)
with a power of 0.1mW is totally reflected at its focus on the bottom of a cover
slide after being reflected at a dichroic mirror (AHF Analysentechnik) and
passing a plan apo N oil immersion objective (Olympus 60x, NA 1,45). Fluo-
rescence signal is collected by the same objective, passes the dichroic mirror,
filtered by an appropriate fluorescence light filters (700DF75, AHF Analysen-
technik) and is collected by an electron-multiplying CCD (EMCCD) camera
(iXon DV887DCS-BV, Andor Technologies). Experiments on live cells with
modified substrate are also carried out at this setup, incorporating a telescope
to magnify the derived image and without the use of the 531 nm excitation.
For dSTORM measurements an equivalent setup was used with additional
laser irradiation at 514 nm and a polychromic beamsplitter (532/647, AHF
Analysentechnik).
3.2 Samples and their Preparation
Biological samples constitute the key element of this work. Here, the exam-
ined enzymes, their buffers, substrates and their arrangement for ensemble
and single molecule measurements are described. Furthermore, all examined
cell lines are presented and the immunostaining of these cells is described.
3.2.1 Enzymes and corresponding Buffers
Carboxypeptidase A (EC no. 3.4.17.1, CAS no. 11075-17-5) from bovine
pancreas was obtained from Sigma Aldrich (Cat.no. C-0261) in aqueous
solution with a molecular weight of 35 kDa.
DNaseI (EC no. 3.1.21.1, CAS no. 9003-98-9) from bovine pancreas was
obtained by Ambion Europe (Cat.no. 2224) in storage buffer (20mM Hepes
pH 7.5, 10mM CaCl2, 10mM MgCl2, 1mM DTT, 50% (v/v) glycerol) with
a molecular weight of 31 kDa. Human DNaseI was greatly gifted by R-
Biopharm AG in Darmstadt and is derived from the commercially available
medicine Pulmozyme® (Roche) upon description. DNaseII (EC no. 3.1.22.1,
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CAS no. 9025-64-3) from bovine spleen was obtained by SIGMA (Cat.no.
D8764) as lyophilized powder, essentially salt free with a molecular weight
of 41 kDa. S1-Nuclease (EC no. 3.1.30.1, CAS no. 37288-25-8) from As-
pergillus oryzae was obtained by SIGMA (Cat.no. N5661) in storage buffer
(30mM sodium acetate, 50mM NaCl, 1mM ZnCl2, 50% glycerol) with a
molecular weight of 36 kDa. DNaseX (EC no. 3.1.22.1, CAS no. 97002-82-9)
was greatly provided by R-Biopharm AG, produced by CRELUX in a stem
concentration of 1mg/ml with a C-terminal 6 xHis-Tag.
DNaseI and DNaseX measurement buffer is as follows: 50mM MOPS-
NaOH pH 6.8, 3mM MgCl2 and 0.25mM CaCl2. DNaseII and S1-Nuclease
measurement buffer consist of 30mM SodiumAcetat, pH 4.6, 1mM ZinkAc-
etat and 5%(v/v) Glycerol. All buffer components were obtained from Sigma.
3.2.2 (Fluorescent) Substrates and Modifications
Peptide probes for CPA analysis were linked to MR121 and purified via HPLC
by ATTO-TEC GmbH Siegen and Biosynthan GmbH, Berlin. Unlabeled Gly-
Trp was obtained from Bachem GmbH, Weil am Rhein (ordering number
G-2220). Labeled and unlabeled DNA Hairpins as well as 3’-thiol-modified
SP2CM (all double HPLC purification grade) were supplied by IBA GmbH,
Goettingen. DNaseAlert™ - substrate was retained from DNaseAlert™QC
System, obtained from Ambion Europe (ordering number AM1970) and dis-
solved in 20µl TE buffer (DNaseAlert™QC System) to yield a 0.1mM stock
solution before further dilution. The Cystein-modified cell-penetrating pep-
tide Antennapedia (Antp, RQIKIWFQNRRMKWKK-C) was synthesized by
Biolux GmbH, Stuttgart. The thiol-modified DNA Hairpins were incubated
with Antp at equimolar concentration in 100mM phosphate buffer pH7.0
(SIGMA, ordering number S8282) and 3mM TCEP (Aldrich, ordering num-
ber C4706) for 6 hours at 35°C and purified via centrifugal filtering.
3.2.3 CPA Single Molecule-Localization
For single molecule measurements with Carboxypeptidase A the enzyme
molecules were bound to the surface as follows: I) CPA was added to a 2.5
fold molar excess of N-Succinimidyl 4-(maleimidomethyl) cyclohexanecaboxy-
late (SMCC, Sigma-Aldrich) and a 2000 fold molar excess of sodium bicar-
bonate (Molecular Probes) to react for one hour at room temperature. Af-
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terwards the solution was purified from unbound SMCC using a Sephadex
G-25 column and reduced in volume by centrifugal filtering (Microcon YM-
50). II) Cy3b-NHS (Amersham Biosciences Europe, Freiburg, Germany) was
bound to an internal C6-amino linker and 3’-modified (Biotin) oligonucleotide
(IBA GmbH, Göttigen, Germany) following a standard protocol, purified
by HPLC and reduced in volume. III) A 10 fold molar excess of Tris(2-
carboxyethyl)phosphine hydrochlorid (TCEP, Sigma-Aldrich) was added to
a 10mM solution of product II. After adding a 10 fold molar excess of CPA
to the solution the mixture reacted over night at 4°C and was then stopped
by addition of mercaptoethanol (Fluka) and purified using a Sephadex G-
25 column. IV) After adding the product to a modified (biotin-streptavidin
conjugation) surface, the complementary oligonucleotide (IBA GmbH, Göt-
tingen, Germany) was added to avoid folding of the complex. As enzyme
substrate, MR121 -Gly -Trp was added during acquisition in a concentra-
tion of 5 · 10-10M.
3.2.4 Cell Cultures
All cell lines used for immunostaining and enzyme detection in living cells
were cultivated in the Applied Laser Physics and Laser Spectroscopy work
group in the faculty for physics in Bielefeld University. Chemicals for cell cul-
turing were ordered at ’PAA: The Cell Culture Company’ if not mentioned
differently. Ordering numbers are given in brackets. For any of these experi-
ments cells were grown in Lab-Tek II chambered coverglasses (Nunc). Those
cells used for ensemble measurements on the multiplate fluorescence reader
arose from cell lines cultured in the Laser Research Laboratory in Munich.
Measurements in the fluorescence spectrophotometer incorporated lysed cells
from R-Biopharm AG in Darmstadt.
Neuroblastoma Cell Line - SK-N-MC
SK-N-MC cell line was gratefully gifted by J. Kopitz from Applied Tumorbiol-
ogy at University Hospital Heidelberg. This epithelial brain neuroblastoma
cell line was derived from the supra-orbital area from a 14 year old female
Caucasian [166].
Adherent SK-N-MC are cultured in RPMI 1640 (PAA ordering number
E15-840) medium containing 10% FCS (ordering number A15-105) at 37°C
in 5% CO2. Two to three times a week at a confluency of 80 -90% cultures are
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split with 0.05% Trypsin containing 0.02% EDTA in PBS (L11-004) following
a standard cell splitting protocol to a subcultivation ratio of 1:6 to 1:12.
Human Lung Carcinoma Cell Line - A-549
A-549 cells were provided by R-Biopharm AG in Darmstadt. The cell line
was isolated from the lung carcinogen tissue of a 58 year old Caucasian man
in 1972 [167].
These epithelial cells grow adherently in monolayer in DMEM high glucose
(4.5 g/l) (E15-843) with 10% FCS (A15-105) and 50µg/ml Gentamicin (P11-
004) at 37°C in 5% CO2. Twice a week confluent cultures are split 1:5 to 1:10
with 0.05% Trypsin containing 0.02% EDTA in PBS (L11-004) following a
standard cell splitting protocol.
Human Bladder Carcinoma Cell Line - ECV-304
The human urinary bladder carcinoma cell line ECV-304, supplied by R-
Biopharm AG in Darmstadt, is a derivative of human urinary bladder carci-
noma cell line T-24 [168–170].
The cells adherently grow as cobblestone monolayers in RPMI 1640 (E15-
840) with 10% FCS (A15-105) and 50µg/ml Gentamicin (P11-004) at 37°C in
5% CO2. Every two to three days cultures are conventionally split in a ratio
of 1:6 to 1:10 with 0.05% Trypsin containing 0.02% EDTA in PBS (L11-004).
Human Cervix Adenocarcinoma Cell Line - HeLa
The 31 year old black Female Henrietta Lacks was treated due to her epith-
eloid cervical adenocarcinoma in 1951. From this treatment the first aneu-
ploid, continuously cultured human cell line arose [171–173], gratefully gifted
by Prof. Hans-Georg Kräusslich from the Department of Virology in the
University Hospital Heidelberg.
These cells grow in DMEM high glucose (4.5 g/l) (E15-843) with 10% FCS
(A15-105) at 37°C in 5% CO2 and are split twice a week with 0.05% Trypsin
containing 0.02% EDTA in PBS (L11-004) following a standard cell splitting
protocol with a dilution of 1:2 to 1:6.
Human Colon Carcinoma Cell Line - LS-174T
LS-174T represents a colon cell line obtained from a colorectal adenocarci-
noma of a 58 year old Caucasian woman. This line is a variant of cell line LS
180 [174] and was gratefully gifted by R-Biopharm AG in Darmstadt.
The adherent epithelial cells grow in DMEM high glucose (4.5 g/l) (E15-
53
3 Materials and Methods
843)with 10% FCS (A15-105) plus 50µg/ml Gentamicin (P11-004) at 37°C in
5% CO2. Two to three times weekly the cells are split with a ration of 1:2 to
1:5 with 0.05% Trypsin containing 0.02% EDTA in PBS (L11-004) following
a standard cell splitting protocol.
Human Colon Carcinoma Cell Line - SW-837
R-Biopharm AG in Darmstadt also provided SW-837, the rectum adenocar-
cinoma cell line of a 53 year old male Caucasian [175].
In RPMI 1640 (E15-840) with 10% FCS (A15-105) plus 50µg/ml Gentam-
icin (P11-004), 37°C and 5% CO2 the cultured cells are split with 0.05%
Trypsin containing 0.02% EDTA in PBS (L11-004) once or twice a week with
a subcultivation ratio of 1:2 to 1:5 in a conventional splitting manner.
HT-29 - Human Colon Carcinoma Cell Line
Established from the primary tumor of a 44 year old Caucasian woman with
colorectal adenocarcinoma in 1964, these adherent, epitheloid cells, gifted
by R-Biopharm AG, Darmstadt, grow as monolayers and in large colonies
[176,177].
Culture conditions are DMEM low glucose (1 g/l) (E15-806) with 10% FCS
(A15-105) and 1% non-essential amino acids (M11-003) supplemented with
50 µg/ml Gentamicin (P11-004) at 37°C and 5% CO2. Confluent cultures are
split every three to six days using 0.05% Trypsin containing 0.02% EDTA in
PBS (L11-004) to a ratio of 1:3 to 1:8 following a standard splitting protocol.
Flp-In™ T-REX™ Human Embryonic Kidney (HEK) 293T Cell Line
The human embryonic kidney cell line HEK 293T grows generally adherently
as monolayer [178]. The cells need to be cultivated in 37°C and 5% CO2 and
split 3 times a week with a ratio of 1:3 to 1:4 with 0.05% Trypsin containing
0.02% EDTA in PBS (L11-004). This cell line served as transfection host for
the commercially available transfection system Flp-In™ T-REX™ (invitro-
gen, ordering number K6500-01). The control cell line is the Zeocin™ and
blasticidin-resistant Flp-In™ T-REX™ host cell line produced in the DNaseX
transfection protocol. Therefore, the culture medium consists of DMEM high
glucose (4.5 g/l) (E15-810) with 10% tetracycline negative FCS (A15-109),
15 µg/ml Blasticidin (P05-017) and 100µg/ml Zeocin™ (invitrogen, ordering
number 45-0430). If the host cell line is further transfected with a vector
containing DNaseX DNA a stable transfected Flp-In™ T-REX™ HEK
293T cell line can be obtained. These cells constantly transcribe DNaseX
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gene and, therefore, produce DNaseX. Here, DMEM high glucose (4.5 g/l)
(E15-810) with 10% tetracycline negative FCS (A15-109) and 150µg/ml Hy-
gromycin B (P15-014) is used as medium. Alternatively, the host cell line can
be modified with the gene of interest and a Tet repressor to form a stable
transfected and inducable Flp-In™ T-REX™ HEK 293T cell line
containing an additional Tet repressor. In the absence of tetracycline this
repressor inhibits the transcription of DNaseX, while upon addition of tetra-
cycline binds to this repressor, leading to the DNaseX transcription. This
repressor also reacts to doxicycline. Tetracycline (SIGMA, ordering number
T7660-5G) and Doxicycline (SIGMA, ordering number D9891-1G) were both
used in a final concentration of 1 µg/ml. The medium for this cell line vari-
ant generally consists of DMEM high glucose (4.5 g/l) (E15-810) with 10%
tetracycline negative FCS (A15-109), 150 µg/ml Hygromycin B (P15-014), 15
µg/ml Blasticidin (P05-017) and 50µ g/ml Gentamicin (P11-004). All HEK
293T cell lines were provided by R-Biopharm AG, Darmstadt.
3.2.5 Chemicals for Immunostaining
The immunostaining procedure incorporates the following chemicals: Phos-
phate Buffered Saline (PBS) was obtained from Sigma Aldrich (ordering num-
ber P4417). Hanks’ Balanced Salt Solution (HBSS) was ordered from invit-
rogen (ordering number 14025). Triton® X-100 solution is supplied by Sigma
Aldrich (ordering number 93443). Normal Goat Serum (NGS) is available at
invitrogen (ordering number PCN5000), as well as RNaseA (ordering num-
ber 12091-039). Primary Antibody ’DNAX’, Protein G purified with a stock
concentration of 0.912mg/ml + 0.1% NaN3, Primary Antibody ’148’, Protein
G purified with a stock concentration of 0.707mg/ml and pre-immune serum
(rabbit) with 0.35mg/ml + 0.1% NaN3 are gratefully gifted by R-Biopharm
AG, Darmstadt. Secondary Antibody - Alexa Fluor®647 goat anti-rabbit IgG
(H+L) (ordering number A-21244), Rhodamin-Phalloidin (ordering number
R415) and Sytox® Green Nucleic Acid Stain (ordering number S7020) are
available at invitrogen. The mounting medium components Mowiol® 4-88
and DABCO were obtained from Sigma Aldrich (ordering number 81381)
respectively Carl Roth (ordering number: 0718.1).
The protocol for the production of the complete mounting medium can
be found in section B.1. This medium not only preserves the samples for a
longer use but also amplifies their fluorescence intensity which is proven in
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section C.1. In case of dSTORM measurements also Glucoseoxidase (Sigma
Aldrich), Catalase (Roche Applied Science) β -Mercaptoethylamine (Sigma
Aldrich) and Glucose (Sigma Aldrich) are used.
3.2.6 Labeling Protocol for LSM and dSTORM-Measurements
For immunostaining experiments different protocols were applied. The stan-
dard protocol starts with a fixation of the cells followed by membrane perme-
abilization. Before primary antibody respectively control protein incubation,
the samples are incubated with blocking buffer to saturate all possible un-
specific binding sites for the secondary antibody. Afterwards, the primary
antibody / antibodies are added to the blocking buffer. Then, labeled sec-
ondary antibody and labeled phalloidin are added to selectively label the
primary antibody and the cytoskeleton. As a last step the nuclear stain is in-
cubated. Finally, the samples are covered with mounting medium to prolong
the stability of the samples.
To minimize DNA staining outside the nucleus, RNase A is added to block-
ing buffer, primary antibody and secondary antibody incubation. Therefore,
these incubation periods are arranged to take place at 37°C to activate the
enzyme. Starting from secondary antibody incubation the samples are, fur-
thermore, continuously covered with aluminum foil to prevent fluorophores
from photo-bleaching. The presented succession is surrounded by a high
number of washing steps to minimize any cross reactivity. The complete and
detailed labeling protocol is presented in section B.4.
For the examination of labeling efficiencies in different cell viabilities the
standard protocol was modified in three different ways. Generally, one ap-
proach incorporates cell fixation before primary antibody incubation, another
approach schedules it in between primary and secondary antibody and the
third approach has the cell staining after secondary antibody incubation.
Apart from that, these three approaches need to be as similar as possible to
each other to allow any comparison of result. Therefore, a permeabilization
and the labeling with the toxic phalloidin had to be spared. Furthermore,
RNase A was left out in each approach to prevent any side effects in the living
cells. Those samples being labeled alive obviously needed to be surrounded
with usual culture conditions. Thus, fixed samples were also kept at 37°C at
equivalent labeling steps. The exact labeling protocols for this experiment
can be found in section B.3.
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In enzyme quantification measurements on the TIRF setup (section 3.1.6)
only the membrane-bound enzymes on different samples were relevant. There-
fore, the standard protocol was applied with only little changes. Cytoskeletal
and nuclear counterstaining were spared. Thus, also RNase A was unneces-
sary. Since the dSTORM technique (see section 2.3.2) requires oxygen re-
moval and the addition of Mercaptoethylamine (MEA), no mounting medium
was used. The cells were stored in PBS until used and changed to measuring
buffer shortly ahead of the experiment. The complete protocol can be found
in section B.5.
3.3 Measurements and Data Evaluation
To understand and analyze the (biological) meaning of an experiment, it is
important to know the measurement details and the data evaluation meth-
ods. In this section the computation of hairpins for nuclease research, the
ensemble measurements and evaluations of these hairpins and other fluo-
rescent substrates and a single molecule measurement of enzyme kinetics is
described. Also, measurements of live cells with modified substrate and of
mostly fixed immunostained cells on a confocal and a super-resolution micro-
scope are described.
3.3.1 Hairpin Computation
Calculations for DNA hairpins were done by mfold web server (version 3.2)
[179–181]. The settings were adjusted to linear DNA sequences in a mM
concentration. Folding temperatures and ionic conditions were adjusted to
the corresponding buffers.
3.3.2 Ensemble Measurements and Data
Absorption and emission spectra of each substrate were measured in PBS.
For MR121 and Atto 655 carrying substrates, absorption was observed from
400 nm to 800 nm at 240 nm/min and fluorescence was excited with 630 nm
and detected from 650 nm to 800 nm. SP2CM-FRET was examined with the
same parameters, while DNaseAlert was excited with 535 nm and detected
from 540 nm to 700 nm in fluorescence spectrum observation. Hydrolysis ex-
periments were set to an excitation wavelength of 630 nm respectively 535 nm
57
3 Materials and Methods
and an observation wavelength at the determined emission maximum of each
sample. The enzyme was added to the substrate solution not until a constant
fluorescence signal was observed. Substrate concentration was sustained be-
low 5µM to avoid reabsorption and reemission effects. All measurements for
CPA analysis were carried out in PBS at 25°C. Measurements for DNaseI
activity were accomplished in a DNaseI reaction buffer at 37°C if not men-
tioned differently, measurements for DNaseII activity were carried out in a
DNaseII reaction buffer at 37°C. Measurements for S1-Nuclease activity took
place in a DNaseII reaction buffer at 20°C.
Data of absorption measurements were exported from UV Winlab (ver-
sion 2.85.04) as ASCII files. All data collected by the Cary Eclipse Fluores-
cence Spectrophotometer were saved as ASCII file (scan application, version
1.1(132); thermal application, version 1.1(133); kinetics application, version
1.1(133)). ASCII files were imported into Origin 8 for further analysis. Spec-
tra were normalized to their maxima. Hydrolysis data was normalized to the
fluorescence intensity at the beginning of hydrolysis and adjusted in start-
ing time to the moment of enzyme addition. Velocities were determined
using an exponential fit I(t) = Isat · (1 − exp(−τ · t)) + Istart · exp(−τ · t),
with Isat representing the fluorescence intensity at saturation and Istart the
fluorescence intensity before addition of enzyme for single step kinetics. Mul-
tiple step kinetics were mathematically adjusted with additional exponential
terms. Data of thermal measurements was normalized to the fluorescence in-
tensity at 20°C. Melting temperatures were determined with the Boltzmann
fit y = A1−A2
1+exp(x−x0
dx
)
+A2, where A1 corresponds to the initial value, A2 to the
final value, x0 to the center and dx to the time constant.
Spectral information for the calculation of relative fluorescence quantum
yields were examined in PBS. Values were determined by Φrel = AbsrefAbssample ×
Emsample
Emref
, where the absorption values at 630 nm and the emission values at
each maximum were considered. Free corresponding fluorophore served as
reference for Absref and Emref .
3.3.3 Single Molecule Measurements and Data
After localization of enzyme molecules by detection of Cy3b fluorescence
in a series of 30 consecutive images with an integration time of 0.1 s the
substrate was added and the probe was permanently excited at 647 nm. The
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resulting fluorescence signals were collected in multiple series of consecutive
images in the frame transfer mode using an integration time of 0.1 s. Data
from single molecule experiments was gathered with provided software by
iXon EMCCD camera and analyzed with a customized LabVIEW software
to export fluorophore positions in an ASCII file and correlate the channels.
ASCII files were further processed by Origin 8 for visualization.
3.3.4 Live Cell Measurements and Data
A-549 cells were grown in a chambered cover glass 24 h prior to use. 4 hours
before the experiment, cells were washed twice with PBS and changed to
colorless L-15 medium with FCS. Cells were than incubated for 4 hours at
37°C. Shortly before use, L-15 plus FCS was removed and replaced by L-15
plus Pyrenebutyrate (SIGMA, ordering number 257354-1G) respectively G-
Actin (invitrogen, ordering number A12375) to yield final concentrations of
7 · 10-7M respectively 5 · 10-5M.
Cell images were acquired with Andor iXon software version 1.3.1.2 respec-
tively Andor Solis software version 4.8.30003.0. Further analysis was done
with these Andor versions and WinSpec version 2.5.16.4. All incident light
images as well as all TIRF images were scaled equally to another and ex-
ported for a further graphical processing in ImageJ [182]. For incident light
and TIRF image overlays, a threshold was applied to the TIRF image to not
cover the cell contours completely.
3.3.5 LSM Measurements and Data
In LSM measurements Sytox® Green Nucleic Acid Stain was excited with
488 nm (Ar+) at 0.3% (see section 3.1.5) and detected in the range of 496 nm
to 540 nm. Rhodamin-Phalloidin was excited with 543 nm (HeNe) at 7%
(see section 3.1.5) and detected in the range of 584 nm to 628 nm. Alexa
Fluor®647 was excited with 633 nm (HeNe) at 20% (see section 3.1.5) and
detected in the range of 650 nm to 747 nm. The applied wavelengths and
fluorophore spectra are presented in figure 3.1.
Furthermore, all excitations were carried out in individual tracks to prevent
crosstalk. The master pinhole was set to a 140µm section and as filter ’MBS
488/543/633’ was used. The region of interest was individually set to match
the object size. Pixel dwell time was kept as equally as possible with the
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Figure 3.1: Spectral ranges in measurements on LSM 710. The three
utilized laser lines and according detection ranges are shown, as well as the
fluorophore absorption and emission spectra in PBS.
’Zen’ Software (Zeiss) at around 2 to 2.6µsec. The number of layers was also
set individually for each object and ranged from 40 to 100. The step size was
kept constant at 0.3 µm. Mastergain was set to 580 and digital gains were 6,
4 and 5 for 488 nm, 543 nm and 633 nm respectively.
Data Processing was done with ’Zen’ Software (Zeiss). After applying de-
sired color schemes and adding a scalebar the 3D image was projected onto
one layer with a maximum intensity projection. These images were then ex-
ported as png files. ImageJ [182] was used to replace the black background
by white color for a printer friendly version of the images and minor modifi-
cations on figure panels for better visibility.
3.3.6 dSTORM Measurements and Data
Immunolabeled cells as described in section 3.2.6 are changed to PBS pH7.4
containing oxygen scavenger (0.5mg/mL glucose oxidase, 40µg/mL catalase,
10% w/v glucose) and 50mm β -mercaptoethylamine (MEA) and sealed with
an adhesive silicon sheet to cover sample from fresh oxygen. For dSTORM
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measurements the samples are excited with 647 nm with a power of 100mW
for readout and 514 nm with a power of 0.9mW for switching the fluorophores
back to the on-state. Movies of 10 000 128 x 128 pixel frames with an integra-
tion time of 10msec at frame transfer with a read-out rate of 10 000Hz were
acquired for 3 cells a sample with Andor iXon software. For TIRF and for
autofluorescence control images the samples were irradiated with 3.2mW of
647 nm respectively with 0.9mW of 514 nm at an integration time of 100msec
on the full chip (512 x 512) as well as on the chosen dSTORM area only.
For data analysis the acquired movies were evaluated frame by frame with
the ’rapid STORM’ software, now distributed by PicoQuant GmbH Berlin
and as previously described by Heilemann et al. [35,183]. Fluorophore spots
exceeding a defined threshold of 700 and an allowed deviation of 0.1 from
an absolutely circular shape were fitted with a two-dimensional Gaussian
function. Its center of mass was defined to be the fluorophores exact posi-
tion. The raw picture derived by rapid STORM analysis is given with an
intensity coding, ranging from red over yellow to white with either black
background (figure 4.62) or gray background (section C.3), accomplished by
color substitution in ImageJ [182] for a printer friendly version. Further-
more, raw rapid STORM pictures are presented with a white background
(accomplished with ImageJ [182]) and a spectral color scale, encoding either
intensities (figure 4.66) or the frame in which respectively the time at which
the spot was detected (figure 4.67).
For further evaluation each list of spot coordinates was imported to Ori-
gin8, converted into a 128 x 128 matrix with a one-fold binning and equally
depicted as color contour plot, showing the amount of hits for each pixel (cf.
figure 4.63). Then a 40 x 40 submatrix of an area clearly filled with mem-
brane was chosen. From this area the total number of hits was counted and
plotted against the doxicycline induction time for every sample. Out of three
samples per value the mean and standard deviation were calculated and used
for either linear fits (controls) or the sigmoidal fit f(t) = I0+(I∞−I0) · tnkn+tn
for the positive sample, where I0 represents the start value, I∞ the saturation
value, n is the Hill coefficient [184], k the time at which half the maximum
value is reached and t the doxicycline induction duration.
Images showing TIRF illumination and autofluorescence at 514 nm were
only adjusted in brightness and contrast with Andor iXon software individ-
ually to show best visibility of the cells.
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4 Results and Discussion
In this chapter the major results obtained in this work will be presented and
discussed in two main sections.
First, results derived via enzyme investigations with fluorescent substrates
are depicted. As a prerequisite the utilized fluorescent substrates are care-
fully examined before being used for enzyme kinetics, the determination of
the label effect on substrate acceptance by the enzymes and the examination
of ideal temperatures and buffers for specific enzyme kinetics with fluorescent
substrates. Fluorescent substrates can not only be used in ensemble measure-
ments but also on a single molecule scale, which will be exemplarily shown
with surface immobilized enzymes, followed by investigations with fluorescent
substrates in living cells.
In the second section the results obtained by enzyme immunostaining are
presented. Here, the prerequisite of a suitable staining method has to be ex-
amined, before the enzyme occurrence in native and transfected mammalian
cell lines can be analyzed with different microscopy methods.
4.1 Enzyme Investigations with fluorescent Substrates
Fluorescent substrates have become a standard method in enzyme research,
because they allow the examination of a multitude of questions in a multitude
of different approaches and measurement setups [47, 161, 185–192, amongst
others].
Two different enzyme subclasses - peptidases and nucleases - are inves-
tigated with miscellaneous fluorescent substrates. Therefore, all of these
substrates are characterized in the first subsection, split by their assigned
enzyme subclass. The following single enzyme kinetics are also split into en-
zyme attributed subsections, while Michaelis-Menten kinetics are only shown
exemplary for one nuclease. For any of the utilized enzymes it is possible
to determine the effect of an attached fluorophore to the substrate accep-
tance, nonetheless, this is neither possible nor reasonable for every utilized
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substrate. Therefore, of each enzyme subclass, only one substitute was cho-
sen to be presented in chapter section 4.1.4. In contrast, the investigation of
ideal temperature settings is useful for any utilized combination of enzyme
and substrate. However, this would elongate this work substantially and is,
therefore, only presented for one peptidase and two nucleases. Also exem-
plary, the localization of Carboxypeptidase A on a single molecular scale is
presented, before the occurrence of nucleases in cells is examined with fluo-
rescent substrates.
4.1.1 Substrate Characterization
When incorporating fluorescent substrates for the research on enzyme activi-
ties, it is essential to characterize these substrates in the absence of enzymes.
This includes their absorption and emission spectra, their stability in vari-
ous conditions and their relative signal yield before enzyme procession. The
results of these measurements are of highest importance when judging on a
substrates potency for enzyme research. Therefore, this data is shown in the
following chapter. Since substrates for peptidases and substrates for nucle-
ases differ from each other due to their purposes, both kinds are presented in
individual sections.
Substrates for Peptidases
Generally, substrates for peptidases consist of peptides1. Depending on the
specific enzyme, these peptides can range from only a few amino acids to long
chains building tertiary structures. For the exopeptidase Carboxypeptidase
A six different substrates were tested, two of which only have a single amino
acid attached to the oxazine derivative MR121, as schematically shown in
figure 4.1. Therefore, they only offer one possible cleavage site.
It has been described, that tryptophan efficiently quenches the red-absorb-
ing oxazine derivative MR121 due to its strong electron donating properties,
while phenylalanine only shows little quenching efficiency on MR121 [28–
31]. As visible in the normalized spectra in figure 4.2, the attachment of a
single amino acid also results in small spectral shifts. While the absorption
spectrum of free MR121 fluorophore shows a maximum at 660 nm, MR121 -
1Enzymes are usually classified upon their major or first detected substrate specificity.
Nonetheless enzymes can also show activity on substrates that do not belong to their
assigned substrate class (cf. section 2.4.1 and section 2.4.2.1).
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a) MR121 -Phe b) MR121 -Trp
Figure 4.1: MR121 -Phenylalanine (Phe) and
MR121 -Tryptophan (Trp) schemes. Both sub-
strates only offer one cleavage site.
Figure 4.2: Normalized MR121, MR121 - Phe and MR121 -
Trp absorption and emission spectra.
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Phenylalanine absorbs most at 662 nm and MR121 -Tryptophan at 664 nm.
The emission spectra of both substrates are equally shifted by 2 nm and 4 nm
from the emission maximum of MR121 at 678 nm, respectively.
Another two of the six substrates are dipeptides, each carrying one tryp-
tophan residue at the C-terminus (see figure 4.3). Between MR121 and
tryptophan either phenylalanine or glycine, the smallest natural amino acid,
was incorporated.
In the normalized spectra both substrates show a 5 nm red-shift of the ab-
sorption maximum while the emission maximum is almost the same compared
to that of free MR121 (see figure 4.4).
The last two of the six substrates incorporated for peptidase research con-
sist of a MR121 attached phenylalanine, followed by either two or three
consecutive tryptophan residues (see figure 4.5).
These substrates, therefore, already offer a variety of cleavage sites. Again,
the normalized substrate spectra are shifted in comparison to those of the free
chromophore (see figure 4.6). While MR121 - Phe - (Trp)2 and MR121 - Phe -
(Trp)3 have an identical fluorescence maximum blue-shift of two to three
nanometers, their absorption spectra differ very strongly. MR121 -Phe -
(Trp)2 shows a familiar spectrum which is red-shifted by 6 nm. MR121 -
Phe - (Trp)3 though shows a red-shift of 9 nm. Furthermore, the plateau in
the absorption spectrum at around 615 nm is not only equally red-shifted,
but immensely increased from 46% of the total absorption to 75%. That can
only be assigned to the third consecutive tryptophan in this oligopeptide.
The raw absorption spectra are also used for the calculation of relative
quantum yields as described in section 3.3.2. The results are presented in
table 4.1. MR121 fluorescence yield is increased by 50% if phenylalanine is
attached to the dye. As expected [30], tryptophan quenches the fluorescence
very efficiently. The incorporation of a spacer results in a distinctly less effi-
cient quenching, because the distance of electron donor and electron acceptor
increases, which leads to less quenching events. The big difference between
MR121 -Gly -Trp and MR121 -Phe -Trp is caused by the fluorescence in-
creasing effect of phenylalanine on the one hand and the less size of glycine
on the other hand. Increasing the number of C-terminal tryptophan residues
amplifies the quenching efficiency, thus these oligopeptides are flexible and,
therefore, allow ’far’ tryptophan residues to come in close proximity with
MR121.
Peptide bonds are known to be rather stable even at high temperatures
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a) MR121 -Gly -Trp b) MR121 -Phe -Trp
Figure 4.3: MR121 -Glycine -Tryptophan and MR121 -
Phenylalanine -Tryptophan schemes. Both substrates offer
two cleavage sites, one of which each is a true peptide bond.
Figure 4.4: Normalized MR121, MR121 -Glycine -
Tryptophan and MR121 - Phenylalanine -Tryptophan ab-
sorption and emission spectra.
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a) MR121 -Phe - (Trp)2 b) MR121 -Phe - (Trp)3
Figure 4.5: MR121 -Phe - (Trp)2 and MR121 - Phe - (Trp)3
schemes. MR121 - Phe - (Trp)2 offers three cleavage sites, two of
which are true peptide bonds, MR121 - Phe - (Trp)3 offers four
cleavage sites with three true peptide bonds.
Figure 4.6: Normalized MR121 - Phe - (Trp)2 and MR121 -
Phe - (Trp)3 absorption and emission spectra.
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Table 4.1: Relative quantum yields
of labeled peptides.
substrate Φrel
MR121 -Phe 1.52
MR121 -Trp 0.01
MR121 -Gly -Trp 0.18
MR121 - Phe -Trp 0.33
MR121 - Phe - (Trp)2 0.17
MR121 - Phe - (Trp)3 0.09
[193,194]. This also applies for the peptide substrates utilized in this work as
can be seen in the normalized temperature graphs in figure 4.7. Obviously,
the thermal behavior of MR121 -Trp results from MR121 itself over the
whole applied thermal range, while MR121 -Phe shows a stronger decrease
of fluorescence intensity than the free chromophore, starting at a tempera-
ture of about 40°C. This indicates, that the fluorescence increasing effect of
phenylalanine declines with rising temperatures.
MR121 - Phe -Trp shows a similar decrease in fluorescence intensity at tem-
peratures higher than 40-50°C, which, therefore, must be dominated by the
same effect. Since, MR121 -Gly -Trp also shows a decrease in fluorescence
intensities in the same range, there must also be an improved quenching due
to the spacer amino acid. Thus the higher the temperature, the higher the
molecular movements and, therefore, the flexibility of a single peptide [195], it
can be assumed, that these short substrates are more efficiently quenched at
high temperatures due to an increased number of contact events. MR121 -
Phe - (Trp)2 and MR121 -Phe - (Trp)3 on the other hand ultimately show
increases in fluorescence intensities at rising temperatures. MR121 - Phe -
(Trp)2 already shows this increase beginning at 30°C, but reaches a plateau
with a 10% higher intensity at 55°C. MR121 - Phe - (Trp)3 shows a rather
stable fluorescence intensity up to 60°C and then rises distinctly. Despite
this small number of substrate components there can already be a lot of al-
ternative interactions and a formation of a spatial structure denaturing at
higher temperatures, which would lead to this ambiguous behavior [196,197].
Still, all these fluorescence intensity changes due to thermal variations are
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Figure 4.7: Thermal behavior of peptide substrates
and free MR121. Graphs are normalized to fluores-
cence intensities at 15°C.
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rather small, allowing the use of peptide substrates even at very high temper-
atures. It has to be regarded though, that a high working temperature will
change the determined relative quantum yields. Measurements in the range
of 15-30°C are entirely feasible without further alterations or additional com-
putations.
Substrates for Nucleases
Nucleases generally hydrolyze DNA2. Most nucleases process DNA in its nat-
urally most often occurring form of a double helix. Still, there are nucleases
that cleave single stranded DNA or complex forms like supercoiled plasmid
DNA (cf. section 2.4.2.2). When designing fluorescent substrates consisting
of DNA, these preferences should be considered and therefore appropriate
domains should be provided. Given, that the design of a supercoiled plasmid
DNA substrate with single and double stranded regions, that can be efficiently
quenched and instantly fluoresces upon any scission, is hardly possible, DNA
hairpins constitute a fairly good substitute.
In this work several DNA hairpins were utilized for the research on DNase I
and DNase II, both preferring double stranded DNA, S1-Nuclease, preferring
single stranded DNA and the barely familiar DNaseX, known to prefer su-
percoiled plasmid DNA (cf. section 2.4).
The designed hairpins can be summarized to two sets of highly related
structures. The first set of ten hairpins and their connections to each other
are presented in figure 4.8.
SP1 and SP2 only differ by minor sequence variations. A modification of
two nucleic acids changes SP2 to SP3, while a variable stem to loop ratio
and an according slight sequence variation distinguishes SP2 and SP4. SP2
was furthermore modified by two different methylation patterns and a sub-
stitution of loop bases to yield SP2CM, SP2AM and SP2AL. A methylation of
SP2AL yields SP2ALAM and a further methylation SP2ALmM. This substrate
is still closely related to SP2CM, which is also further modified by a variation
of the quenching mechanism.
Figure 4.9 shows the detailed structures of SP1, SP3 and SP4. These DNA
hairpins are not directly related to each other (cf. figure 4.8) but to a fa-
vorable substitute which will be presented later on. Still, this subset yields
2Enzymes are usually classified upon their major or first detected substrate specificity.
Nonetheless enzymes can also show activity on substrates that do not belong to their
assigned substrate class.
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Figure 4.8: Concept map of the set of ten DNA hairpins called
SmartProbes (SP).
an efficient introduction into DNA hairpin discussion, since it offers a com-
parably strong structure variation and, therefore, a rapid and early overview
on structural effects. SP1, SP3 and SP4 all carry an Atto 655 fluorophore
at the 5’ - end of the nucleic acid sequence. Each 3’ - end consists of several
guanosine residues, which are known to efficiently quench Atto 655 [30,32–34].
DNA hairpins built in this manner are generally called Smart Probes (in the
following abbreviated with ’SP’).
The nucleic acid sequence of SP1 is designed to form a double stranded
region forming the hairpin stem of eight base pairs and a single stranded
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region of 6 bases to form the hairpin loop. The loop only consists of thymine
residues due to its small shape which allows a high loop flexibility and, there-
fore, a short loop sequence. Furthermore, neither thymine nor its associ-
ation partner adenine effect Atto 655 fluorescence due to their high oxida-
tion potentials [30, 32]. The stem region comprises adenine - thymine and
cytosine - guanine pairs in a succession that allows only one distinct folding
structure [179]. Furthermore, guanine is placed sequentially far away from
Atto 655 and as close as possible at hairpin formation. Since guanine posi-
tions have an important effect on fluorophore quenching [198, 199], they are
consequently presented differently than the other nucleotide bases.
a) SP1 b) SP3 c) SP4
Figure 4.9: SP1, SP3 and SP4 structures.
SP3 also has a stem of 8 base pairs and a loop of six thymine residues.
Furthermore, there is an overlap of three bases at the 3’ - end. Those three
bases, approximated to be closest to Atto 655 in a hairpin formation, con-
sist of 7-Deaza-2’-deoxyguanosine (G7) [200], which has even higher electron
donating properties than guanosine itself [32]. To allow only one folding
structure [179] and still incorporate as many guanines as possible, the dou-
ble stranded sequence alternates stronger between base pairs than SP1 stem
sequence.
SP4 consists of a five base pair long stem and a ten thymines long loop. It
also has an overlap of three guanines at the 3’ - end of the sequence and can
only form one structure [179].
As figure 4.10 shows, the attachment of nucleotide sequences changes the
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Figure 4.10: Absorption and emission spectra of SP1, SP3
and SP4 compared to those of free Atto 655.
Figure 4.11: Thermal stability of SP1, SP3 and SP4 compared
to that of free Atto 655.
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absorption and emission spectra to longer wavelengths. While Atto 655 has an
absorption maximum at 662 nm, all three smart probes reveal an absorption
maximum at around 667 nm. The emission maximum also shifts by 5 nm
from 680 nm for Atto 655 to 685 nm for SP1, SP3 and SP4.
Phosphodiester bonds in a DNA strand are very stable even at high tem-
peratures. Base pairing hydrogen bonds, though, are only stable up to a
specific temperature, destined by the buffer composition and the amount of
surrounding base pairs [201, 202]. Once hydrogen bonds break, the hairpin
formation denatures and guanosine residues lose spatial contact to Atto 655,
which results in decreasing quenching efficiencies. This can be observed in fig-
ure 4.11. Up to 50°C the normalized fluorescence intensities of SP1, SP3 and
SP4 follow the intensity of free Atto 655. Between 50°C and 90°C Atto 655
fluorescence intensity continuously decreases, while SP1 fluorescence intensity
slightly rises up to 70°C, where a much stronger increase in intensity begins.
A saturation value is not reached until 90°C, therefore, a melting temperature
cannot be distinctly determined, a Boltzmann fit, though, suggests 91.9 °C
± 1.3 °C. SP3 normalized fluorescence intensity distinctly rises between 50°C
and 90°C, indicating a saturation value at very high temperatures. Here,
the determined melting temperature amounts to 96 °C ± 1.6 °C. SP4 fluo-
rescence intensity stays rather constant up to 60°C before rising up to 90°C.
Despite there is no distinct saturation plateau, a melting temperature can be
determined to 76.3 °C ± 0.2 °C.
Table 4.2: Calculated melting temperatures, Gibbs free energy
and evaluated relative quantum yields of SP1, SP3 and SP4.
calculated Gibbs
melting free evaluated
substrate temperature energy Φrel
[ °C ] [ kcal/mol ]
SP1 82.9 -7.48 0.22
SP3 80.9 -8.01 0.15
SP4 65.3 -3.15 0.28
All determined melting temperature top the calculated values [179] as pre-
sented in table 4.2 by 10°C and more. Since calculations are made for indi-
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vidual DNA strands and an intramolecular binding is comparably stronger,
it can be assumed that actual melting temperatures indeed meet the deter-
mined values better than the calculated ones, which is already indicated by
the temperature dependency graphs in figure 4.11.
Zuker also provides calculations of the free Gibbs energy of the utilized
smart probes [179]. These energies mostly correlate with stem to loop length
ratio as can be seen in table 4.2. This ratio, the melting characteristics and
the amount of guanine respectively 7-Deaza-2’-deoxyguanosine determine the
relative quantum yield of the smart probes in comparison to Atto 655. While
SP1 fluoresces with 22% of the intensity free Atto 655 shows, the attachment
of a guanine overlap and the incorporation of modified guanine in SP3 lowers
the relative quantum yield to 0.15. The variation of stem to loop length ratio
results in less efficient quenching despite the utilization of a 3-mer guanine
overlap in SP4.
Concerning quenching efficiency and melting characteristics, SP1 and SP3
clearly dominate over SP4. Their evolutionary intermediate SP2 and five
modifications of it are presented in figure 4.12. SP2 has the very same nu-
cleic acid sequence as SP3, except for the two guanine modifications at po-
sition 22 and 23. Here, SP2 has standard guanine bases. Therefore, SP2
differs from SP1 only by small sequence variations and the 3-mer guanine
overlap3. SP2 was modified by methylations to yield SP2AM, which carries a
N6-Methyl-2’-deoxyadenosine (N6-Methyl-2’-dA) at position 17 and SP2CM,
which incorporates N4-Methyl-deoxycytidine (N4-Methyl dC) at position 2.
A further modification of SP2 is the substitution of all thymines in the hair-
pin loop by adenosine residues, yielding SP2AL. This smart probe was again
methylated with N6-Methyl-2’-dA at position 17 and additionally at position
12 to yield SP2ALAM. A supplementary modification with N4-Methyl dC at
position 2 finally yields SP2ALmM.
As can be seen in figure 4.13 and figure 4.14, SP2 and all its variations
show the same 5 nm redshift of absorption and emission maxima, compared
to free Atto 655 as SP1, SP3 and SP4.
Figure 4.15 shows the melting characteristics of SP2, SP2AM and SP2CM
compared to that of free Atto 655. These hairpins reveal a lower normalized
fluorescence intensity than Atto 655 up to 60°C for SP2 and SP2AM and 70°C
for SP2CM. The hairpin stem in this sequence obviously contracts in this tem-
3For the connections between any of these smart probes also see figure 4.8.
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a) SP2 b) SP2AM c) SP2CM
d) SP2AL e) SP2ALAM f) SP2ALmM
Figure 4.12: SP2, SP2AM, SP2CM, SP2AL,
SP2ALAM and SP2ALmM structures.
perature range, increasing the quenching efficiency. Around 65°C both SP2
and SP2AM show a strong increase in fluorescence, which demonstrates that
the hairpin structure denatures, preventing efficient quenching. Since SP2CM
carries the very same nucleic acid sequence but shows the same fluorescence
intensity effects each at a ten degrees higher temperature, it can be assumed
that the hairpin does not actually denature at higher temperatures, but that
the N4-Methyl dC modification in such a constantly close distance to the flu-
orophore also has a quenching effect. Determined melting temperatures are
88.3 °C ± 1.2 °C for SP2, 87.5 °C ± 1.3 °C for SP2AM and 88.9 °C ± 1.7 °C
for SP2CM, which yields 88.2 °C ± 0.8 °C for all.
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Figure 4.13: Absorption and emission spectra of SP2, SP2AM
and SP2CM compared to those of free Atto 655.
Figure 4.14: Absorption and emission spectra of SP2AL,
SP2ALAM and SP2ALmM compared to those of free Atto 655.
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Figure 4.15: Thermal stability of SP2, SP2AM and SP2CM
compared to free Atto 655.
Figure 4.16: Thermal stability of SP2AL, SP2ALAM and
SP2ALmM compared to free Atto 655.
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Melting characteristics of SP2AL, SP2ALAM and SP2ALmM compared to
free Atto 655 are presented in figure 4.16. These three smart probes show
a normalized fluorescence intensity which equals that of Atto 655 only up
to 40°C after which the hairpins start a slow increase in fluorescence up to
75°C. The twofold N6-Methyl-2’-dA modified SP2ALAM shows a lower fluores-
cence intensity than the unmethylated SP2AL, while the multiple methylated
SP2ALmM shows the highest fluorescence intensity over a wide thermal range.
Melting temperatures could be determined to 84 °C ± 0.5 °C for SP2AL and
86.6 °C ± 0.7 °C for SP2ALAM. For SP2ALmM no reasonable melting temper-
ature could be determined by Boltzmann fits.
Table 4.3: Calculated melting temperatures, Gibbs free energy
and evaluated relative quantum yields of SP2, SP2AM, SP2CM,
SP2AL, SP2ALAM and SP2ALmM.
calculated Gibbs
melting free evaluated
substrate temperature4 energy4 Φrel
[ °C ] [ kcal/mol ]
SP2 80.2 -7.91 0.19
SP2AM 68.5 -4.46 0.24
SP2CM 78.1 -5.26 0.14
SP2AL 80.9 -8.01 0.37
SP2ALAM 69.2 -4.56 0.23
SP2ALmM 59.6 -1.91 0.20
The determined melting temperatures for SP2 and its modifications also
override the computed melting temperatures by several degrees [179]. SP2,
SP2AM and SP2CM showed a higher melting temperature than SP2AL and
its methylated version although computationally expected differently. This
indicates on the one hand, that methylated bases pair ordinarily with their
nucleic acid matches, and on the other hand, that a hairpin with a 6-mer
loop, consisting only of adenines, is indeed not as stable as a hairpin with a
4Since the effect of N6-Methyl-2’-dA and N4-Methyl dC are not predictable with ’mfold’
[179], methylated bases were stated as non-pairing bases.
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6-mer loop of only thymines. The calculated melting temperatures and Gibbs
free energies should, therefore, only be conditionally regarded for hairpin
structures.
Comparing SP2 with SP1 and SP3 in regard to structures and melting
temperatures, one should expect nearly identical melting temperatures, since
the base pairs are nearly identical as well. Computed melting temperatures
(see table 4.2 and table 4.3), indeed, only show slight deviations. Determined
melting temperatures though vary between 88.3 °C ± 1.2 °C for SP2 and
96.0 °C ± 1.6 °C for SP3. It should be assumed, that SP3 and possibly also
SP1 determined melting temperatures are not realistic due to the unconfident
Boltzmann fit, and should ,therefore, be in the range of the SP2 melting
temperature.
Temperature profiles (figure 4.15, figure 4.16) have already indicated rel-
ative quantum yields of SP2 and its direct relatives. SP2 has a relative
quantum yield of 0.19 compared to free Atto 655, which averages SP1 and
SP3 relative quantum yields (cf. table 4.2). N6-Methyl-2’-dA at position 17
(SP2AM) decreases the quenching efficiency considerably. To the same ex-
tent N4-Methyl dC at position 2 (SP2CM) increases the quenching efficiency
as has been expected by temperature profiles (figure 4.15). Thus, SP2CM
represents the best quenched smart probe in this set. The SP2AL relative
quantum yield of 0.37 again proves the reduced stability of the hairpin by a
deoxynucleoside substitution in the loop. Here, both methylation variations
increase the quenching efficiency, not reaching an efficiency as good as that
of the unmethylated SP2.
The favored fluorescent substrates for enzyme research have been FRET
systems over PET systems, because FRET is easily to incorporate in any
sample and accessible at any desired wavelength. Also, FRET usually has
a very high quenching efficiency, since it works at distances one order of
magnitude higher than PET [47, 150, 203–205]. On the other hand, FRET
systems carry several disadvantages over PET systems. Due to the necessity
of two modifications (e.g. either two fluorophores or one fluorophore and a
dark quencher) the synthesis consumes a longer time, results in higher costs
and, statistically, the amount of not properly labeled substrates is higher
than in a process that only involves one modification. Furthermore, the
probability for the natural substrate to be accepted by an enzyme, especially
for very small substrates, is much higher if there is only one foreign substance
attached to it.
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Therefore, FRET systems should only be used if their advances rule out the
intrinsic drawbacks. To evaluate this ratio, SP2CM was modified by a substi-
tution of photo-induced electron transfer quenching to fluorescence resonance
energy transfer to a dark quencher (cf figure 4.8). Therefore, Atto 655 was
displaced by Dy 631 and the appropriate quencher DyQ660 was attached
to the 3’-end of the nucleotide sequence. The structure of this molecular
beacon5, SP2CM-FRET, is presented in figure 4.17.
Figure 4.17: SP2CM-FRET structure.
Naturally, this substrate shows absorption and emission spectra that are
different to the smart probes, because it carries another fluorophore. The
derived spectra are presented in figure 4.18.
Dy 631 shows an emission maximum at 654 nm. The absorption spectrum
of this molecular beacon shows two peaks, resulting from the absorption max-
imum of the fluorophore and the dark quencher. The absorption maximum,
which corresponds to fluorophore absorption, is at 610 nm. Melting charac-
teristics of this molecular beacon are similar to those of the corresponding
smart probe, except for slight differences influenced by varied fluorophores and
the additional thermal influence of the dark quencher. The relative quantum
yield of SP2CM-FRET6 amounts to 0.17 at neutral pH.
In this case, FRET quenching obviously cannot compete with PET quench-
5DNA hairpins, carrying a FRET pair, are called molecular beacons instead of smart
probes.
6Here, the intact molecular beacon is related to an enzyme-processed beacon, so a part of
the nucleotide sequence is most likely still attached to the fluorophore.
82
4.1 Enzyme Investigations with fluorescent Substrates
Figure 4.18: Absorption and emission spectra of SP2CM -
FRET compared to those of free Atto 655.
ing and would have to be optimized by different quenching FRET pairs and
positions. Also, a combination of FRET and PET could be utilized. Since the
presented smart probes already deliver very satisfactory quenching efficien-
cies, the intrinsic drawbacks of molecular beacons do not need to be risked,
so a further quenching modification can be abandoned.
The second set of smart probes only consists of three pieces, named VIP7,
depicted in figure 4.19. VIP control consists of a 17 base pair long hair-
pin stem and a nine bases long loop, formed only of adenine residues. The
complete nucleotide sequence carries solely three guanines, in order to avoid
quenching of Atto 655 attached to the 5’-end of this hairpin. Therefore, this
smart probe merely has a control function, as the name indicates.
VIP ds carries a 14 base pair stem, a nine guanine loop and a three gua-
nine overlap at the 3’-end of the sequence. In total, 19 out of the 40 bases
are guanosine residues, indicating a strong quenching potential on the at-
tached Atto,655. This smart probe is called VIP ds, since only upon a double
stranded (ds) scission it would immediately start fluorescing. Upon single
stranded (ss) scission, it would either keep its double stranded region, or
7In analogy to the smart probes, these substrates were called very intelligent probes, ab-
breviated VIP.
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a) VIP control b) VIP ds c) VIP ss
Figure 4.19: VIP control, VIP ds and VIP ss schemes.
fold into a smaller hairpin, again positioning guanines in close proximity to
Atto 655 [179]. VIP ss on the other hand functions as a single stranded scis-
sion marker. This smart probe carries a 17 base pair stem with only three
guanines and a nine guanosine residues loop. Therefore, its Atto 655 is not
quenched initially and will not be upon ds scission. Upon ss scission though,
the remaining nucleotide forms a new, smaller hairpin, bringing the guanosine
residues into close proximity to Atto 655 [179].
Regarding the absorption and emission spectra, which are presented in fig-
ure 4.20, all VIP probes show a slight red shift of absorption maximum by
6 - 8 nm and an emission maxima red shift by 4 - 6 nm. The absorption spec-
trum, furthermore, shows, that the Atto 655 absorption plateau at around
615 nm with a normalized absorption intensity of 0.47 is also red shifted by
5 -7 nm for all VIP probes, but shows a difference in absorption intensities.
While the non quenched VIP control even shows a slightly higher normalized
absorption of 0.48, VIP ds has a normalized absorption intensity of 0.41 and
VIP ss a value of 0.44. Thus, it can be assumed, that this value corresponds
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Figure 4.20: Absorption and emission spectra of VIP control,
VIP ds, VIP ss compared to those of free Atto 655.
Figure 4.21: Thermal stability of VIP control, VIP ds, VIP
ss compared to free Atto 655.
85
4 Results and Discussion
to the amount of guanosine residues in the nucleotide sequence of the smart
probe.
Figure 4.21 presents the thermal characteristics of the VIP probes in com-
parison to free Atto 655. Although VIP control was designed to be un-
quenched, its fluorescence intensity does not overlay the free chromophores
thermal fluorescence characteristics. Instead, beginning around 43 °C, VIP
control shows a higher normalized fluorescence intensity, meaning there is a
nucleotide effect on Atto 655, despite its very small amount of guanines. A
melting temperature cannot be fitted for this course, though. VIP ds, thus
initially quenched, shows a strong thermal fluorescence intensity dependency,
beginning at 40 °C. A Boltzmann fit determines the melting temperature to
79.3 °C ± 0.6 °C. VIP ss, initially non-quenched, also shows a characteristic
increase in fluorescence intensity, starting not until 60 °C. The determined
melting temperature is 76.7 °C ± 1.2 °C. Since VIP ss and VIP control carry
almost identical nucleotide sequences and, therefore, show nearly identical
base pairing (cf. figure 4.19), it can be assumed, that VIP control has a
similar melting temperature as VIP ss.
This guesswork is supported by computed melting temperatures and the
Gibbs free energies [179], given in table 4.4.
Table 4.4: Calculated melting temperatures, Gibbs free energy
and evaluated relative quantum yields of VIP control, VIP ds
and VIP ss.
calculated Gibbs
melting free evaluated
substrate temperature energy Φrel
[ °C ] [ kcal/mol ]
VIP control 71.8 -11.1 0.95
VIP ds 79.1 -12.23 0.26
VIP ss 71.4 -11.23 0.79
VIP ss and VIP control show nearly identical computed values. VIP ss de-
termined melting temperature tops the computed value by several degrees (cf.
table 4.2), while VIP ds determined melting temperature perfectly matches
the calculated value. Evaluated relative quantum yields given in this table
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prove the assumption made above. VIP control is very slightly quenched, but
VIP ss, carrying the same amount of guanines in the nearly identical hairpin
stem, is quenched a lot more. This can only be assigned to the guanosine
loop despite its distance from the chromophore, suggesting long range energy
transfer [88, 199, 206]. As expected, VIP ds is efficiently quenched to yield
only 26% of the fluorescence intensity free Atto 655 shows, which is not as
good as could have been expected by a comparison to SP2 and SP4 structures
and their relative quantum yields.
To investigate the advantage of smart probes over other substrates, also
the commercially available nuclease substrate ’DNaseAlert’ was examined.
DNaseAlert is published to be a synthetic oligonucleotide, carrying a HEX™
reporter dye. The normalized spectra of this substrate are depicted in fig-
ure 4.22. The absorption maximum is around 537 nm and the emission max-
imum at 553 nm. Therefore, this fluorescein based substrate has a very small
Stokes shift at a spectral range that is not ideally suited for biological sam-
ples.
Figure 4.22: Absorption and emission spectra of DNaseAlert
substrate.
DNaseAlert shows a constantly rising fluorescence intensity with rising tem-
perature, as presented in figure 4.23. Since the detailed structure of this sub-
strate is not published, this cannot be further interpreted. Still, DNaseAlert
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Figure 4.23: Thermal stability of DNaseAlert substrate.
has a major advantage over all presented smart probes: This substrate has
a relative fluorescence intensity in its initial state8 of 0.03 at neutral pH -
about a fifth of the best quenched examined smart probe.
4.1.2 Enzyme Kinetics
The fluorescent substrates, that have so far only been tested for temporal
and spectral characteristics, need to be examined in the presence of an en-
zyme to judge on their suitability for their assigned research. The results of
these measurements are presented in this chapter, which again is divided into
enzyme subclass assigned sections.
Peptidases and their Substrates
The peptide substrates, introduced in section 4.1.1, were designed for the use
with Carboxypeptidase A. This enzyme is known to process peptide bonds
between nearly every amino acids by C-terminally releasing mono-, di- or
tripeptides [65–68, 207] (cf. section 2.4.2.1). Therefore, in any utilized pep-
tide substrate the C-terminal tryptophan residues can be stripped, which
would then diffuse away from the fluorophore, disabling the quenching mech-
8related to its enzyme processed state
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anism. Thus, a strong increase in fluorescence should be obtained upon
enzyme addition to a substrate, while the substrate itself ideally shows a
constant fluorescence intensity during the complete measurement time scale.
Figure 4.24: Fluorescence intensity variation of
MR121 - Phe -Trp in absence and in presence of
Carboxypeptidase A.
Figure 4.24 shows MR121 - Phe -Trp fluorescence intensity over time in
presence and in absence of Carboxypeptidase A. After enzyme addition, the
fluorescence intensity immediately rises, while it stays absolutely constant for
six hours, if no enzyme is present. The same behavior occurs with any other
utilized peptide substrates (data not shown).
Figure 4.25 shows a set of comparable measurements with all introduced
peptide substrates. MR121 - Phe shows a slight decrease in fluorescence in-
tensity, reaching a 0.98 fold initial intensity after 6 hours. Thus, it is not
possible to make a statement about an enzyme procession of this substrate.
MR121 -Trp shows a very slow increase in fluorescence upon Carboxypep-
tidase A addition. 6 hours after addition , the intensity has only reached a
signal that is 1.7 fold as high as the starting intensity. After 45 hours, the
signal reached a 5.5 fold starting intensity. Regarding the relative quantum
yield of 0.01 (cf. table 4.1) a signal 100 fold as high as that at the beginning
of the reaction should be possible. MR121 -Gly -Trp and MR121 - Phe -Trp
both show a comparably fast increase in fluorescence intensity. After 2.5
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Figure 4.25: Normalized fluorescence intensity
plots of all utilized peptide substrates upon addition
of Carboxypeptidase A.
90
4.1 Enzyme Investigations with fluorescent Substrates
hours the saturation of a 5.6 respectively to a 3.3 fold initial intensity is al-
most reached, which is in perfect accordance to the examined relative quan-
tum yields. MR121 -Phe - (Trp)2 approximates its saturation intensity of a
9.0 fold starting intensity already 20 minutes after enzyme addition, while
MR121 - Phe - (Trp)3 takes more than 2 hours to reach a 17.3 fold start-
ing intensity. Multiplied by their relative quantum yields, both substrates
reveal a final intensity, that is 1.5 fold the signal shown by free MR121,
similar to MR121 -Phe relative quantum yield. This indicates, that both of
these substrates are relieved from all tryptophans they carried, but mostly
keep their attached phenylalanine for the complete observation time of 100
minutes. Since MR121 -Phe -Trp is obviously processed into free MR121
without any attached phenylalanine, this could indicate a general preference
of Carboxypeptidase A for producing dipeptides over monopeptides. Fur-
thermore, the question whether MR121 - Phe is processed at all needs to be
asked.
HPLC measurements were used to address these problems. MR121 - Phe
and Carboxypeptidase A were incubated for 24 hours before HPLC analysis
started. A distinct MR121 signal elevated next to a high peak of unprocessed
MR121 - Phe. MR121 - Phe -Trp, equally treated, was found to be processed
at both possible cleavage sites, mostly though stepwise. Therefore, a stepwise
scission of MR121 - Phe - (Trp)2 and MR121 - Phe - (Trp)3 is very likely, which
would be more slowly and, therefore, possibly not be finished in the presented
observation time of 100 minutes, due to the higher amount of amino acids.
Most intriguing in HPLC measurements was the measurement on MR121 -
Gly -Trp. Even after four days of incubation with Carboxypeptidase A, when
both slowly processed substrates MR121 -Phe and MR121 -Trp had been
completely converted into amino acids and free fluorophore, MR121 -Gly -
Trp was solely cleaved into MR121 -Gly and free tryptophan. MR121 -Gly
was not processed by this enzyme by any means, implying there is no hidden
competitive inhibition in this reaction.
MR121 -Gly -Trp, therefore, represents the ideal fluorescent substrate for
Carboxypeptidase A research, because it is efficiently quenched in its intact
state with a relative quantum yield of 0.18, it is rapidly processed by the
enzyme and the only process that can occur between these two reactants is
clearly visible.
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Nucleases and their Substrates
Most nucleases do not only work on specific sequences. Therefore, it has to
be expected that the designed smart probes are accepted by several nucleases.
Still, DNA sequences can be modified in order to optimize the desired accep-
tance and downgrade others. The presented smart probes were customized to
allow a discrimination between DNaseI and the very similar DNaseX. Most
important for smart probe functionality is a nucleolytic cleavage, that results
in a breakage of the DNA backbone. At an appropriate combination of cleav-
age position, double stranded region size and sample temperature, base pairs
detach from each other, ultimately resulting in the degradation of the double
stranded region. By diffusion fluorophore and quenchers lose contact, yield-
ing an increase in fluorescence. On the time scale and measurement settings
of such a reaction, the smart probe needs to stably fluoresce, if there is no
enzyme present. Figure 4.26 representatively proves with SP1 and DNaseI
Figure 4.26: Fluorescence intensity variation of
SP1 in absence and in presence of bovine DNaseI.
presence and its absence, that this demand can be answered.
Since a noteworthy number of smart probes was examined with DNaseI,
DNaseII, S1-Nuclease and DNaseX in this work, the results are reasonably
split into several graphs. Figure 4.27 shows the normalized fluorescence in-
tensity plots of SP1 and its successors SP2 and SP3 (cf. figure 4.8) upon
addition of bovine DNaseI. 10 minutes after enzyme addition, SP1 approx-
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Figure 4.27: Normalized fluorescence intensity plots of
all SP1, SP2 and SP3 upon addition of bovine DNaseI in
DNaseI-buffer.
imates its saturation intensity, which is 6.3 fold higher than the starting
intensity. SP2 is processed in around 5 minutes to yield a 8.1 fold intensity
and for SP3 it takes 7 minutes to reach a 9.6 fold intensity as that at the
beginning of the process. The comparison of examined fluorescence increase
with relative quantum yields (table 4.2, table 4.3) reveals, that these samples
actually show a stronger increase than they should be able to. This must be
accounted to the effect of the specific DNaseI buffer on the fluorophore and
the quenching mechanism9.
Thus SP2 is processed the fastest and shows a strong increase in fluores-
cence intensity upon DNaseI addition without any high-cost 3’-modifications,
it offers a good basis for nuclease comparison. For the best contrast in smart
probe structure, SP4 is integrated into this arrangement, which is depicted in
figure 4.28.
For this measurement, each enzyme was tested in an appropriate environ-
ment (cf. section 2.4 and section 3.2.1) and equivalent substrate concentra-
tions. Enzyme concentrations were adjusted to show sufficient results within
9Relative quantum yields in DNaseI-buffer are generally at around 70% of those in PBS.
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a)
b)
Figure 4.28: Normalized fluorescence intensity plots of
SP2 and SP4 upon addition of bovine DNaseI ( a) ), DNa-
seII ( b) ), S1-Nuclease ( c) ) and DNaseX ( d) ).
30 minutes10,11. While SP2 is completely processed by DNaseI in 25 minutes,
10This results in a stretched increase in normalized fluorescence increase of SP2 in presence
of DNaseI of figure 4.28 a) in comparison to that one shown in figure 4.27.
11This adjustment could not be realized for DNaseX without accepting very high dilution
effects on fluorescence signals due to its little activity. Therefore DNaseX measurements
were allowed to result in remarkable signals within 80 minutes.
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c)
d)
Figure 4.28: Normalized fluorescence intensity courses of
SP2 and SP4 upon addition of bovine DNaseI ( a) ), DNa-
seII ( b) ), S1-Nuclease ( c) ) and DNaseX ( d) ).
SP4 already approximates its maximum fluorescence intensity after 12 min-
utes. As expected by relative quantum yields, the signal that is obtained by
SP4 is not as high as that of SP2. DNaseII processes SP2 and SP4 in similar
time scales, whereas SP4 actually yields a stronger increase in fluorescence
intensity than SP2. Generally, the achieved signal increase by DNaseII is very
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low compared to the signal obtained by DNaseI, because DNaseII requires a
buffer at much lower pH value, which negatively effects initial quenching ef-
ficiencies. Next to the same pH value reduction, smart probes in S1-Nuclease
research also meet a temperature decrease by 17°C, which suits initial quench-
ing efficiencies better. As anticipated due to S1-Nuclease specificity for single
stranded DNA [156, 208], SP4 reaches its saturation value faster than SP2,
because it offers a larger hairpin loop. Unlike the other tested nucleases,
DNaseX clearly shows that it processes SP2 faster than SP4. While the SP2
sample reaches its saturation 100 minutes after enzyme addition, the nor-
malized fluorescence intensity graph showing SP4 signal, does not indicate
any saturation. For a discrimination of DNaseX from other nucleases, SP2
constitutes an optimal basis.
Since DNaseX is suggested to detect and destroy foreign DNA [43], it can be
assumed, that this enzyme might be sensitive to methylation patterns which
contribute to the epigenetic code [209]. Therefore, SP2 was methylated in
different ways. The methylation effects on substrate acceptance for DNaseX
and its homologue DNaseI are presented in figure 4.29.
The increase in fluorescence intensity of SP2 upon DNaseI cleavage is de-
termined to 7.8 fold compared to the intensity before enzyme addition (cf.
figure 4.27). Half of this increase is reached after 11 minutes. SP2AM shows
the same velocity as SP2, but a different maximum intensity of only 5.9 fold
the starting intensity in accordance to relative fluorescence quantum yields
(cf. table 4.3). A methylation of adenine at position 17 does, therefore, not
effect the procession of this smart probe by DNaseI. A methylation of cyto-
sine at position 2 on the other hand, reaches half of its maximum increase
to a 9.5 fold starting intensity already at 7.5 minutes, meaning that DNa-
seI is strongly attracted by SP2CM. The substitution of all loop inherited
thymines to adenines does not only affect the relative quantum yield and,
therefore, the fluorescence increase that is obtained upon cleavage by DNa-
seI, but also its attraction to this enzyme. Half of the increase SP2AL shows,
has only happened 13 minutes after nuclease addition. Again, the methyla-
tion of adenines, that was applied in SP2ALAM, does not change its procession
velocity by DNaseI, because half of its fluorescence increase has happened at
13 minutes as well. The additional methylation of cytosine at position 2, that
yields SP2ALmM, decelerates the observed kinetics. 18 minutes after DNaseI
addition, half of the determined maximum signal increase is reached.
Summing up DNaseI kinetics, N6-Methyl-2’-dA does not effect smart probe
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a)
b)
Figure 4.29: Normalized fluorescence intensity plots of
SP2, SP2AM, SP2CM, SP2AL, SP2ALAM and SP2ALmM
upon addition of bovine DNaseI ( a) and b) ).
digestion, let it be in the hairpin loop or stem region, while N4-Methyl dC at
position 2 distinctly induces changes to DNaseI kinetics. Here, it can only be
assumed, that DNaseI only prefers the cytosine methylation, as long as there
are little or no other methylations present or close by. Furthermore, the wider
structure, induced by SP2AL, decreases the digestion velocity, which can be
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c)
d)
Figure 4.29: Normalized fluorescence intensity plots of
SP2, SP2AM, SP2CM, SP2AL, SP2ALAM and SP2ALmM
upon addition of DNaseX ( c) and d) )
accounted to the reduced preferred double stranded region. For DNaseI re-
search, therefore, SP2CM generates the ideal smart probes, because it provides
the fastest and strongest feedback of all examined hairpin substrates.
The equivalent measurements, carried out with DNaseX, do not reveal
or even indicate a fluorescence intensity saturation value, despite their long
98
4.1 Enzyme Investigations with fluorescent Substrates
observation times of up to 42 hours. Therefore, a detailed evaluation is
hardly possible. Presuming a similar behavior of all examined smart probes
in these comparable measurements12, the following precarious conclusions can
be drawn: Half of the supposed maximum fluorescence increase is reached for
SP2AM after 590 minutes, followed by SP2CM with 745 minutes. Then, SP2,
SP2ALmM and SP2ALAM show their half maximum fluorescence increase at
840 minutes, 845 minutes, and 875 minutes, respectively. Finally, SP2AL
reaches its half maximum value at 940 minutes. Thus, it can be assumed,
that DNaseX indeed prefers a methylation pattern, especially of N6-Methyl-
2’-dA at position 17, and totally neglects an adenine loop, particularly if the
sequence does not carry any methylation. This ranking list13 clearly distin-
guishes DNaseX from DNaseI and could be taken into account for a further
adaption of smart probes for research on either one of these nucleases. The
DNaseI favorite SP2CM also displays a fair candidate for DNaseX research,
because of its good compromise between velocity and quenching efficiency.
Therefore, SP2CM was modified to SP2CM-FRET (cf. figure 4.17) for a
balance of quenching mechanisms. Both hairpin versions were then examined
in presence of all introduced nucleases, as presented in figure 4.30.
SP2CM shows a familiar increase in fluorescence intensity upon addition of
DNaseI, while the equivalent FRET quenched hairpin shows a different course
and, most interestingly, a lower relative increase in fluorescence intensity.
This indicates, that FRET quenching of this hairpin is not as efficient as PET
quenching of the smart probe. With DNaseII at acidic pH value, this behavior
tilts over. Here, SP2CM-FRET clearly dominates over SP2CM. Remarkably,
both observed fluorescence kinetics show a characteristic increase shape, that
can also be found for SP2 and SP4 in DNaseII presence in figure 4.28. This
clearly proves that DNaseII processes the hairpins differently than DNaseI.
In S1-Nuclease presence SP2CM shows a quite common fluorescence intensity
plot with a low saturation intensity due to the acidic pH value. SP2CM-
FRET on the other hand reveals a peculiar development. After a maximum
value has been reached, the fluorescence intensity distinctly decreases. Since
all measurements were equally accomplished, this cannot be accounted to
12DNaseI and DNaseX were examined in the same buffer, at the same temperature and
with equal substrate concentrations.
13This ranking list is only presumed, because it resulted from the assumption, that the
utilized smart probes reach saturation values upon DNaseX scission, that are similar to
those yielded by DNaseI cleavage.
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a)
b)
Figure 4.30: Normalized fluorescence intensity courses of
SP2CM and SP2CM-FRET upon addition of bovine DNaseI
(a)), DNaseII (b)), S1-Nuclease (c)) and DNaseX (d)).
any photophysical process and must, therefore, be associated with the S1-
Nuclease itself. Possible explanations for this are a nicking of the attached
fluorophore by S1-Nuclease or a cleavage of the label bond, which itself could
have amplified the fluorescence yield.
Both hairpin variations show a familiar shape of fluorescence intensity in-
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c)
d)
Figure 4.30: Normalized fluorescence intensity plots of
SP2CM and SP2CM-FRET upon addition of bovine DNaseI
(a)), DNaseII (b)), S1-Nuclease (c)) and DNaseX (d)).
crease in presence of DNaseX, where again SP2CM reveals a higher relative
saturation intensity. Comparing the applied quenching mechanisms, it can
be summarized that at neutral pH the PET quenched SP2CM gives better
results, while at acidic pH, SP2CM-FRET enables a higher increase in fluo-
rescence intensities.
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In presence of DNaseI, SP2CM reveals a half maximum time of 5 min-
utes. SP2CM-FRET shows a completely different fluorescence intensity plot
with a half maximum time of only 1.5 minutes. In the DNaseII sample,
SP2CM reaches half of its determined fluorescence intensity gain 7 minutes
after enzyme addition and SP2CM-FRET in only 3.25 minutes. Due to the
SP2CM-FRET fluorescence decrease in presence of S1-Nuclease, a half maxi-
mum time cannot be determined. Apparently though, it also seems to occur
earlier than that of SP2CM 4.75 minutes after enzyme addition. Since SP2CM
does not reach a fluorescence intensity saturation in DNaseX sample within
the observation time, the half maximum time of SP2CM clearly exceeds 2.75
minutes, which is the duration it takes DNaseX to convert SP2CM-FRET to
show half of its maximum signal increase. Therefore, with every examined
nuclease, SP2CM-FRET is processed distinctly faster than SP2CM. Since the
sequences of these hairpins are identical, this means that the attachments
greatly affect enzyme affinities to specific substrates. Most remarkably, the
utilized double modification suits all nucleases better than a single labeling of
Atto 655. It should be assumed, though, that this is attributed to the specific
utilized fluorophores or dark quenchers more than to the number of chemical
modifications (cf. section 4.1.4).
The second set of smart probes, designed for allowing a discrimination be-
tween double and single stranded scission of nucleases, was examined with
DNaseI, known to preferentially process ds DNA and S1-Nuclease, preferring
ss DNA. The results were then used to characterize DNaseX scission. The
normalized fluorescence intensity profiles are presented in figure 4.31.
VIP control is hardly quenched due to its lack of guanosine residues (cf.
figure 4.19, table 4.4) and should, therefore, not show any variation in fluo-
rescence intensity upon nuclease addition14. After a distinct dilution effect
VIP control does show an increase in fluorescence during the observation time
of 100 minutes upon double stranded nickage by DNaseI and single stranded
scission by S1-Nuclease. This affirms the theory of long range energy transfer
that has been discussed before.
VIP ds, efficiently quenched in its initial state (cf. table 4.4), is designed to
show a distinct increase upon any ds cleavage. If this smart probe is cut in the
single stranded loop domain, the remaining nucleotide sequence, theoretically,
readopts a hairpin structure, independent of the exact cutting position [179].
14except for a small dilution effect
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a) DNaseI
b) S1-Nuclease
Figure 4.31: Normalized fluorescence intensity plots of
VIP control, VIP ds and VIP ss upon addition of bovine
DNaseI (a)), S1-Nuclease (b)) and DNaseX (c)).
This hairpin is then again efficiently quenched, due to a minimum amount
of two guanines, pairing with the 5’-adenines before being processed again.
In case the ss domain at the 3’-end is cleaved, the smart probe should show
an increase in fluorescence, not restoring the full signal yield, though (cf.
figure 4.19). Therefore ideally, this hairpin shows an immediate result upon
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c) DNaseX
Figure 4.31: Normalized fluorescence intensity courses of
VIP control, VIP ds and VIP ss upon addition of bovine
DNaseI (a)), S1-Nuclease (b)) and DNaseX (c)).
ds scission and a delayed increase upon any ss scission.
VIP ss is slightly quenched (cf. table 4.4), due to long range electron
transfer to loop inherited guanosine residues (cf. figure 4.19). Upon dou-
ble stranded scission this smart probe is supposed to fully fluoresce, because
there are none but as most one guanine left in the remaining Atto 655 at-
tached nucleotide sequence. Upon single stranded DNA scission, which is
only possible in the hairpin loop, the remaining nucleotide sequence forms a
smaller hairpin structure, independent of the exact cleavage site, bringing a
nucleotide overlap of at least one guanosine residue into close contact with
Atto 655. Therefore, this substrate should show a decrease in fluorescence
intensity upon ss scission, before the established overlap can be cleaved and
fluorescence is restored.
Figure 4.31 shows, that the theoretical considerations do not completely
meet the observed kinetics, though. As anticipated, VIP ds shows an in-
crease in fluorescence in presence of DNaseI, while VIP ss mostly abides
its initial value, instead of slightly increasing. In presence of S1-Nuclease,
VIP ds, supposed to slightly increase in fluorescence intensity, shows a re-
markable slope, which does not reveal any delay in kinetics and can only be
attributed to a fast procession of the 3’-guanosine overlap. VIP ss shows the
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same fluorescence intensity characteristic as VIP control, without the sup-
posed fluorescence decrease. A conceivable excision of the fluorophore alone
would result in an immediate, stronger increase. Therefore, the formation
and degradation of the supposed intermediate hairpin structure must occur
concurrently and well-balanced.
Because of the aberration of obtained fluorescent courses from expected
characteristics, that are even hard to interpret for enzymes with known sub-
strate preferences, it is impossible to use these smart probes for the determi-
nation of an unknown preference, as can be observed in figure 4.31 c). Here,
all hairpins reveal a slight increase in fluorescence intensity upon DNaseX
addition, which would, in case of VIP ds, indicate a single stranded scission,
and a double stranded scission in case of VIP ss.
The last kinetic characterization was performed with the commercially
available nuclease substrate ’DNaseAlert’. These normalized fluorescence in-
tensity profiles are presented in figure 4.32.
Figure 4.32: DNaseAlert upon addition of DNaseI, DNa-
seII, S1-Nuclease and DNaseX.
Clearly, DNaseAlert is processed by all examined nucleases, yielding a re-
markable signal increase of up to 37.5 fold. As for smart probes, the maximum
signal and the fluorescence intensity courses are strongly dependent on the
specific nuclease and its required measurement settings. For general nucle-
ase detection and for most descriptive research on isolated nucleases, this
substrate is fairly applicable. When it comes to the question of sequence
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specificity and fluorophore assigned conversion effects, it is futile, though.
Furthermore, an adaption of this substrate to other spectral ranges, as eas-
ily adjustable with smart probes and especially molecular beacons, is simply
impossible. Therefore, if not in need of an immense signal increase15, labeled
hairpins are to be preferred.
4.1.3 Michaelis-Menten Kinetics
Next to singular kinetics, as presented in section 4.1.2, smart probes can be
utilized for the research of Michaelis-Menten parameters (see section 2.4.1),
which will exemplarily be shown for S1-Nuclease on SP4. Here, three different
enzyme concentrations were used with several substrate concentrations each.
Of each combination, three samples were examined. Plotting the determined
starting velocities against the determined substrate concentrations results in
the graph, depicted in figure 4.33.
The higher the substrate concentrations, the more the data points seem to
mismatch the general course, beginning from 4 · 10-6 M smart probe concen-
tration. There, the fluorophore density is high enough to allow reabsorption
effects, hampering the acquisition of true starting velocities.
Still, a numerical evaluation of these plots leads to the values presented in
table 4.5.
Table 4.5: Enzyme concentrations, corresponding maximum
velocities (vmax) and Michaelis-Menten constants (KM ) of S1-
Nuclease with SP4.
enzyme vmax KM
concentration [a.u.] [µM]
[E]1 0.100U/ml (2.5 ± 0.3) · 10-6 1.0 ± 0.4
[E]2 0.020U/ml (5.3 ± 0.8) · 10-8 0.4 ± 0.4
[E]3 0.005U/ml (3.8 ± 1.2) · 10-6 29.7 ± 11.3
Low enzyme concentrations obviously result in doubtful Michaelis-Menten
15There are several molecular beacons with immense possible signal increases, as have been
described by Li et al. [46]. Furthermore, smart probe quenching can most likely be improved
by several, small variations.
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Figure 4.33: Michaelis-Menten kinetics of S1-Nuclease with SP4
with 3 different enzyme concentrations.
parameters. [E]1 on the other hand, results in the need of high substrate
concentrations as well, leading to interactions between the high number of
fluorophores. Despite the reasonability of the determined KM by [E]1, the
variations of parameters for high substrate concentrations, which mostly de-
termine the Michaelis-Menten parameters, are too big to rely on the deter-
mined values.
A lower enzyme concentration does not avoid these problems until a concen-
tration is reached, where new problems16 occur. Therefore, Michaelis-Menten
parameters can only be determined for low Michaelis-Menten constants of up
to 2 · 10-6, which are rare for hydrolases in general and could not be observed
for any of the utilized enzymes.
The smart probe concentration can be increased without reabsorption ef-
fects though, if only a subset of the substrates were fluorescently labeled.
16These account the lack of reproducibility due to very small sample amounts and very long
reaction times, that tend to hide side effects like cuvette wall adsorption and concentration
variations due to evaporation.
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This implies, however, that labeled hairpins are equally processed as unla-
beled substrate, which will be examined in section 4.1.4.
4.1.4 Determination of Label Effect to Substrate Acceptance
A general concern in enzyme research based on fluorescent substrates is the
question, whether the attached modification effects the acceptance and ve-
locities, an enzyme shows on a specific substrate. To address this task,
MR121 -Gly -Trp and unlabeled Gly -Trp were mixed in different ratios, be-
fore Carboxypeptidase A was added identically to each sample. As before,
fluorescence intensity profiles were normalized to their starting intensities. A
selection of these are presented in figure 4.34.
Figure 4.34: Normalized fluorescence intensity profiles of
MR121 -Gly -Trp and Gly -Trp in different ratios upon addi-
tion of Carboxypeptidase A.
Clearly, there are only small variations of velocities and saturation val-
ues. A numerical evaluation of these courses results in the graph depicted in
figure 4.35.
The higher the degree of labeled substrates, the lower the time constant
of the reaction gets. Since it was proven that MR121 -Gly -Trp is only pro-
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Figure 4.35: Time constants and maximum fluorescence in-
crease of different ratios of labeled MR121 -Gly -Trp to unla-
beled Gly -Trp upon addition of Carboxypeptidase A.
cessed between glycine and tryptophan (cf. section 4.1.2), both constituents
offer exactly the same cleaving possibility. Therefore, Carboxypeptidase A
distinctly favors the unlabeled Gly -Trp. Most remarkably, also the fluores-
cence increase to saturation changes with the ratio of labeled substrate. The
original data17 reveals, that absolute starting and saturation intensities do
not head into a distinct direction but fluctuate statistically.
An equivalent measurement with bovine DNaseI and SP2, labeled and un-
labeled, is presented in figure 4.36.
Again, only slight variations of velocities and saturation values can be seen.
Evaluating the normalized fluorescence profiles numerically, results in a sim-
ilar picture as with Carboxypeptidase A, depicted in figure 4.37. Here, the
time constants only slightly decrease with increasing labeling percentage of
the substrate, proving the preference of DNaseI to process unlabeled sub-
strate just a little better.
With increasing labeling ratio of the examined hairpin, the fluorescence
increase to saturation also rises. The original data17of this measurements
also shows an increase of absolute starting and saturation intensities with
17Data not shown.
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Figure 4.36: Normalized fluorescence intensity profiles of la-
beled and unlabeled SP2 in different ratios upon addition of
DNaseI.
Figure 4.37: Time constants and maximum fluorescence in-
crease of different ratios of labeled SP2 to unlabeled SP2 upon
addition of bovine DNaseI.
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the ratio of labeled hairpin. This indicates, that the labeling degree of the
smart probes is most likely to be higher than 1, which would explain the
correlation of the ratio between saturation and initial fluorescence intensity
with the percentage of labeled hairpin.
Since both examined hydrolases are definitely slowed down by labeled en-
zyme substrates, the predominance of the two fold labeled SP2CM-FRET
over SP2CM, as presented in section 4.1.2, is even more remarkable. Regard-
ing these two effects, this leads to the consideration that Atto 655 could be
a fluorophore that is not specifically favored by any nuclease, which possi-
bly also accounts for its peptide homologue MR121 in Carboxypeptidase A
acceptance.
4.1.5 Evaluation of ideal Temperature Settings
Fluorescent peptidase substrates are rather thermally stable (cf. figure 4.7).
Therefore, they can also be used for kinetic measurements at various tem-
peratures, thus, for measurements concerning temperature preferences of an
enzyme.
MR121 -Gly -Trp samples were equally measured with Carboxypeptidase
A at different temperatures. Plotting the computationally determined time
constants of the reaction against the applied temperatures, reveal the thermal
preferences of this enzyme. These can be seen in figure 4.38.
Clearly, Carboxypeptidase A shows a stronger activity on MR121 -Gly -
Trp at higher temperatures. Still, no distinct course is observable. There
appear to be local activity maxima at 25°C, 40°C and around 60°C. The
published activity maximum of 25°C [68, 210] could, therefore, be locally
affirmed, but any reaction occurring at 35°C and above is distinctly faster.
Regarding the fact that Carboxypeptidase A is a pancreatic enzyme, this
and the local maximum at 40°C are indeed very reasonable18. Since the
determined time constants at 45°C, 50°C and 65°C are very similar to each
other, and only 60°C strongly peaks out, an error could be assumed for this
high value. However, in further measurements this high activity could be
reproduced. Therefore, it has to be approved, that, indeed, Carboxypeptidase
A shows an unexpected maximum activity on MR121 -Gly -Trp around 60°C.
18This Carboxypeptidase A is from a bovine source and the paunch temperature is around
39°C.
111
4 Results and Discussion
Figure 4.38: Time constants of kinetic measurements with Carboxypep-
tidase A and MR121 -Gly -Trp, plotted against applied measurement tem-
peratures. The single time constants (grey), derived from three individual
measurements, were additionally averaged (red).
A different plotting type was chosen to analyze the maximum activity of
DNaseI19 and DNaseX on SP2 and SP4, respectively. SP2 has calculated
melting temperature of 80.2°C (cf. table 4.3). As figure 4.15 shows, this smart
probe does not lose its hairpin formation up to 70°C. Therefore, SP2 is still
ideally suited for measurements at high temperatures. If SP2 was cleaved in
the single stranded loop domain, which could generally occur for DNaseI and
DNaseX, a very stable product would result. The highest conceivable product
melting temperature would be 40.3°C [179]. Therefore, this smart probe can
only be utilized for thermal preference measurements between 40°C and 70°C.
For temperatures below 40°C, a hairpin with shorter stem length has to be
utilized. Here, SP4 with a calculated melting temperature of 65.3°C (cf.
table 4.2), a very constant fluorescence intensity up to 55°C (cf. figure 4.11)
19Here, human DNaseI was utilized.
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and a highest conceivable product melting temperature of 14.9°C [179], is
ideally suited.
To be able to see nuclease activities as well as possible enzyme denaturation
at higher temperatures, figure 4.39 shows the relative fluorescence intensities,
normalized to each starting temperature at 5, 10 and 15 minutes after DNa-
seI addition. Regarding the fluorescence intensities 5 minutes after substrate
addition, the activities increase up to a temperature of 50°C. After that, the
fluorescence intensities decrease again. Generally the fluorescence intensities
10 minutes after enzyme addition reveal the same result. At 60°C and 70°C,
though, they have not increased any further, despite not having reached the
maximum possible intensity. This shows an inactivation of DNaseI at these
temperatures after approximately 5 minutes. Since 15 minutes after DNa-
seI addition, fluorescence intensities at these temperatures have not changed
unlike 20°C to 50°C. Analyzing the gain height at each temperature and tem-
poral interval, it is possible to read out the progress of each reaction. At 50°C
the reactions with both SP4 and SP2 nearly reached a saturation after 15
minutes, whereas at 40°C and 30°C the reactions are consecutively slowing
down. At 20°C the gain height of each temporal interval looks quite identical,
revealing, that this reaction is still working in its steady state.
From this measurement the maximum activity of DNaseI is observed with
SP2 at 50°C. However, this measurement technique generally only observes
single data points and misses intermediate temperatures. A refining mea-
surement in the range of 40°C to 60°C should follow after this crude approx-
imation of an ideal measurement temperature.
The same measurement yields a different picture, when applied to DNa-
seX, as visualized in figure 4.40. Generally, the fluorescence intensity gain
upon DNaseX scission between 20°C and 40°C is very low with both smart
probes. The maximum intensity gain occurs at 56°C. At 66°C a denaturation
of DNaseX can be observed 5 minutes after enzyme addition, while at 70°C
an instant denaturation occurs. Again, this type of measurement misses in-
termediate temperatures and should, therefore, be refined especially around
56°C.
To circumvent the need of a set of individual measurements for each applied
temperature, a new experimental approach was utilized for refined thermal
activity maxima research that takes advantage of the steady state in the be-
ginning of enzyme kinetics. By adjusting the concentrations of the substrate
and the enzyme, the steady state phase of a reaction can be prolonged to an
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a) SP4
b) SP2
Figure 4.39: Normalized fluorescence intensities of SP4 (a))
and SP2 (b)) at different temperatures 5, 10 and 15 minutes
after addition of DNaseI.
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a) SP4
b) SP2
Figure 4.40: Normalized fluorescence intensities of SP4 (a))
and SP2 (b)) at different temperatures 5, 10 and 15 minutes
after addition of DNaseX.
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appropriate duration. If the reaction temperature is varied constantly during
this steady state phase, the initially linear fluorescence intensity course, will
change, revealing temperature preferences. An example of how such a steady
state phase looks like at varying temperatures is given in figure 4.41.
Figure 4.41: Steady state fluorescence in-
tensity measurements of DNaseX and SP4
at varying temperature.
As can be seen, the four individual samples perfectly match each other
with only one aberration at high temperature. The observed fluorescence in-
tensity profiles reflect the activity preferences of the enzyme and the thermal
fluorescence intensity variations of intact smart probes20, which can be eas-
ily subtracted. Derivations of the resulting graphs, therefore, directly reveal
continuous thermal enzyme activities for a wide range of temperatures in a
minimum of time.
Due to a thermal overlap of SP4 and SP2 graphs by some degrees, both
obtained activity graphs can even be normalized to another. Complete DNa-
seI and DNaseX graphs were then adjusted to hit at 45°C yielding a perfect
comparison of nuclease activities in figure 4.42. As shown in figure 4.41, DNa-
seX shows a maximum velocity at 56°C. If the temperature gets higher than
that, the velocity drastically decreases, mostly due to denaturation. DNaseI,
on the other hand, still increases in its activity up to 70°C, which is still in
20A prerequisite for steady state phases is a huge amount of unprocessed substrate, thus a
negotiable amount of fluorescent product. Therefore, the influence of this constituent can
be disregarded.
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Figure 4.42: Normalized activities of DNaseI and DNaseX over varying
temperatures.
perfect accordance to figure 4.39, where a five minutes increase hides initial
slopes that occur before a likely inactivation.
The introduced experimental approach for temperature preferences proved
to result in satisfactory results in accordance to single kinetic measurements
with a high accuracy. Therefore, this method can generally be applied for any
enzyme with its appropriate fluorescent substrate, as exclusive measurement,
as a verification for single kinetic measurements or for an initial setting of
temperatures to be sampled with single kinetic measurements.
Unfortunately, temperature is the only measurement parameter that can
constantly be changed during a measurement in a standard fluorescence spec-
trometer. In a flow device, this method can also be used with fluorescent sub-
strates for the examination of buffer preferences like pH values and activator
concentrations. Furthermore, inhibition processes can be examined.
4.1.6 Single Molecule Enzyme Localization
In this section the suitability of PET quenched fluorescent substrates for
enzyme investigations on a single molecular level is briefly documented.
Carboxypeptidase A is indirectly bound to a 16-mer double stranded DNA,
which itself is labeled with a fluorophore, spectrally separated from MR121
and bound to bovine serum albumin (BSA) molecules, attached to a surface
(see figure 4.43 b)). Therefore, CPA is surface bound and its position is easily
detected upon appropriate illumination.
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a) CPA (red) and substrate (black) localizations in a 137 µmx68.5µm section.
Black squares represent correlated localizations.
b) sample assembly c) localization correlation
Figure 4.43: Single molecule Carboxypeptidase A and substrate localizations,
sample assembly scheme and localization correlation result.
During illumination that irradiates MR121 by total internal reflection, the
addition of MR121 -Gly -Trp (see section 4.1.1) leads to short fluorescence
signal bursts in close proximity to the coverslide. This happens each time
a substrate is processed by a Carboxypeptidase A molecule, because this
substrate requires only one incision to fully fluoresce (cf. section 4.1.2). Col-
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lecting the position of hits over time and plotting them with all localized
CPA molecules results in figure 4.43 a).
Obviously, there is a wide distribution of substrate localizations, that do
not necessarily cover CPA spots. It is striking though, that there are several
accumulations of substrate spots, slightly left and downwards shifted to en-
zyme localizations. This could first of all indicate a spectral detection channel
shift. Figure 4.43 c) shows the result of a line- and row-wise adjustment of
one frame to the other. Here, a distinct correlation peak is reached when the
substrate localizations are shifted by 7 nm to the right and up. In this gen-
eral, big shift still smaller variations take place due to different orientations
the CPA molecules can take, because of its flexible surface attachment.
Still, there are CPA localizations without any substrate localizations close
by, as well as MR121 -Gly -Trp localizations without any neighbored enzyme
hits. For this, there is a variety of explanations. A destined Carboxypepti-
dase A position can, first of all, not bear an enzyme due to miscarried labeling
or a detachment in later processing. Furthermore, an attached enzyme can
be inactive. Both scenarios would result in missing substrate localizations at
supposed enzyme position. Analogous, there can be surface attached CPA
molecules, that are not fluorescently labeled. This would result in MR121 -
Gly -Trp localizations without any enzyme localization near by and should
mostly account for unassigned substrate localization accumulations. Further-
more, there are single substrate localizations without corresponding enzyme
localizations. Generally, there can be freely diffusing enzyme due to miscar-
ried synthesis and purification, yielding fluorescent products over the com-
plete sample. Fluorescent peptide probes were found to interact with BSA
in enzyme kinetics though (data not shown), which is, therefore, also most
likely to occur in this sample, because the complete surface is covered with
BSA molecules (cf. figure 4.43 b)).
This sample assembly is, therefore, only conditionally suitable for inves-
tigations on Carboxypeptidase A due to the interaction between BSA and
peptide substrates. Furthermore, this assembly is not at all transferable to
nuclease investigations, because in sample synthesis the nuclease would de-
grade any incorporated DNA spacer, breaking the surface attachment system.
Nonetheless, this measurement countervails to proof the general suitability
of fluorescent substrates for enzyme research on a single molecule scale.
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4.1.7 Enzymes in Cells
Enzymes do not naturally occur in purified environments, that have so far
been employed for any measurement presented in this work. To examine
on the usefulness of fluorescent substrates in natural environments, several
smart probes were tested on different cell types in various ways.
SP2, SP3 and SP4 were added to a constant number of LS-174T cells (see
section 3.2.4) and their fluorescence intensity was monitored over time. The
normalized fluorescence intensity progression is presented in figure 4.44.
Figure 4.44: Normalized fluorescence intensity progressions
over time of SP2, SP3 and SP4 in samples with either intact,
living (crosses) or lysed (circles) LS-174T cells.
Neither of the utilized smart probes shows any remarkable variation in flu-
orescence intensity in samples with intact, living cells over 40 hours. Smart
probes incubated with lysed cells, though, show distinct increases in fluores-
cence intensity, which still haven’t reached saturation values after 40 hours.
Here, at first sight, SP4 shows the strongest increase in the shortest time,
followed nearly equivalently by SP2 and SP3. Regarding the fact, that these
substrates are quenched differently efficiently and, therefore, yield diverse rel-
ative saturation values, this appearance needs to be evaluated further. SP4,
with a relative quantum yield of 0.28, can generally reach an intensity that is
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3.57 fold higher than the starting intensity. Here, after 40 hours, 63% of the
possible increase are reached. SP2 reaches only 36% of its potential relative
fluorescence intensity and SP3 only arrives at 27%. So, first sight estimation
already gave the right impression, that enzymes revealed by lysis of LS-174T
cells preferably process SP4 over the smart probes with a longer stem and
a shorter loop. When risking a closer look to the smart probes fluorescence
intensities, incubated with living cells, one can notice, that final values reflect
the same substrate order as in lysed cells. The final SP4 fluorescence inten-
sity is slightly higher than that of SP2, followed by SP3. This might indicate
a little action on intact cells as well. Regarding the measurement time scale
though, it is most likely, that these signals derive from cells that died during
the measurement, revealing the same enzymes as lysed cells but merely in
a smaller final concentration. It has to be accepted, therefore, that smart
probes themselves do not react with enzymes in or at intact cells, meaning
that they cannot enter a cell membrane by themselves.
To utilize smart probes in cell-measurements, these substrates have to be
inserted artificially. There are many approaches to this, including the slow
and inefficient liposome or dendrimer based transfection techniques [211,212]
or invasive methods like microinjection [213] and electroporation [214]. A
promising alternative is the utilization of cell-penetrating peptides (CPPs),
that generate a fast and efficient hairpin uptake, without hampering their
structure and usability upon internalization [215]. Amongst the many CPPs
that have been described and characterized [216–226], the ’optimal cell-
penetrating peptide’ Antennapedia (Antp) [222] was used due to its fine
uptake characteristics in different cell types and its low toxicity. Antp was
linked to SP2CM by a disulfide bridge, which is cleaved by the reducing envi-
ronment of the cytoplasm [215], allowing the same cleavage mechanism of the
smart probe as in artificial ensemble measurements. The Antp-linked SP2CM
was incubated with chamber slide-grown A-549 cells in non-colored medium
at room temperature and monitored over time on a total internal reflection
fluorescence (TIRF) microscope. Furthermore, cells were preincubated with
pyrenebutyrate to increase the Antp uptake [227]. A 90 minutes incubation
results in the images depicted in figure 4.45.
While in the incident light picture a single cell is clearly visible, the TIRF
image only shows nearly homogeneously distributed fluorescence signal, which
does not reveal any cellular accumulation, as is clearly visible in the merged
image. Since it has been reported, that DNaseI is secreted by exocrine glands
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a) incident light b) merged image c) TIRF image
Figure 4.45: A-549 cells in colorless medium, preincubated with pyrenebutyrate
and imaged on a TIRF microscope, 90 minutes after Antp-linked SP2CM addi-
tion. a) shows a 32µmx32 µm incident light image, c) shows the corresponding
raw TIRF image and b) shows a merged picture in which the TIRF signal was
threshold selected for enhanced visibility.
[228], there must be a cell release mechanism for DNaseI. Therefore, DNaseI
existing in the medium can process the smart probes before they can enter the
cell. Since Antp is bound to the 3’-end of the sequence, Atto 655, attached
to the 5’-end, is not capable of entering the cell anymore. This scenario
would, therefore, lead to a small fraction of fluorescence intensity assigned
to Atto 655 inside the cell via properly endocytosed Antp-linked SP2CM and
another fraction of fluorescence, resulting from DNaseI activity outside the
cell.
An addition of 7 · 10-7M G-Actin, which selectively inhibits DNaseI [39] ,
results in the images depicted in figure 4.46.
The cell shape that can be seen in the incident light picture is also indicated
in the TIRF image. The fluorescence signal clearly accumulates in the cell
after 90 minutes, while there is only little signal outside the cells as the merged
picture proves. Thus, the signals in figure 4.45 result from DNaseI procession
outside the cells, which are efficiently reduced by G-Actin addition.
To examine the supposed uptake increasing effect of pyrenebutyrate [227],
a further measurement with G-Actin, without pyrenebutyrate was accom-
plished in the same manner. The result is shown in figure 4.47.
Clearly, there is fluorescence signal within the cell, but there is also a high
amount of signal outside of it. This can only be attributed to a decreased
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a) incident light b) merged image c) TIRF image
Figure 4.46: A-549 cells in colorless medium containing G-Actin, preincubated
with pyrenebutyrate and imaged on a TIRF microscope, 90 minutes after Antp-
linked SP2CM addition. a) shows a 32 µmx32 µm incident light image, c) shows
the corresponding raw TIRF image and b) shows a merged picture in which the
TIRF signal was threshold selected for enhanced visibility.
a) incident light b) merged image c) TIRF image
Figure 4.47: A-549 cells in colorless medium containing G-Actin, imaged on
a TIRF microscope, 90 minutes after Antp-linked SP2CM addition. a) shows a
32 µmx32 µm incident light image, c) shows the corresponding raw TIRF image
and b) shows a merged picture in which the TIRF signal was threshold selected
for enhanced visibility.
uptake kinetics, because DNaseI activity is inhibited.
In general, smart probes can pass cell membranes by the attachment of the
cell-penetrating peptide Antennapedia. This uptake is distinctly increased by
pyrenebutyrate, but can be deteriorated by destruction of the modified smart
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probe outside of the cell, e.g. a procession by DNaseI, which can be inhibited
by G-Actin addition. Once the modified smart probe has entered the cell, the
successive processes are totally ambiguous, though. There might not be any
smart probe action at all, there might be a scission by any present nucleases
or any other enzyme, capable of DNA degradation, there might also be en-
zymatic action other than hydrolysis or also hybridization to complementary
DNA.
Therefore, Antp-linked smart probes are suited for intracellular investiga-
tions that are harmless to the cells at relatively low concentrations, but at
best only those, that encounter only one or very few possible processes in the
cell. Cellular nuclease research should thus be addressed differently, as done
in section 4.2 for example.
4.2 Enzyme Investigations via Immunostaining
Immunostaining constitutes a universal tool for the investigation of any bound
antigen. Therefore, also fixed enzymes in cells can be examined with the ap-
propriate specific antibody. This primary antibody is then labeled specifically
with a chromophore attached to a secondary antibody directed against the
primary antibody.
In this section the effect of different labeling strategies for an immunostain-
ing of DNaseX is examined. The best labeling method is then used to depict
the occurrence of DNaseX in divers native mammalian cell types with two
different specific primary antibodies. Furthermore, the DNaseX expression
of a cell line in its native and at different expression states after transfection
with two different DNaseX transfection mechanisms is shown and numerically
evaluated via single molecule based localization microscopy.
4.2.1 Labeling Methods
There is a multitude of different protocols for labeling mammalian cells, incor-
porating various chemicals, temperatures and incubation times. Nonetheless,
immunostaining experts use very similar successions of labeling steps. There-
fore, the standard protocol in this work (see section 3.2.6) evolved from a
highly tested protocol, published by microscopic experts [229] (see Appendix
B.2). The standard protocol consists of six main steps, surrounded by a high
number of washing cycles. The cells are first fixed and their membranes are
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permeabilized. After a saturation of potent unspecific binding sites the cells
are incubated with primary antibody or negative control proteins, followed
by secondary antibody and finally nuclear counterstaining incubation.
However, some experimenters claim the importance of living cells during
antibody incubation. To investigate on this effect the chosen standard pro-
tocol was further modified into three different protocols (see section 3.2.6),
scheduling the cell fixation once before primary antibody (I )), once between
primary and secondary antibody (II )) and once after secondary antibody
incubation (III )). Since a permeabilization of living cells hampers their via-
bility, this step was left out for the first protocol as well. Primary antibody
’DNAX’ dissolved in PBS, respectively accustomed cell culture medium, was
incubated at 37 °Celsius in all samples. For a negative control, protein pre-
immune serum, derived from the same source as the primary antibody be-
fore immunization, was used in the same way as primary antibody. Alexa
Fluor® 647 labeled secondary antibody was processed equally. The nuclear
counterstaining with Sytox® Green Nucleic Acid Stain was applied as the last
step at fixed cells equally in all protocols. Despite the different proceedings
all cells were treated as equally as possible and can, therefore, be considered
comparable to each other.
After labeling the samples were embedded in antifading mounting medium
and measured likewise on a confocal microscope in several vertical layers. For
a manageable demonstration these layers are projected onto one single plane
that shows the maximum intensity derived for that coordinate. Figure 4.48
shows the main results of this measurement, while the complete set of images
is depicted in Appendix C.2.
Despite the unique cell shapes I ) and II ) show very similar looking cells
in respect to both the samples (a )) and the controls (b )). Since the cells
in I ) were fixed before and the cells in II ) fixed after primary antibody
incubation, the viability of the cell during primary antibody incubation does
not alter the labeling efficiency. Figure 4.48 III ) clearly shows a different
result. Here secondary antibody attachment onto the living cell took place,
but obviously the membrane was damaged due to this treatment. Also the
counterstaining result in the control samples looks different to those of I )
and II ), although the cells were already fixed at this point in every labeling
protocol. This indicates that the incubation with secondary antibody on
living cells not only affects the membrane, but also other cell compartments
and, therefore, the viability of the complete cell. These results demand a cell
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Ia) Ib)
IIa) IIb)
Figure 4.48: Examination of different labeling procedures. I ) Cell fix-
ation before incubation with primary antibody, II ) Cell fixation between
primary and secondary antibody incubation, III ) Cell fixation after incu-
bation with secondary antibody. a ) incubated with primary antibody and
Alexa Fluor® 647 linked secondary antibody (red), b ) incubated with pre-
immune serum and Alexa Fluor® 647 linked secondary antibody (red). Both
samples counterstained with Sytox® Green Nucleic Acid Stain (yellow) after
fixation. Cells confocally scanned in several layers and projected onto one
plane showing the maximum intensity per pixel.
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IIIa) IIIb)
Figure 4.48: Examination of different labeling procedures. Description see
second picture part.
fixation between primary and secondary antibody at the latest. To keep the
cell stress level as low as possible and, furthermore, allow a penetration of
primary and secondary antibody into the cell, a fixation at the very beginning
of the labeling protocol should generally be favored and was applied to any
other immunostaining that is shown in this work.
4.2.2 DNaseX occurrence in native mammalian Cell Lines
In 2001 Shiokawa et al. published DNaseX transcript concentrations in dif-
ferent tissues compared to DNaseI mRNA amount in human pancreas [39].
Only heart and skeletal muscle revealed a higher amount than 30% to the
reference value in the applied RNA dot blots. Lung, bladder, uterus and
colon showed an amount of up to 30% while no DNaseX transcript could be
detected in the whole human brain.
In their European patent application from 2002 Coy et al. described their
research and prediction on the biological importance of DNaseX [40]. Accord-
ing to them this enzyme appears in cells which have a high turnover and plays
an important role in apoptosis, whereas the absence of DNaseX might, there-
fore, be connected with diseases like AIDS, systemic lupus erythematodes,
cystic fibrosis and cancer.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.49: Maximum intensity projections of confocally derived z-
stacks of SK-N-MC cells. Nucleus labeled with Sytox® Green Nucleic
Acid Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin
(grey), DNaseX immunostained with Alexa Fluor®647 (red). Samples
equally measured and scaled. a ) and b ) show the effect of different
primary antibodies, c ) incubated with primary antibody ’DNAX’ and
counterstained, without secondary antibody, d ) shows the outcome by
utilization of pre-immune serum instead of a primary antibody.
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Due to these facts the knowledge about DNaseX occurrence in tumorigenic
cell lines of different tissues constitutes new evidence for the biological rele-
vance of DNaseX, which is until now suggested to hinder foreign DNA from
entering the cell [43]. Cells of one brain, one lung, one bladder, one uterus
and three colon tissue cell lines were, therefore, fixed and permeabilized. Four
samples of each cell line were prepared for two different primary antibodies,
a pre-immune serum and a blank control. During a secondary antibody in-
cubation the cytoskeleton counterstaining reactant rhodamine phalloidin was
added to all samples. Furthermore, all samples of every cell line were coun-
terstained with Sytox® Green Nucleic Acid Stain and embedded in mounting
medium. The detailed protocol is described in section 3.2.6. Afterwards, the
cells were measured in different vertical layers on a confocal microscope as
described in section 3.1.5. The maximum intensity projections onto single
planes are presented in this chapter.
Figure 4.49 shows a set of four images of brain neuroblastoma SK-N-MC
cells. These very small cells consist of a large nucleus and only little cyto-
plasm. Both applied primary DNaseX antibodies do not yield a fluorescent
signal, but show the same pattern as the pre-immune serum and negative con-
trol upon all applied irradiation wavelengths. This cell line does obviously
not express DNaseX in a concentration that can be detected despite this very
sensitive method. Since neither the RNA dot blots revealed DNaseX tran-
script in the whole brain, it can be assumed that there is no DNaseX protein
present in this tissue. Furthermore, this confirms the prediction made by Coy
et al. [40] for neuroblastoma constitutes the most common cancer in infancy
which generally has a healing prognosis of down to 30%. Here a connection
between a hampered apoptosis and the cancer affection is plausible.
The human lung carcinoma cell line A-549 (see figure 4.50) shows a com-
pletely different morphology than the previous cells. They have a lot larger
cytoplasm and do not necessarily gather with other cells, but most often oc-
cur individually. The sample containing primary antibody ’DNAX’ shows
a distinct fluorophore signal upon illumination with the appropriate wave-
length homogeneously distributed in the cytoplasm, while primary antibody
’AK148’ does not lead to any positive result. Since the negative control does
not show any positive signal either, it can be assumed that ’DNAX’ is more
sensitive than ’AK148’. This means that despite their carcinogen nature there
is DNaseX protein present in A-549 cells, confirming the RNA dot blot results
on lung tissue.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control
Figure 4.50: Maximum intensity projections of confocally derived z-
stacks of A-549 cells. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). Samples equally
measured and scaled. a ) and b ) show the effect of different primary
antibodies, c ) incubated with primary antibody ’DNAX’ and coun-
terstained, without secondary antibody. For this experiment no pre-
immune serum was available.
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Human urinary bladder carcinoma cell line ECV-304 (see figure 4.51) shows
a morphology and growth behavior similar to that of A-549 cells. Only little
antigen can be detected with ’DNAX’ primary antibody, while an incubation
with pre-immune serum results in a comparable signal. ’AK148’ yields even
lower secondary antibody binding events. The derived signal is likewise
homogeneously distributed within the cytoplasm. Due to this low signal and
the contradictory data it is not possible to postulate a conclusion about the
DNaseX occurrence in ECV-304 cells despite their bladder carcinoma origin.
The well established HeLa cell line samples represent uterine tissue and
show accumulations of several cells (see figure 4.52). Here both primary
antibodies result in similar secondary antibody signals, while the strongest
signal is obtained in the pre-immune serum sample. Again the signal is
distributed homogeneously in the cytoplasm and a distinct statement about
DNaseX expression is not feasible despite their carcinogen origin and positive
RNA dot blot results.
The fifth tissue species examined in this work is depicted by three different
substitutes. LS-174T, SW-837 and HT-29 represent human colon carcinoma
cell lines. The typical conglomerations of LS-174T cells (see figure 4.53) show
a fluorescent signal after incubation with secondary antibody upon appropri-
ate irradiation for both primary antibodies and the pre-immune serum. As
in ECV-304 the strongest signal is obtained in the ’DNAX’ sample, followed
by pre-immune serum. Both show a homogeneous distribution of secondary
antibody. ’AK148’ again only yields little signal, mostly in the nuclei.
The same distributions and measures of ’AK148’ and pre-immune serum
can be found in SW-837 cells (see figure 4.54). Primary antibody ’DNAX’,
though, leads to a remarkable signal in this cell type. DNaseX is localized
in the nucleus, in the cytoplasm and on the membrane. Furthermore, there
are comparably large areas completely stained with secondary antibody flu-
orophore. The reason for these agglomerations and the type of compartment
carrying this signal remains unknown, but could be linked to the exceptional
tight compositions built by several individuals in this cell line though.
The conglomerations of HT-29 cells (see figure 4.55) finally reveal a situ-
ation that was described by literature [43] and expected by theory: While
there are only few spots in the pre-immune serum sample both ’AK148’ and
’DNAX’ show distinct secondary antibody signals, which seem to be located
on the cell membrane with a high ratio. To verify this assumption a cross
section of a small agglomeration of immunostained HT-29 cells is shown in
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.51: Maximum intensity projections of confocally derived z-
stacks of ECV-304 cells. Nucleus labeled with Sytox® Green Nucleic
Acid Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin
(grey), DNaseX immunostained with Alexa Fluor®647 (red). Samples
equally measured and scaled. a ) and b ) show the effect of different
primary antibodies, c ) incubated with primary antibody ’DNAX’ and
counterstained, without secondary antibody, d ) shows the outcome by
utilization of pre-immune serum instead of a primary antibody.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.52: Maximum intensity projections of confocally derived z-
stacks of HeLa cells. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). Samples equally
measured and scaled. a ) and b ) show the effect of different primary
antibodies, c ) incubated with primary antibody ’DNAX’ and counter-
stained, without secondary antibody, d ) shows the outcome by utiliza-
tion of pre-immune serum instead of a primary antibody.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.53: Maximum intensity projections of confocally derived z-
stacks of LS-174T cells. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). Samples equally
measured and scaled. a ) and b ) show the effect of different primary
antibodies, c ) incubated with primary antibody ’DNAX’ and counter-
stained, without secondary antibody, d ) shows the outcome by utiliza-
tion of pre-immune serum instead of a primary antibody.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.54: Maximum intensity projections of confocally derived z-
stacks of SW-837 cells. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). Samples equally
measured and scaled. a ) and b ) show the effect of different primary
antibodies, c ) incubated with primary antibody ’DNAX’ and counter-
stained, without secondary antibody, d ) shows the outcome by utiliza-
tion of pre-immune serum instead of a primary antibody.
135
4 Results and Discussion
a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control d) pre-immune serum
Figure 4.55: Maximum intensity projections of confocally derived z-
stacks of HT-29 cells. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). Samples equally
measured and scaled. a ) and b ) show the effect of different primary
antibodies, c ) incubated with primary antibody ’DNAX’ and counter-
stained, without secondary antibody, d ) shows the outcome by utiliza-
tion of pre-immune serum instead of a primary antibody.
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figure 4.56.
The lower surface of HT-29 cells (figure 4.56 (blue frame)) reveals a high
density of DNaseX signals. Also the membranes in between cells as well as
the membrane on top and on the side of single cells (figure 4.56 (red frame))
contain DNaseX. Figure 4.56 (green frame), furthermore, exposes DNaseX
accumulations at or inside the nucleus.
A central layer of these HT-29 cells was used to evaluate the colocalization
of DNaseX with the membrane and with the nucleus computationally. Fig-
ure 4.57 shows the chosen layer with complete staining (a )) and those signals
correlated to each other (b )). When a background excluding threshold is
applied to this correlation, the remaining DNaseX localizations can be di-
vided into those hitting a left over cytoskeleton localization and those placed
somewhere else. This distribution is shown in figure 4.57 c ), where the black
dots code the colocalized DNaseX spots with the membrane. The applied
threshold and signal distributions are presented in d ). Figure 4.58 repre-
sents the same method for the colocalization of DNaseX and nucleus with
the same threshold and color codings. These graphs show, that the largest
proportion of detected DNaseX molecules in HT-29 cells is indeed located
on the membrane. Only a few DNaseX spots are not colocalized with the
membrane. Most of those though are colocalized with the nucleus. This eval-
uation indicates that the appearance of DNaseX containing nuclei in other
cell lines also holds. The biological relevance for this enzyme distribution
has only partly been described [43]. If the only task fulfilled by DNaseX
was to provide a barrier for foreign DNA for entering the cell, a localization
on the membrane and also in the cytoplasm during protein expression or
vesicle transport would be plausible. The reason for DNaseX occurrence in
a nucleus is highly remarkable though, given that DNaseX does not follow
strong substrate preferences and can therefore process cell associated DNA,
compromising the cell metabolism and induce apoptosis. This could, there-
fore, indicate the precise connection between DNaseX occurrence and those
diseases with a disturbed apoptose mechanism (cf. [40]). Nonetheless, it is
astonishing, that DNaseX is imported into the nucleus, not carrying a nuclear
localization signal [41].
A specialty of HT-29 cells is the heterogeneous distribution of DNaseX over
the membrane. Generally the enzyme seems to be concentrated on membrane
sections neighboring other cells (cf. figure 4.55). Also the bottom surface of
the cell building the interface to the chamber slide seems to contain more
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Figure 4.56: Orthogonal cut through HT-29 cells. Nucleus
labeled with Sytox® Green Nucleic Acid Stain (yellow), cy-
toskeleton labeled with rhodamine-phalloidin (grey), DNaseX
immunostained with ’DNAX’ primary antibody and Alexa
Fluor®647 labeled secondary antibody (red). The large sec-
tion (blue frame) shows a 57µmx57 µm section of the lower
surface of the cell. The red and green lines indicate the sec-
tions depicted in the red and green framed areas (right and top
pictures). The blue lines in these frames represent the lower
cell surface depicted in the main frame.
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a) b) c)
d)
Figure 4.57: Colocalization of DNaseX and membrane signal in HT-29
central layer. a ) Central layer of HT-29 cells. Nucleus labeled with Sytox®
Green Nucleic Acid Stain (yellow), cytoskeleton labeled with rhodamine-
phalloidin (grey), DNaseX immunostained with ’DNAX’ primary antibody
and Alexa Fluor®647 labeled secondary antibody (red). b ) Central layer
of HT-29 cells as in a ) without nucleus visualization. c ) Colocalization
image of b ). Black represents colocalized spots, green represents DNaseX
spots not localized on the membrane. d ) colocalization graph: 1 represents
DNaseX signals, 2 represents membrane signals and 3 represents colocalized
spots.
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DNaseX than equivalently large areas at top or side membrane sections (cf.
figure 4.56). Following Shiokawa [43], this could indicate the individual cells
potential to recognize neighbored cells as likely invasion sites and their ability
to establish a defense alignment. Furthermore, the greatly various DNaseX
concentrations of individual cells are highly remarkable (cf. especially fig-
ure 4.55 b ) ). Here no distinct pattern is apparent. The allocation might,
therefore, be dependent upon a huge number of factors, most likely though
the cell age or its viability.
All three examined colon cell lines revealed a distinct DNaseX occurrence,
despite their tumorigenic nature, fortified by the RNA dot blots (cf. [39]).
Still, there is a high diversity of DNaseX expression between the different cell
lines. Except for the SK-N-MC brain neuroblastoma cell line all presented
cell lines were tested to carry a DNaseX transcript concentration of up to
30% of the DNaseI gene found in adult pancreas. Since the signals that could
be detected in different tissues with immunostaining are highly divergent,
the range given by Shiokawa et al. ( [39]) is not ideally suited for DNaseX
expression quantification in native mammalian cells and tissues.
There is still one unanswered question that emerged from these measure-
ments. In every cell line carrying DNaseX the pre-immune serum yielded a
high signal in DNaseX detection, although it was meant to serve as a negative
control. This signal was mostly even higher than that of primary antibody
’AK148’. This is quite unsettling at first sight. Since the employed pre-
immune serum samples in these experiments yielded a signal that corresponds
to the signal obtained by the primary antibodies respectively the supposed
DNaseX amounts, the negative control does not nearly show a similar result,
and, furthermore samples with only secondary antibody21 do not show any
similar signal, it is most likely that there is no unspecific binding in the pre-
immune serum samples. Hence, this signal must result from a component
only present in these samples, which solely is the pre-immune serum itself.
The utilized pre-immune serum originates from the same animal individuum
as ’DNAX’. In a standard procedure an immunization success is determined
by the ratio of desired antibody in antisera to that of the pre-immune serum.
Possibly, the ’negative’ serum does contain an intrinsic DNaseX antibody in a
concentration, that can almost saturate the DNaseX present in the depicted
cell lines. If so, a measurement with different concentrations of pre-immune
21These samples can be seen in section C.2, figure 4.65 and section C.3.
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a) b) c)
d)
Figure 4.58: Colocalization of DNaseX and nucleus signal in HT-29 central
layer. a ) Central layer of HT-29 cells. Nucleus labeled with Sytox® Green
Nucleic Acid Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin
(grey), DNaseX immunostained with ’DNAX’ primary antibody and Alexa
Fluor®647 labeled secondary antibody (red). b ) Central layer of HT-29
cells as in a ) without membrane visualization. c ) Colocalization image
of b ). Black represents colocalized spots, green represents DNaseX spots
not localized in the nucleus. d ) colocalization graph: 1 represents DNaseX
signals, 2 represents nucleus signals and 3 represents colocalized spots.
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serum would show.
4.2.3 DNaseX occurrence in transfected HEK cells
The generally minor expression of DNaseX in native mammalian cell lines
hampers the research on DNaseX characteristics in a native environment.
Therefore, the simulation of a native environment at a high expression level
can be favorable for research on DNaseX characteristics like its localization
for instance.
There are cell lines that are specially adapted for gene transfections. One
of these is the tumorigenic human embryonic kidney cell line called Flp-In™-
293 or HEK293T [178]. This cell line was labeled with two different primary
antibodies and a blank control as described in section 3.2.6. All samples were
measured on a confocal microscope (see section 3.1.5) in different layers and
projected onto a single one showing the maximum intensity derived for each
coordinate.
In their non-transfected form these cells show only little DNaseX expression
confirmed by a similar DNaseX gene expression level as in lung, urine bladder,
uterus and colon tissue (cf. section 4.2.2) [39]. This expression is depicted
in figure 4.59 a ) with primary antibody ’DNAX’. Primary antibody ’AK148’
yields a lot less secondary antibody signal, while the negative control proves
that there is no unspecific binding of the fluorescent label. These human
embryonic kidney cells have very unique shapes which can be seen due to
the cytoskeleton staining. However, in these cells the habitual concentration
of rhodamine-phalloidin generates a staining efficiency, which is a lot smaller
than in other labeled cells (cf. section 4.2.2).
If the very same cell line is steadily transfected with a DNaseX coding
plasmid, the cells are to constantly express DNaseX. After following the
same labeling and measuring method as described above, highly immuno-
labeled cells are obtained, as can be seen in figure 4.60. As in HT-29 cells
(cf. section 4.2.2) the enzyme is especially located on the cell membrane
here. A very high amount of DNaseX is expressed upon transfection, recog-
nized and bound by primary antibody ’DNAX’ as well as by ’AK148’. The
stronger signal yielded by ’DNAX’ over ’AK148’ yet conceals the likewise
weak cytoskeletal fluorescent label and supports the results presented in sec-
tion 4.2.2.
An overexpression of the DNaseX gene is not necessarily advantageous in
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control
Figure 4.59: Maximum intensity projections of confocally derived z-
stacks of non-transfected HEK293T cells. Nucleus labeled with Sytox®
Green Nucleic Acid Stain (yellow), cytoskeleton labeled with rhodamine-
phalloidin (grey), DNaseX immunostained with Alexa Fluor®647 (red).
Samples equally measured and scaled. a ) and b ) show the effect of
different primary antibodies, while c ) was incubated with primary an-
tibody ’DNAX’ and counterstained, without the secondary labeled an-
tibody. For this experiment no pre-immune serum was available.
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a) primary antibody ’DNAX’ b) primary antibody ’AK148’
c) negative control
Figure 4.60: Maximum intensity projections of confocally derived z-
stacks of steadily transfected HEK293T cells continuously expressing
DNaseX. Nucleus labeled with Sytox® Green Nucleic Acid Stain (yel-
low), cytoskeleton labeled with rhodamine-phalloidin (grey), DNaseX
immunostained with Alexa Fluor®647 (red). Samples equally measured
and scaled. a ) and b ) show the effect of different primary antibodies,
while c ) was incubated with primary antibody ’DNAX’ and counter-
stained, without the secondary labeled antibody. For this experiment
no pre-immune serum was available.
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Ia) IIa)
Ib) IIb)
Figure 4.61: Maximum intensity projections of confocally derived z-
stacks of steadily transfected HEK293T cells expressing DNaseX upon
antibiotic induction. Description see second image part.
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Ic) IIc)
Id) IId)
Figure 4.61: Maximum intensity projections of confocally derived z-
stacks of steadily transfected HEK293T cells expressing DNaseX upon
antibiotic induction. Nucleus labeled with Sytox® Green Nucleic Acid
Stain (yellow), cytoskeleton labeled with rhodamine-phalloidin (grey),
DNaseX immunostained with Alexa Fluor®647 (red). I ) shows cells
induced with tetracycline, II ) with doxicycline induction for 2.5 (a )), 5
(b )), 24 (c )) and 48 hours (d )). Samples equally measured and scaled.
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all cases. When studying membrane assembly for instance, an adjustable
amount of DNaseX is preferable. This can be achieved by a transfection with
a modified DNaseX gene, that is only transcribed upon an antibiotic trigger.
Altering the duration of trigger incubation, therefore, should result in ad-
justed DNaseX amounts. Figure 4.61 shows a set of images of those modified
cells that were equally labeled with ’DNAX’ following the standard protocol
(see section 3.2.6), except for an order of magnitude higher concentration of
cytoskeletal label. Here a wide incubation duration range with two different
antibiotics was applied. Obviously a maximum expression level is already
reached after 24 hours of both tetracycline and doxicycline induction. While
the DNaseX amounts of the two 2.5 hours induction durations appear very
similar to each other, at 5 hours induction duration the doxicycline sample
seems to contain more enzyme than the corresponding tetracycline sample.
Nonetheless, a strong correlation between antibiotic induction duration and
DNaseX is clearly visible for both triggers.
4.2.4 High Resolution Measurements and Quantification of
Membrane-bound DNaseX
The temporal dependency between Doxicycline induction and DNaseX ex-
pression provides an ideal query for superresolution microscopy. DNaseX
inducable HEK293T cells of different Doxicycline induction durations were
stained (see section 3.2.6) and examined on a TIRF setup (see section 3.1.6).
Due to autofluorescent properties of mammalian cells at short wavelengths
(cf. figure 2.21) cells of all labeling degrees could be detected via illumination
with 514 nm. Figure 4.62 a ) shows an autofluorescence picture of HEK293T
cells, with the typical low signal to background ratio and the defocused pro-
file.
Figure 4.62 b ) shows the very same spot with total internal reflection
illumination at 647 nm, focused onto the surface of the cell, yielding a high
signal to background ratio. A small part of this area is chosen (see figure 4.62
c )) to be examined via dSTORM. Whereas c ) shows a blurry picture of the
junction of the two cells the picture that is reconstructed from the dSTORM
movie (d )) reveals distinct spots and the true assembly of the two cells.
For a post-processing of the dSTORM data it has to be taken into account
that only part of the surface is actually covered with membrane. Therefore
an individual 40 x 40 pixels area of each sample and spot is defined for further
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a) Autofluorescence at 514 nm b) TIRF illumination at 647 nm,
512x512 pixels
c) TIRF illumination at 647 nm,
128 x 128 pixels
d) Computed dSTORM picture
Figure 4.62: Set of derived images for the example of one spot of
the 32 h Doxicycline induction sample
evaluation (see figure 4.63).
Some examined spots of different tested doxicycline induction durations are
presented in figure 4.64. Clearly, the number of hits in a defined area increases
with the duration of induction. Counting the number of hits in these areas
for three spots per sample, and plotting this over induction duration, results
in the graph shown in figure 4.65. Also negative controls with only primary
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Figure 4.63: Numerical data processing of the 128 x 128 pixels area
with a one fold binning. The color bar shows the number of hits.
respectively and only secondary antibody, respectively, were measured. The
complete set of images can be found in Appendix C.3.
In the completely immunostained samples a distinct correlation between
doxicycline induction duration and DNaseX expression can be confirmed nu-
merically, although in most cases there is a remarkable strong variation of
hits between the examined spots of one doxicycline induction duration sam-
ple. After 4.11 ± 0.47 hours of induction half of the maximum DNaseX
expression is reached already. The maximum number of counts adds up to
22667.8 ± 2131.9 for an averaged 1600 pixels area of membrane and is almost
reached after 6 hours of doxicycline induction.
The averaged total number of hits at no doxicycline induction amounts to
6585.7 ± 1261.7 , representing 30% of the maximum value. This value is
significantly higher than that of the control sample with only primary anti-
body, which sums up to 452.8 ± 106 at no doxicycline induction, representing
only 7% of the corresponding sample value. The control sample with only
secondary antibody shows 2024.7 ± 519.2 hits at no doxicycline induction,
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a) 0 h b) 2 h
c) 4 h d) 6 h
Figure 4.64: Numerical data processing of 128 x 128 pixels areas with a one
fold binning for different Doxicycline induction durations.
150
4.2 Enzyme Investigations via Immunostaining
e) 10 h f) 24 h
g) 32 h h) calibration bar
Figure 4.64: Numerical data processing of 128 x 128 pixels areas with a
one fold binning for different Doxicycline induction durations. h ) shows the
calibration bar that applies for all graphs.
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Figure 4.65: DNaseX expression over Doxicycline induction duration. Each
Doxicycline induction period was examined with primary and secondary anti-
body (blue), only primary antibody (green) and only secondary antibody (red)
with three spots in each sample (small dots). The big dots represent the mean
values.
representing 31% of the corresponding sample value. This means there is
a constant level of DNaseX in the DNaseX inducable HEK293T cells, which
could be determined by either the expression mechanism or the cell line itself.
When looking at the computed dSTORM pictures of the samples it is obvi-
ous, that the total hits are not homogeneously distributed over the membrane,
but gathered in clusters. Figure 4.66 shows a frequency coded, computed
membrane image of a 24 hours doxicycline induced cell. Most of the easily to
distinguish accumulations show a maximum of hit in the center of the cluster.
Coding the same color bar of this picture differently, results in figure 4.67.
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Figure 4.66: Computed dSTORM image of a HEK 293T cell, Doxi-
cycline induced for 24 h. Clusters are frequency coded. Left: complete
area, right: enlarged area of four clusters.
Here, the computed DNaseX locations are coded for their appearance within
the dSTORM movie, thus temporally.
Figure 4.67: Computed dSTORM image of a HEK 293T cell, Doxicy-
cline induced for 24 h. Clusters are temporally coded. Left: complete
area, right: enlarged area of four clusters.
The homogeneous distribution of calibration bar colors in the familiar clus-
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ters proves the stability of the microscopic setup, the fixed position of the
molecules and therefore the true existence of these clusters. The size of these
clusters ranges from about 100 to 500 nm in this example, while they tend to
be a lot smaller in other samples (cf. Appendix C.3). Bearing the GPI-anchor
and biological relevance of DNaseX in mind, this could be a first evidence for
a DNaseX localization in lipid rafts [230] and their suggested task to hinder
foreign DNA from entering the cell membrane [43,231,232].
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Next to their important tasks in many aspects of every day life and their role
in the functioning of any biological process, enzymes have been associated
with an immense number of severe diseases within the past decades, includ-
ing the most harmful sanitary harassments of HIV infection, stroke, heart
disease and cancer [1–27]. The important, complex and versatile research
field of enzymology, therefore, has keenly been approached with a high num-
ber of investigation techniques. Amongst many conventional methods, the
fluorescence based approach is least invasive to the enzymes. Most common
methods in this field include the rather insensitive Western Blot [157, 233]
and the intensity amplified ELISA [234–236]. These approaches suit well for
the simple detection of an enzyme up to a quantification of different enzyme
concentrations. However, very small amounts of enzyme, that most often
suffice to cause physical and medical reactions in biological systems, cannot
be detected with these approaches. Furthermore, an examination of enzyme
activities, that can be used as information about disease severeness and treat-
ment success, is not feasible. In this work, two promising approaches of fluo-
rescence based enzyme research to these tasks were presented and evaluated
for several members of the enzyme class of hydrolases.
Carboxypeptidase A, acting on peptide bonds, except to those bridging
arginine, proline and hydroxyproline [65], is a pancreatic enzyme, that is
widely known and incorporated in enzyme research [57, 65, 237–242]. Fur-
thermore, Carboxypeptidase A can be used as supplement in specific enzyme
detection systems, taking advantage of its particular amino acid disfavor and
its exopeptidic characteristics [31] (see section 2.4.2.1).
DNaseI and its close relative DNaseX have been widely associated with
diseases like systemic lupus erythematosus and various cancer types [3–24].
For medical analyses it can be crucial, to discriminate these nucleases from
each other. This is not easily possible, because they share a lot of character-
istics [39]. For a detailed differentiation, also DNaseII and S1-Nuclease were
accounted into this study (see section 2.4.2.2).
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The first presented fluorescence based enzyme research approach utilized
special fluorescent substrates, which differ from established colorimetric
substrates [47,161,185–192, amongst others] by their exploitation of intrinsic
electron donating properties of the naturally occurring amino acid tryptophan
and the nucleic acid guanosine (see section 2.2.2) [28–34].
Six different peptide substrates for Carboxypeptidase A research were ex-
amined, which all carry MR121 at the N-terminus. C-terminally, up to three
tryptophans were attached, resulting in different fluorescence intensities. La-
beled monopeptides showed relative fluorescence quantum yields of 1.52 for
MR121 - Phe and 0.01 for MR121 -Trp. Spacing the fluorophore and the
quencher by one amino acid, raised the quantum yield to 0.18 for MR121 -
Gly -Trp and 0.33 for MR121 - Phe -Trp. Additional tryptophans reduced
this yield to 0.17 for MR121 - Phe - (Trp)2 and 0.09 for MR121 -Phe - (Trp)3.
All peptide probes showed an absorption maximum around 664 nm and an
emission maximum around 684 nm. These maxima were slightly red-shifted to
those of free MR121. Additionally, MR121 -Phe - (Trp)3 showed a distinctly
increased absorption around 615 nm. The attachment of amino acids to
MR121 also resulted in differing variations of thermal characteristics. While
MR121 -Trp equaled free MR121 thermal behavior, MR121 - Phe, MR121 -
Gly -Trp and MR121 - Phe -Trp showed decreases in fluorescence intensity
with rising temperatures. MR121 -Phe - (Trp)2 and MR121 - Phe - (Trp)3 ul-
timately showed strong increases in fluorescence intensities (see section 4.1.1).
Once, the peptide substrates were processed by Carboxypeptidase A, the
cleaved tryptophan residues diffused away from the fluorophore, disabling the
quenching mechanism. The fluorescence intensity immediately rose, while it
stayed constant in samples without enzyme. The observed increase in fluo-
rescence intensity mostly correlated directly with the examined relative flu-
orescence quantum yields. MR121 -Trp was processed too slowly to finish
observation within a reliable measurement period. MR121 -Gly -Trp and
MR121 - Phe -Trp procession was overrun by MR121 - Phe - (Trp)3 hydroly-
sis. The fastest signal that could be obtained was achieved by cleavage of
MR121 - Phe - (Trp)2. Kinetic measurements on MR121 - Phe did not show
any remarkable variation in fluorescence intensity. HPLC measurements re-
vealed, though, that MR121 -Phe could indeed be cleaved very slowly by
Carboxypeptidase A. MR121 - Phe -Trp was found to be processed at both
possible cleavage sites in an essentially stepwise manner. MR121 -Gly -Trp,
though, was solely cleaved into MR121 -Gly and free tryptophan. This sub-
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strate, therefore, represents the ideal Carboxypeptidase A peptide probe (see
section 4.1.2).
Thus, MR121 -Gly -Trp was utilized to examine, whether the attached
fluorophore hampers the acceptance by the enzyme and its velocity. The
time constants of Carboxypeptidase A on samples with different ratios of
MR121-labeled and unlabeled Gly -Trp revealed, that the enzyme indeed
favored the unlabeled Gly -Trp (see section 4.1.4).
Reaction kinetics of MR121 -Gly -Trp and Carboxypeptidase A at differ-
ent temperatures displayed the thermal preferences of this peptidase. The
higher the temperature, the faster the substrate was processed. In this gen-
eral course, several local activity maxima were found at 25°C, 40°C and
around 60°C. The high activity at 25°C affirmed the published enzyme pref-
erence [68,210], while an activity maximum at 40°C could be explained by the
bovine pancreatic enzyme source. Since further measurements confirmed the
unexpected local maximum around 60°C, a new optimum reaction tempera-
ture for bovine Carboxypeptidase A on MR121 -Gly -Trp has to be approved
(see section 4.1.5).
A last application of MR121 -Gly -Trp on Carboxypeptidase A qualita-
tively proved the general suitability of fluorescent substrates for enzyme re-
search on a single molecular scale. Enzymes were bound to a BSA-covered
surface and localized by their linker label. As soon as the substrate was added
to the sample, fluorescence signal bursts in correlation to the Carboxypepti-
dase A positions occurred (see section 4.1.6).
For nuclease research, several smart probes were developed. These DNA
hairpins carry Atto 655 fluorophores at the 5’ - end and several guanosine
residues at the 3’ - end of their nucleotide sequence. By examination of the
commercially available substrate ’DNaseAlert’ the general predominance of
the smart probes was shown, since this substrate was processed by all ex-
amined nucleases and can not be modified in its acceptance nor its spectral
range (see section 4.1.2).
The first set of smart probes was dedicated to the research on the effect of
sequence variations, stem-to-loop-ratio differences and changes in the methy-
lation patterns. All examined DNA hairpins showed a 5 nm red-shift in ab-
sorption and emission maxima to free Atto 655. The computationally de-
termined melting temperatures of 59.6°C (SP2ALmM) to 82.9°C (SP1) were
generally found to be lower than the experimentally examined values by sev-
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eral degrees. Relative quantum yields of these substrates varied from 0.14
for the best quenched smart probe, SP2CM, to 0.37 for SP2AL, proving that a
N4-Methyl dC modification in close proximity to Atto 655 has an additional
quenching effect. Furthermore, the ordinary base pairing of methylated bases
with their nucleic acid matches, and a decreased stability of a hairpin with
an adenine loop in contrast to an equivalent loop of only thymines was shown
(see section 4.1.1).
The utilized smart probes were proved to stably fluoresce in absence of
enzyme, while they distinctly rose immediately upon the addition of a nucle-
ase. Small sequence variations, thereby, efficiently changed enzyme velocities,
uniquely for each specific nuclease. While DNaseI, DNaseII and S1-Nuclease
preferred a DNA hairpin with a comparably large loop and small stem (SP4),
DNaseX processed a smart probe with small loop and long stem (SP2) fastest.
The applied modifications on this smart probe revealed a preferation of DNa-
seX for methylation patterns and a disfavor for adenine loops. DNaseI on
the other hand revealed a differentiated reaction to methylations. It was
specifically attracted to a single N4-Methyl dC and completely disregarded
single N6-Methyl-2’-dA modifications. Several methylations in one smart
probe were not favored by this nuclease. For DNaseI research, SP2CM gen-
erates the ideal substrate, while SP2AM represents the optimal candidate for
DNaseX investigations (see section 4.1.2).
Since SP2CM is the most efficiently quenched smart probe utilized in this
work and it is simultaneously greatly processed and accepted by all nucleases,
it was used as a model substrate for the examination of quenching variation
consequences. The substitution of Atto 655 and the additional attachment of
a dark quencher yielded a FRET quenched hairpin (SP2CM-FRET), which
was efficiently quenched and faster processed by every examined nuclease.
This behavior led to the assumption, that Atto 655 is specifically unfavored by
all utilized enzymes. S1-Nuclease kinetics, furthermore, revealed a procession
of the attached fluorophore or a cleavage of the label bond. In general,
SP2CM-FRET could not compete with the according PET probe, because it
offered only little advantages but bore a high number of disadvantages that
FRET samples commonly suffer from (see section 4.1.1 and section 4.1.2).
The second set of utilized smart probes consisted of an assembly of three
substrates, designed to reveal cleavage site preferences in respect to double
and single stranded domains. These smart probes showed long range energy
transfer as detected by their relative quantum yields of 0.26 to 0.95 and their
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thermal fluorescence dependencies (see section 4.1.1). Fluorescence kinetics
upon known double and single stranded scissions displayed the complexity
of nucleolytic processes, because the substrates did not show exactly the ex-
pected fluorescence intensity profile. Therefore, it turned out that this set
of smart probes is not feasible for the determination of an unknown reaction
preference (see section 4.1.2).
Smart probes were shown to be widely applicable in a high number of
various enzyme research tasks. The general feasibility of these substrates
for Michaelis-Menten examinations was presented with SP4, processed by
S1-Nuclease. The evaluation with three different enzyme concentrations re-
vealed, that there are global difficulties at the fluorescence based determina-
tion of Michaelis-Menten constants higher than 2 · 10-6M, (see section 4.1.3).
The exemplary investigation on the effect of the attached fluorophore to
acceptance and kinetics of an enzyme, which could be utilized to circumvent
the problems in the determination of Michaelis-Menten constants, was ac-
complished with DNaseI and SP2. Time constants, that were derived from
enzyme kinetics on samples of various ratios of labeled to unlabeled hairpin,
proved that DNaseI favors unlabeled substrates (see section 4.1.4).
SP2 and its counterpart SP4 served for an evaluation of ideal working
temperatures of DNaseI and DNaseX. Single enzyme kinetics at various tem-
peratures offered maximum substrate conversion at 50°C for DNaseI and at
56°C for DNaseX. A new approach for the investigation of ideal temperatures,
that was presented in this work, covered a wide thermal range in a minimum
of time by utilization of the steady state kinetics only. By this means, the
temperature optimum for DNaseX was approved, while it could be more
closely defined for DNaseI. The introduced steady state method was success-
fully used for the determination of ideal temperature settings with fluorescent
substrates and can also be used for the examination of buffer preferences, ac-
tivator concentrations and inhibition processes (see section 4.1.5).
The suitability of smart probes in complex environments was shown in
living cells with several DNA hairpins. These substrates did not pass cell
membranes themselves, but showed distinct activities on lysed cells. When
attached to a cell-penetrating peptide, SP2CM was capable of entering the
cell, and the uptake was accelerated by pyrenebutyrate and aided by G-Actin,
which inhibits extracellular DNaseI.
In a nutshell, smart probes proved to be a highly versatile, efficient and
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adjustable tool for the research on enzyme activities. The only drawback of
this approach occurs for non-specifically working enzymes in heterogeneous
environments, because there, increases in fluorescence intensity do not nec-
essarily reveal enzyme activities. The general predominance of unlabeled
substrate for Carboxypeptidase A as well as for DNaseI and the preference of
SP2CM-FRET over SP2CM for any nuclease, suggested a broad animosity of
hydrolases against the utilized oxazine derivatives, which can be easily exam-
ined by testing the acceptance of DNA hairpins, carrying other fluorophores
for either FRET or PET quenching.
The presented second approach for fluorescence based enzyme research was
completely focused on DNaseX detection. The immunostaining method
utilized specific primary antibodies, that were bound to intracellular DNa-
seX. The incubation with labeled secondary antibody resulted in the efficient
detection of DNaseX.
In a first examination it was found, that the cell viability at primary anti-
body incubation does not have an effect on labeling efficiency. The secondary
antibody staining worked with live as well as fixed cells, but harmed several
compartments of live cells (see section 4.2). To avoid this problem and to
allow intracellular accumulation of primary and secondary antibody, the fixa-
tion was, furthermore, destined to the very beginning of the labeling protocol.
This optimized labeling strategy was then used for a variety of native cells
(see section 4.2.2). The brain neuroblastoma cell line SK-N-MC was not
found to carry DNaseX. A-549 (lung carcinoma), ECV-304 (urinary bladder
carcinoma) and HeLa (cervix carcinoma) cell lines only showed little signal
correlated to DNaseX presence. Three individual colon cancer cell lines (LS-
174T, SW-837 and HT-29) revealed distinct DNaseX signal.
The largest proportion of detected DNaseX molecules was generally mem-
brane bound, affirming the assumed task to provide a barrier for foreign DNA
to enter the cell [43]. Other localizations of DNaseX were concentrated in the
nucleus, which is astonishing due to its missing nuclear localization signal [41]
and its revealed unspecific DNA degradation. This could therefore indicate
the precise connection between DNaseX occurrence and those diseases with
a disturbed apoptose mechanism. Furthermore, large areas completely filled
with DNaseX and very heterogeneous distributions on the membranes and in
between individual cells were found.
Specially transfected human embryonic kidney cell lines were shown to
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carry a DNaseX level that correlates with the expression trigger induction
duration (see section 4.2.3). This connection was further evaluated with the
high resolved dSTORM method (see section 4.2.4). Here, an intrinsic enzyme
level was revealed for the transfected HEK cells. Furthermore, the examined
enzyme was disclosed to form clusters with a diameter up to 500 nm on the
membrane, that built a first hint for DNaseX localization in lipid rafts [232].
Enzyme research based on immunostaining was shown to constitute an effi-
cient labeling strategy for DNaseX, which can be applied on any immobilized
enzyme and investigated by a variety of different microscopy methods, e.g.
high resolution techniques. The latter application will be of highest impact
to microscopic as well as enzymatic research, because cellular structures like
lipid rafts are too small to be observed with a standard microscope. With a
counterstaining of cholesterol [232], colocalizations of DNaseX and lipid rafts
could be easily revealed. Furthermore, localization patterns of DNaseX on
native cell lines can be highly resolved and examined for colocalizations.
Due to their nature, the two presented fluorescent approaches for enzyme
research highly differ in their preparation, suitability and obtainable results.
While an active enzyme is crucial for the utilization of fluorescent substrates,
no activity can be visualized by immunostaining. On the other hand, an
enzyme localization, which is easily possibly with labeled detection antibod-
ies, is not feasible with fluorescent substrates in heterogeneous environments.
Therefore, these approaches perfectly complement each other.
An ideal, universal solution would combine these two features into a single
method without their intrinsic disadvantages. This, indeed, can be achieved
by the incorporation of streptavidin coated, magnetic beads. These can effi-
ciently bind biotinylated, specific antibody. The enzymatic antigen can then
be captured in heterogeneous samples like blood or cell lysis. In a washing
step, the magnetic properties of the bead can be used to efficiently remove
unbound capture antibodies and enzyme. Now, a labeled and specific detec-
tion antibody can be added to the sample, which allows the quantification of
the protein of interest in a specific volume [243–245]. Instead of a detection
antibody addition, also fluorescent substrates can be added to the sample.
These are then processed if the enzyme is still active when bound to the
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antibody1. Consequently, the concentration as well as the specific activity
of the enzyme in question, ’fished’ out of a heterogeneous sample, can be
easily monitored on a standard widefield fluorescence microscope, yet even a
fluorescence microplate reader.
a) Enzyme quantification with detec-
tion antibodies
b) Enzyme activity analysis with flu-
orescent substrates
Figure 5.1: Schematic structure of bead based enzyme research. Specific
enzyme antibodies are captured onto a bead due to the strong Biotin-
Streptavidin affinity. After the antibody-antigen coupling, either labeled
detection antibody (a)) is added for a sensitive enzyme quantification or
fluorescent substrates (b)) are added for the investigation on enzyme activ-
ities.
1This activity has indeed been examined for antibody bound DNaseX.
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B.1 Protocol for Preparation of Mowiol-DABCO
This recipe is deduced from a protocol published by Michael Mastrangelo and
Eric Yehling from University of Rochester - Medical Center. They declare
that Mowiol goes into solution with difficulty and therefore it would be best
to make a large batch and freeze aliquots at -20°Celsius.
Prepare in clean 250 ml flask or beaker:
1. 24 g analytical grade glycerol
2. 9.6 g Mowiol 4-88
3. 24ml distilled water
4. 48ml 0.2M Tris buffer, pH 8.5
5. Gently shake in 37°Celsius incubator for 4-5 hours until the majority
of the Mowiol powder has gone into solution.
6. Aliquot into 50 ml centrifuge tubes, weigh and balance.
7. Centrifuge at 5000 g for 15min., carefully remove the supernatant.
8. Aliquot into 0.8ml conical tubes and freeze until use.
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B.2 Original Labeling Protocol
Specimen Preparation Using Synthetic Fluorophores and
Immunofluorescence
This labeling protocol is described as [229] in bibliography and only copied
to this document due to possible alterations on the corresponding webpage.
Staining Adherent Cells with Intermediate Filament Primary Antibodies
and Synthetic Fluorophores
A majority of the common fibroblast and epithelial cell lines derived from
humans and laboratory animals produce brightly colored fluorescent speci-
mens highlighting specific proteins in the intermediate filament network (such
as vimentin and desmin) when stained with a cocktail that includes anti-
intermediate filament antibodies conjugated to common low molecular weight
synthetic fluorescent probes. Among the most useful fluorescent markers for
visualization of intermediate filaments (as well as actin) are rhodamine, flu-
orescein, the Alexa Fluor series, and the cyanine dyes. Counterstaining for
nuclei using a variety of popular DNA-binding dyes follows treatment with
the antibodies and filamentous actin probes. This protocol details a general-
ized procedure for staining adherent cells.
Presented in Figure 1 [229] is a widefield fluorescence image revealing the
vimentin intermediate filament and filamentous actin networks present in
adherent mink uterus endometrium epithelial cells (GMMe line). The cells
were immunofluorescently labeled with mouse anti-vimentin primary anti-
bodies followed by goat anti-mouse secondary antibodies conjugated to Texas
Red-X. In addition, the specimen was counterstained with phalloidin conju-
gated to Alexa Fluor 488 and DAPI, targeting the actin network and nuclei,
respectively. Images were recorded in grayscale with a QImaging Retiga
Fast-EXi camera system coupled to an Olympus BX-51 microscope equipped
with bandpass emission fluorescence filter optical blocks provided by Omega
Optical. During the processing stage, individual image channels were pseu-
docolored with RGB values corresponding to each of the fluorophore emission
spectral profiles.
A wide variety of primary antibodies targeting other antigens can be em-
ployed in combination with anti-intermediate filament antibodies. In addi-
tion, synthetic fluorophores, such as the MitoTrackers, can also be used as
counterstains. Because the mixed aldehyde and detergent fixative described
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below can obscure some antigen markers, primary antibodies to other targets
should first be tested alone before mixing into cocktails with intermediate
filament antibodies.
Reagents
• Cytoskeletal Buffer (CB) - Suspend 18.14 grams of the biological
buffer PIPES (free base; 60 millimolar) in one liter of double-distilled
water. Add 6.50 grams of HEPES buffer (27 millimolar), 3.80 grams of
EGTA (10 millimolar), and 0.99 grams of magnesium sulfate (heptahy-
drate; 4 millimolar). Stir and adjust the pH to 7.0 with concentrated
sodium hydroxide. The PIPES buffer crystals will not completely dis-
solve until the buffer pH nears neutrality, but should then form a clear
solution.
• Phosphate Buffered Saline (PBS) with Calcium and Magne-
sium - Dissolve 0.2 grams of potassium chloride, 0.2 grams of monobasic
potassium phosphate, 8.0 grams of sodium chloride, and 1.74 grams of
dibasic sodium phosphate (heptahydrate) in one liter of double-distilled
water. After dissolving these reagents, add 0.132 grams of calcium
chloride dihydrate and 0.10 grams of magnesium chloride hexahydrate.
Adjust the pH to 7.2 with concentrated sodium hydroxide. Addition
of the divalent alkaline earth metals to the buffer solution is helpful
to ensure that uncondensed chromatin remains intact and contained
within the nucleus during the staining procedure, dramatically decreas-
ing background fluorescence levels when using DNA probes excited by
ultraviolet irradiation (DAPI and Hoechst). This buffer should be used
with cryosections.
• Mixed Aldehyde and Detergent Fixative - Dissolve 3 grams of
electron microscope grade paraformaldehyde powder in 100 milliliters
of CB with heating, and then filter when the solution appears clear.
After cooling and filtering, add 1.5 milliliters of 20-percent Triton X-100
(made in CB) and 100 microliters of 50-percent glutaraldehyde. The
final concentration of reagents should be 3 percent paraformaldehyde,
0.3 percent Triton X-100, and 0.05 percent glutaraldehyde. Mix the
resulting solution well before use. This reagent should be made fresh
daily.
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• Blocking Buffer - 10 percent normal goat serum (NGS) in PBS con-
taining 0.05 percent Triton X-100 (add 2-3 milligrams sodium azide per
100 milliliters of blocking buffer to eliminate the growth of microorgan-
isms). If secondary antibodies to a host other than goat are being used,
prepare the Blocking Buffer with normal serum from that species.
• PBS-Triton Wash Buffer - For wash sequences immediately before
blocking and once again before staining with nuclear dyes, use PBS
containing 0.05 percent Triton X-100.
• PBS-Triton Wash Buffer with Blocking Serum - For wash se-
quences between the primary and secondary antibody incubations and
immediately after the secondary antibody treatment, use PBS contain-
ing 0.05 percent Triton X-100 and 1 percent normal host (goat) serum.
• Primary Antibody Cocktail - Add the appropriate volume of con-
centrated primary antibody (for example, anti-vimentin) stock solution
to Blocking Buffer diluted 50-percent with PBS-Triton Wash Buffer
(to yield a final concentration 5-percent normal goat serum). Several
primary antibodies from different hosts can be mixed into a cocktail.
Adherent cells on coverslips should be treated with 100 microliters of
primary antibody cocktail.
• Secondary Antibody/Phalloidin Cocktail - Add the appropriate
volume of secondary antibody conjugated to the selected fluorophore
(for example, 8 microliters of goat anti-mouse heavy and light chain
secondary IgG with Alexa Fluor 350 at 2 milligrams per milliliter) to 1
milliliter of Blocking Buffer diluted 50-percent with PBS-Triton Wash
Buffer (to yield a final concentration 5-percent normal goat or other
host serum). If the cells are to be simultaneously counterstained with
phalloidin, add 20-40 microliters of concentrated stock solution (6.6
micromolar) to 1 milliliter of the Blocking Buffer. As with the primary
antibody mixture, adherent cells on coverslips should be treated with
100 microliters of primary antibody cocktail.
• Nuclear Dye - Prepare fresh dilutions of the nuclear dye immediately
prior to staining. When using SYTOX, DRAQ5, and the cyanine nu-
clear stains, background fluorescence can be significantly reduced (es-
pecially in the cytoplasm) by adding 10 milligrams of RNase to the
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Blocking Buffer. In this case, block the cells or tissues at 37 degrees
Celsius, rather than at room temperature, in order to activate the en-
zyme.
• Nuclear Dye Wash Buffer - Hoechst and SYTOX dyes require Hanks
Balanced Salt Solution (Hanks BSS), while DAPI, as well as the
monomeric and dimeric cyanine nuclear stains, can be used with PBS.
Nuclear Counterstain Dilutions
• Hoechst (33342 and 33258) - Dilute 5 microliters of 10 milligram/
milliliter stock solution in 150 milliliters of Hanks BSS (treat for 30
minutes).
• SYTOX Green and Orange - Dilute 10 microliters of concentrated
stock solution (5 millimolar in dimethyl sulfoxide) in 250 milliliters of
Hanks BSS (treat for 30 minutes).
• DAPI - Dilute 5 microliters of 10 milligram/milliliter stock solution
in 150 milliliters of PBS diluted 50-percent with double-distilled water
(treat for 5 minutes).
• Monomeric and Dimeric Cyanine Dyes - Dilute the concentrated
stock solution (for example, TO-PRO-3; usually 1 millimolar) as rec-
ommended by the manufacturer (1:20 to 1:1000) into PBS (treat for 5
to 30 minutes).
• DRAQ5 - Dilute the concentrated stock solution (usually 1 millimolar)
as recommended by the manufacturer (1:20 to 1:1000) into PBS (treat
for 5 to 30 minutes).
Procedure
Aspirate the growth medium from a Petri dish containing healthy cells ad-
hered to coverslips and replace with pre-warmed (37 degrees Celsius) CB
buffer to remove medium and serum proteins (use 3 milliliters of buffer for
60-millimeter Petri dishes). Wash the cells twice for 5 minutes (each wash)
with the pre-warmed CB buffer, and incubate the cells at 37 degrees Celsius
during the wash cycles. Each Petri dish should be individually marked with
the primary antibodies and other stains used for the coverslips in that dish.
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Coverslips should remain with the original Petri dish for each step in the
entire procedure.
Fix the cells by adding the appropriate volume of pre-warmed (37 degrees
Celsius) mixed aldehyde fixer to each Petri dish and rapidly transfer the
dishes to the incubator. Fix for 10 minutes.
Remove the Petri dishes from the incubator and wash once with CB buffer
for 5 minutes and twice with PBS-Triton Wash Buffer (5 minutes each wash)
before blocking.
Remove the PBS-Triton Wash Buffer and block nonspecific secondary anti-
body binding sites with 10-percent normal host serum Blocking Buffer. Treat
the adherent cells for 60 minutes at room temperature with the Blocking
Buffer and slowly rotate the Petri dishes as the cells are being blocked on an
orbital shaker at 5-10 revolutions per minute. Coverslip Staining Support
During the blocking step, prepare antibody treatment supports by covering
2 x 3-inch microscope slides with Parafilm, as illustrated in Figure 2. Secure
the Parafilm so that it adheres tightly and is smoothly distributed along the
glass surface (no blisters). After blocking, carefully remove the coverslips
from the Petri dishes and place them cell-side down on a 100 microliter drop
of diluted primary antibody cocktail in 50-percent blocking buffer deposited
on a Parafilm-covered slide. Between 3 and 6 coverslips (depending on size)
can be placed on a single slide. Next, place the slides in a humidity chamber
(see Figure 3) and incubate the coverslips in the humidity chamber for 1.5
hours at 37 degrees Celsius. If the primary antibodies are not conjugated to
fluorophores, it is not necessary to protect the coverslips from light at this
point.
After primary antibody treatment, return the coverslips to the original
Petri dishes and wash three times at room temperature (5 to 10 minutes for
each wash) with PBS-Triton Wash Buffer with Blocking Serum to remove
unbound primary antibodies. Slowly rotate the Petri dishes as the cells are
being washed on an orbital shaker at 5-10 revolutions per minute.
After washing, carefully remove the coverslips from the Petri dishes and
place them cell-side down on a 100 microliter drop of diluted secondary anti-
body cocktail in 50-percent blocking buffer deposited on a Parafilm-covered
slide. Once again, place the slides in a humidity chamber (see Figure 3) and
incubate the coverslips in the humidity chamber for 1 hour at 37 degrees
Celsius if smaller secondary antibody fragments are being used, or 1.5 hours
for entire antibody molecules. It is important to cover the humidity chamber
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with aluminum foil during this step to protect the fluorophores from light.
Humidity Chamber Configuration
After secondary antibody treatment, return the coverslips to the original
Petri dishes and wash three times at room temperature (5 to 10 minutes for
each wash) with PBS-Triton Wash Buffer with Blocking Serum to remove
unbound secondary antibodies. Slowly rotate the Petri dishes as the cells are
being washed on an orbital shaker at 5-10 revolutions per minute.
In preparation for nuclear staining, wash the cells twice with PBS-Triton
Wash Buffer for 5 minutes (each wash). Slowly rotate the Petri dishes as the
cells are being washed on an orbital shaker at 5-10 revolutions per minute.
For DAPI and cyanine nuclear counterstains, add the diluted dye in PBS
(dilute PBS to 50 percent with double-distilled water for DAPI) to the Petri
dish and treat the coverslips for the recommended time: 5-10 minutes for
DAPI; 15-30 minutes for cyanine dyes (protect from light with aluminum
foil). When using Hoechst or SYTOX stains (30 minute incubation), first
wash the slides in Hanks Balanced Salt Solution for two buffer exchanges
prior to counterstaining.
Wash the counterstained coverslips with either PBS or Hanks Balanced
Salt Solution (depending upon the nuclear dye) for three times at 5 minutes
for each wash. Protect from light with aluminum foil.
In order to remove excess salt, wash the cells three times for 2 to 3 minutes
(each wash) in distilled water. Note that this step is only necessary if the
coverslips are to be air-dried overnight before mounting.
After the final distilled water washing step, carefully remove the coverslips
from the Petri dish with tweezers and wipe excess water from the back and
edges. Lean the coverslips on their sides against the labeled Petri dish cover
and allow them to dry overnight. Protect the drying coverslips from light
with an aluminum baking tray. After drying, mount the coverslips (cell-side
down) on clean microscope slides using the appropriate mounting medium.
Contributing Authors:
Nathan S. Claxton, Gregory K. Ottenberg, Scott G. Olenych, John D.
Griffin, and Michael W. Davidson - National High Magnetic Field Laboratory,
1800 East Paul Dirac Dr., The Florida State University, Tallahassee, Florida, 32310.
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http://www.olympusfluoview.com/applications/protocols/
cellsintermediatefilaments.html - Sep 30th 2009
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B.3 Protocol for Examination of labeling Procedure
These labeling procedures evolved from the standard protocol (see page 206)
and were used to examine the labeling success in respect to the cell fixation.
Cells were cultivated in cells were grown in Lab-Tek II chambered coverglasses
for at least 24 hours in custom culture conditions before the experiment
started.
Due to its toxicity no labeled phalloidin was used. Sytox® Green Nucleic
Acid Stain was incubated only after fixation. Procedures were temporally
adjusted so that Sytox® Green Nucleic Acid Stain incubation took place si-
multaneously in every sample.
Fixation before Incubation with primary Antibody
1. Fixation
• Take cells out of incubator.
• Add 50µl Paraformaldehyde (20%) to 200µl medium (to yield a
final concentration of 4%).
• Incubate for 5 min.
2. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
3. Preparation with Blocking Buffer
• Add 100µl blocking buffer (Normal Goat Serum 66% in PBS to a
final concentration of 5%).
• Incubate at 37°C for 60min.
4. Incubation with primary Antibody
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• Add primary antibody respectively negative control protein dis-
solved in 100µl blocking buffer to yield a final amount of 1.5 x 10-12
mol/chamber.
• Incubate at 37°C for 90 min.
5. Washing
• Add washing buffer (PBS with 0.05% TritonX-100 and 1% NGS)
to each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
• Repeat twice.
• Remove solution completely.
6. Incubation with secondary Antibody
• Add Alexa Fluor® 647 goat anti-rabbit IgG dissolved in 100µl
blocking buffer with a final amount of 3.5 x 10-12 mol/chamber.
• Cover cells with aluminium foil to prevent from bleaching.
• Incubate at 37°C for 90 min.
7. Washing
• Add PBS Triton wash buffer (PBS with 0.05% TritonX-100) to
each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
• Repeat twice.
8. Preparation for Nuclear Staining
• Add PBS Triton wash buffer while simultaneously removing solu-
tion.
• Incubate for 5 min.
• Repeat once.
9. Nuclear Staining with Sytox® Green Nucleic Acid Stain
• Add Hanks’ Balanced Salt Solution while simultaneously removing
solution.
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• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
• Add Sytox® Green Nucleic Acid Stain in HBSS to yield a final
amount of 2.5 x 10-12 mol/chamber.
• Incubate for 30 min.
10. Washing
• Add HBSS while simultaneously removing solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
11. Sealing
• Add 200µl Mowiol/DABCO to each chamber.
• Let dry over night at 4°C.
Fixation between Incubation with primary and secondary Antibody
1. Washing
• Remove old medium.
• Add fresh medium to each chamber.
• Incubate at 37°C, 5% CO2 for 15 min.
• Remove medium.
2. Preparation with Blocking Buffer
• Add 100µl blocking medium (Normal Goat Serum 66% in fresh
medium to a final concentration of 5%).
• Incubate at 37°C, 5% CO2 for 60min.
3. Incubation with primary Antibody
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• Add primary antibody respectively negative control protein dis-
solved in 100µl fresh medium to yield a final amount of 1.5 x 10-12
mol/chamber.
• Incubate at 37°C, 5% CO2 for 90 min.
4. Fixation
• Take cells out of incubator.
• Add 50µl Paraformaldehyde (20%) to 200µl medium (to yield a
final concentration of 4%).
• Incubate for 5 min.
5. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
6. Incubation with secondary Antibody
• Add Alexa Fluor® 647 goat anti-rabbit IgG dissolved in 100µl
blocking buffer with a final amount of 3.5 x 10-12 mol/chamber.
• Cover cells with aluminium foil to prevent from bleaching.
• Incubate at 37°C for 90 min.
7. Washing
• Add PBS Triton wash buffer (PBS with 0.05% TritonX-100) to
each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
• Repeat twice.
8. Preparation for Nuclear Staining
• Add PBS Triton wash buffer while simultaneously removing solu-
tion.
• Incubate for 5 min.
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• Repeat once.
9. Nuclear Staining with Sytox® Green Nucleic Acid Stain
• Add Hanks’ Balanced Salt Solution while simultaneously removing
solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
• Add Sytox® Green Nucleic Acid Stain in HBSS to yield a final
amount of 2.5 x 10-12 mol/chamber.
• Incubate for 30 min.
10. Washing
• Add HBSS while simultaneously removing solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
11. Sealing
• Add 200µl Mowiol/DABCO to each chamber.
• Let dry over night at 4°C.
Fixation after Incubation with secondary Antibody
1. Washing
• Remove old medium.
• Add fresh medium to each chamber.
• Incubate at 37°C, 5% CO2 for 15 min.
• Remove medium.
2. Preparation with Blocking Buffer
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• Add 100µl blocking medium (Normal Goat Serum 66% in fresh
medium to a final concentration of 5%).
• Incubate at 37°C, 5% CO2 for 60min.
3. Incubation with primary Antibody
• Add primary antibody respectively negative control protein dis-
solved in 100µl fresh medium to yield a final amount of 1.5 x 10-12
mol/chamber.
• Incubate at 37°C, 5% CO2 for 90 min.
4. Washing
• Add fresh medium to each chamber while simultaneously removing
solution.
• Incubate at 37°C, 5% CO2 for 15 min.
• Repeat twice.
• Remove medium.
5. Incubation with secondary Antibody
• Add Alexa Fluor® 647 goat anti-rabbit IgG dissolved in 100µl fresh
medium with a final amount of 3.5 x 10-12 mol/chamber.
• Cover cells with aluminium foil to prevent from bleaching.
• Incubate at 37°C for 90 min.
6. Fixation
• Take cells out of incubator.
• Add 50µl Paraformaldehyde (20%) to 200µl medium (to yield a
final concentration of 4%).
• Incubate for 5 min.
7. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
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8. Preparation for Nuclear Staining
• Add PBS Triton wash buffer while simultaneously removing solu-
tion.
• Incubate for 5 min.
• Repeat once.
9. Nuclear Staining with Sytox® Green Nucleic Acid Stain
• Add Hanks’ Balanced Salt Solution while simultaneously removing
solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
• Add Sytox® Green Nucleic Acid Stain in HBSS to yield a final
amount of 2.5 x 10-12 mol/chamber.
• Incubate for 30 min.
10. Washing
• Add HBSS while simultaneously removing solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
11. Sealing
• Add 200µl Mowiol/DABCO to each chamber.
• Let dry over night at 4°C.
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B.4 Standard labeling Protocol for triple stained
mammalian Cells
This labeling procedure has been optimized for the employed antibodies,
counterstaining chemicals and cell types (see section 3.2). Each cell type
was cultivated in Lab-Tek II chambered coverglasses for at least 24 hours in
custom culture conditions. The complete procedure lasts approximately 8
hours.
1. Fixation
• Take cells out of incubator.
• Add 50µl Paraformaldehyde (20%) to 200µl medium (to yield a
final concentration of 4%).
• Incubate for 10 min. In case of HEK 293T cells only incubate for
5 min.
2. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
3. Permeabilisation
• Add 200µl TritonX-100 0,5% (v/v) in PBS.
• Incubate for 10 min.
4. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
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5. Preparation with Blocking Buffer
• Add PBS Triton wash buffer (PBS with 0.05% TritonX-100).
• Incubate for 5 min.
• Remove solution completely.
• Add 100µl blocking buffer (Normal Goat Serum 66% in PBS to a
final concentration of 5% containing 10mg RNase (reduces back-
ground fluorescence of Sytox® Green Nucleic Acid Stain)).
• Incubate at 37°C for 60min to activate the enzyme.
6. Incubation with primary Antibody
• Add primary antibody respectively negative control protein dis-
solved in 100µl blocking buffer to yield a final amount of 1.5 x 10-12
mol/chamber.
• Incubate for at 37°C 90 min.
7. Washing
• Add washing buffer (PBS with 0.05% TritonX-100 and 1% NGS)
to each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
• Repeat twice.
• Remove solution completely.
8. Incubation with secondary Antibody and labeled Phalloidin
• Add secondary antibody cocktail (Alexa Fluor® 647 goat anti-
rabbit IgG with a final amount of 3.5 x 10-12 mol/chamber and
rhodamine phalloidin with a final amount of 1 x 10-7 mol/chamber
dissolved in 100µl blocking buffer).in
• Cover cells with aluminium foil to prevent from bleaching.
• Incubate for at 37°C 90 min.
9. Washing
• Add washing buffer (PBS with 0.05% TritonX-100 and 1% NGS)
to each chamber while simultaneously removing solution.
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• Incubate with washing buffer for 5 min.
• Repeat twice.
10. Preparation for Nuclear Staining
• Add PBS Triton wash buffer while simultaneously removing solu-
tion.
• Incubate for 5 min.
• Repeat once.
11. Nuclear Staining with Sytox® Green Nucleic Acid Stain
• Add Hanks’ Balanced Salt Solution while simultaneously removing
solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
• Add Sytox® Green Nucleic Acid Stain in HBSS to yield a final
amount of 2.5 x 10-12 mol/chamber.
• Incubate for 20 min.
12. Washing
• Add HBSS while simultaneously removing solution.
• Incubate for 5 min.
• Repeat once.
• Remove solution completely.
13. Sealing
• Add 200µl Mowiol/DABCO to each chamber.
• Let dry over night at 4°C.
Samples can also be imaged in PBS yielding lower fluorescence intensities.
Sealed samples can be examined after months, not showing distinct changes
in fluorescence intensities if stored in the dark at 4°C.
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B.5 Labeling Protocol for dSTORM Measurement
This labeling procedure is similar to the standard protocol (see page 206).
Cells were cultivated in Lab-Tek II chambered coverglasses in custom culture
conditions. Doxicycline induction took place at different points of time to
achieve various induction durations but almost equal culture durations of
every sample. In total cells were cultivated for 50 hours of which 32, 24, 10,
6, 4, 2 or 0 hours were Doxicycline induced.
Due to the nature of these experiments neither labeled phalloidin nor
Sytox® Green Nucleic Acid Stain was used. Primary and secondary Anti-
body concentrations were raised to a five-fold of the standard protocol to
secure the saturation of DNaseX molecules.
1. Fixation
• Take cells out of incubator.
• Add 50µl Paraformaldehyde (20%) to 200µl medium (to yield a
final concentration of 4%).
• Incubate for 5 min.
2. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
3. Permeabilisation
• Add 200µl TritonX-100 0,5% (v/v) in PBS.
• Incubate for 10 min.
4. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
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• Repeat twice.
• Remove solution completely.
5. Preparation with Blocking Buffer
• Add PBS Triton wash buffer (PBS with 0.05% TritonX-100).
• Incubate for 5 min.
• Remove solution completely.
• Add 100µl blocking buffer (Normal Goat Serum 66% in PBS to a
final concentration of 5%).
• Incubate at room temperature for 60min.
6. Incubation with primary Antibody
• Add DNAX primary antibody dissolved in 100µl blocking buffer
to yield a final amount of 6.5 x 10-12 mol/chamber.
• Incubate at room temperature for 90 min.
7. Washing
• Add washing buffer (PBS with 0.05% TritonX-100 and 1% NGS)
to each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
• Repeat twice.
• Remove solution completely.
8. Incubation with secondary Antibody
• Add Alexa Fluor® 647 goat anti-rabbit IgG dissolved in 100µl
blocking buffer with a final amount of 1.65 x 10-11 mol/chamber.
• Cover cells with aluminium foil to prevent from bleaching.
• Incubate at room temperature for 90 min.
9. Washing
• Add washing buffer (PBS with 0.05% TritonX-100 and 1% NGS)
to each chamber while simultaneously removing solution.
• Incubate with washing buffer for 5 min.
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• Repeat twice.
10. Washing
• Add PBS to each chamber while simultaneously removing solution.
• Incubate with PBS for 5 min.
• Repeat twice.
• Remove solution completely.
• Add 200µl PBS.
11. Measurement Preparation
• Remove PBS.
• Add switching buffer: PBS pH7.4 containing oxygen scavenger
(0.5mg/mL glucose oxidase, 40µg/mL catalase, 10% w/v glucose)
and 50mm β -mercaptoethylamine (MEA).
• Seal to prevent from oxygen.
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C.1 Mowiol®-DABCO Effect on Fluorescent Labels
In this measurement cells were characteristically stained and measured on a
confocal mircroscop in different layers. These layers were then projected onto
a single layer, showing the maximum intensity derived for each coordinate.
As a first step the cells were embedded in PBS and measured. The same
samples were then covered with Mowiol®-DABCO and stored overnight at
4°Celsius for the mounting medium to dry. 24 hours later the samples were
equally measured and presented.
A distinct increase in fluorescence intensities is obtained for the antibody
label Alexa Fluor®647 as well as for Sytox® Green Nucleic Acid Stain, while
the autofluorescence seems to decrease upon Mowiol®-DABCO embedding.
Therefore it is assumed that Mowiol®-DABCO generally has a positive effect
on fluorescence yield over the complete range of applied fluorophores in this
work.
a) PBS b) Mowiol®-DABCO
Mounting medium effect on Alexa Fluor®647 in A-549 cells.
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Ia) Autofluorescence in PBS Ib) Autofluorescence in Mowiol®-
DABCO
IIa) Sytox® Green in PBS IIb) Sytox® Green in Mowiol®-
DABCO
Mounting medium effect on Sytox® Green Nucleic Acid Stain (1:80000) in
Cos7 (African Green Kidney) cells.
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C.2 Examination of labeling Procedure - Complete Set
of Images
Ia) IIa) IIIa)
Ib) IIb) IIIb)
Examination of different labeling procedures. Cell fixation before incubation
with primary antibody (I), between incubation with primary and secondary
antibody (II) and after incubation with secondary antibody (III). a ) la-
beled with primary and Alexa Fluor® 647 linked secondary antibody (red),
b ) labeled with Alexa Fluor® 647 linked secondary antibody (red) but no
primary antibody, c ) labeled with pre-immune serum and Alexa Fluor® 647
linked secondary antibody (red), d ) labeled with primary antibody but no
Alexa Fluor® 647 linked secondary antibody. All samples counterstained
with Sytox® Green Nucleic Acid Stain (yellow) after fixation. Cells confo-
cally scanned in several layers and projected onto one plane.
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Id) IId) IIId)
Ie) IIe) IIIe)
Examination of different labeling procedures. Cell fixation before incubation
with primary antibody (I), between incubation with primary and secondary
antibody (II) and after incubation with secondary antibody (III). a ) la-
beled with primary and Alexa Fluor® 647 linked secondary antibody (red),
b ) labeled with Alexa Fluor® 647 linked secondary antibody (red) but no
primary antibody, c ) labeled with pre-immune serum and Alexa Fluor® 647
linked secondary antibody (red), d ) labeled with primary antibody but no
Alexa Fluor® 647 linked secondary antibody. All samples counterstained
with Sytox® Green Nucleic Acid Stain (yellow) after fixation. Cells confo-
cally scanned in several layers and projected onto one plane.
216
C.3 Complete Set of Images from dSTORM Measurement
C.3 Complete Set of Images from dSTORM
Measurement
As additional information here there are all samples that were taken into
account for the numerical evaluation (see section 4.2.4). First all samples with
primary and secondary antibody and then the controls with only primary
respectively only secondary antibody are shown. For each sample there are
three individual cells (I, II, III), each shown at autofluorescence at 514 nm
on 512x512 pixels (a), total internal reflection at 647 nm on 512x512 pixels
(b), total internal reflection at 647 nm on 128x128 pixels (c), intensity scaled
hits of the same area shown in c) by dSTORM software (d) and processed
dSTORM data showing the 40x40 pixels area used for counting the number
of hits (e). a) - c) are scaled individually, d) - e) are equally processed and
scaled.
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 0 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 2 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 4 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 6 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 10 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 24 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
sample: 32 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 0 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 2 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 4 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 6 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 10 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 24 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only primary antibody: 32 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 0 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 2 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 4 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 6 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 10 hours of doxicycline induction
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Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 24 hours of doxicycline induction
Ia) Ib) Ic) Id) Ie)
IIa) IIb) IIc) IId) IIe)
IIIa) IIIb) IIIc) IIId) IIIe)
control with only secondary antibody: 32 hours of doxicycline induction
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